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endonuclease sites, (b) Plasmid constructs containing each o f the truncated 
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ABSTRACT
Herpes simplex virus type 1 (HSV-1) specifies at least 11 glycoproteins that 
are expressed in infected cells and in virions. HSV-1 enters into cells via fusion o f 
the viral envelope with cellular membranes and can spread to adjacent cells via 
fusion o f cellular membranes. Glycoproteins gB, gD, gH, and gL are known to be 
essential for virus entry, virus spread, and virus induced cell-to-cell fusion. The 
majority o f spontaneous single amino acid changes that cause extensive cell fusion 
map within the Ul53 gene encoding glycoprotein K (gK); however, the role o f gK 
in virus entry and virus egress had not been defined. Specific antibodies against 
portions o f gK expressed in E. coli were raised in mice and detected gK as a 40-kDa 
protein in purified virions. To investigate the effect o f gK in virus entry via the 
known HSV-1 HveAh and HveCh receptors, two recombinant viruses were 
constructed, KOS/EGFP (wild-type) and AgK/EGFP (gK null) expressing the 
enhanced green fluorescent protein (EGFP) constitutively. The simian homolog o f 
HveA (HveAs) was cloned, sequenced, and CHO/HveAs transformed cell-lines 
were isolated. The AgK/EGFP virus failed to enter into CHO/HveAs, while 
AgK/EGFP prepared in complementing Vero (VK302) cells entered efficiently. In 
contrast, AgK/EGFP entered efficiently into CHO/HveAh and CHO/HveCh cells.
A series o f hybrid receptors were made expressing different portions o f HveAh and 
HveAs and were used to map a short region o f HveAh that conferred receptor- 
mediated entry to an HveAs receptor background. The role o f gK in virion 
morphogenesis and egress was addressed by constructing a panel o f recombinant 
viruses expressing gK carboxyl-terminal truncations and single amino acid
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substitutions. Two cellular vesicular transport m otifs, a  cysteine-rich m otif and a 
tyrosine-based m otif were found to be essential for infectious virus production, 
intracellular virion transport, and virus egress. Therefore, gK may interact with 
vesicular transport pathways during virion morphogenesis and egress. The overall 
results from this research suggest that HSV-1 gK is a multifunctional protein 
involved in receptor utilization during virus entry and transport o f virion particles to 
extracellular spaces through cellular vesicular transport pathways during virus 
egress.
xxi
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CHAPTER I
INTRODUCTION
STATEMENT OF RESEARCH PROBLEM AND HYPOTHESIS
Herpes Simplex Virus type I (HSV-1) is  a neurotropic and neurovirulent 
virus that is a causative agent o f cold sores, genital lesions, comeal blindness, and 
viral encephalitis (Whitley et al, 1997). Although herpes viruses have been an area 
o f intense study, some of the basic mechanisms involved in pathogenesis remain 
unsolved. There is not a clear understanding o f  virus attachment, entry, intracellular 
virion transport, envelopment or egress.
HSV-1 specifies at least 11 glycoproteins: gB, gC, gD, gE, gG, gH, gl, gJ, 
gK, gL, and gM, which are expressed during productive virus replication. These 
glycoproteins function during virus entry, cell-to-cell spread, and egress o f 
infectious virion particles (Roizman and Sears, 1996; Spear, 1993a; Spear, 1993b). 
Syncytial mutations (syri) that cause extensive virus-induced cell fusion can arise in 
at least 4 different regions o f the viral genome including the Ul20 gene (Baines et 
al., 1991; MacLean etal., 1991); the Ul24 gene (Jacobson et al., 1989; Sanders et 
al., 1982); the UL27 gene encoding glycoprotein B (gB) (Bzilc et al., 1984; Pellett et 
al., 1985) and the Ul53 gene coding for glycoprotein K (gK) (Bond and Person, 
1984; Debroy et al., 1985; Pogue-Geile et al., 1984; Ryechan et al., 1979).
Syncytial mutations in the Ul53 (gK) gene are m ore frequently isolated than 
syncytial mutations in any other genes (Bond and Person, 1984; Bond et al., 1982; 
Debroy et al., 1985; Dolter et al., 1994; Pogue-Geile et al., 1984; Pogue-Geile and 
Spear, 1987; Read etal., 1980; Ryechan eta l., 1979).
1
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Recently, it was shown that gK is involved in infectious virus production 
and virion egress (Jayachandra e t al., 1997). Furthermore, extrapolation o f data 
from other mutant viruses suggests that gK may also function in virus entry. 
Therefore, the hypothesis for these investigations is HSV-1 glycoprotein K is a 
regulator o f multiple membrane fusion events during HSV-1 virus entry, 
intracellular virion transport, and cellular egress.
STATEMENT OF RESEARCH OBJECTIVES
It was the goal o f this research to develop an understanding o f the structure 
and function o f HSV-1 gK in the herpesvirus lifecycle by investigating the effects o f 
specific mutations and deletions on both virus entry and egress. The overall 
research objectives were divided into two main categories. Each of these main 
objectives was then subdivided into specific research aims, which were designed to 
address the two main objectives. The specific research aim s were:
I. The role o f HSV-1 gK in virus entry.
1. To generate a panel o f recombinant viruses that express an indicator 
cassette in order to facilitate the monitoring o f  successful viral entry into 
permissive cells.
2. To generate and characterize Chinese hamster ovary (CHO) cell-lines 
that express the African Green Monkey Kidney (Vero) cells HveA 
receptor homolog.
3. To determine if  HSV-1 glycoprotein K is a structural component o f the 
virion.
2
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4. To determine the role o f HSV-1 glycoprotein K  in receptor utilization.
Q. Characterization o f the role o f HSV-1 gK in virus egress.
1. To analyze the role o f domains o f HSV-1 gK in virus egress.
2. To determine if  conserved amino acid motifs within gK are essential for 
HSV-1 gK function.
The results from this research suggest that HSV-1 gK is a multifunctional 
protein involved in differential receptor utilization and transport o f virion particles 
to extracellular spaces. The results from these examinations are presented as four 
individual chapters following a review o f the current literature in herpes virology. 
The chapters are presented as follows:
1. Expression o f the Enhanced Green Fluorescent Protein by Herpes Simplex 
Virus Type 1 (HSV-1) as an in Vitro or in Vivo Marker for Virus Entry and 
Replication.
2. Functional Characterization o f the HveA homolog Specified by African 
Green Monkey Kidney Cells through the Use of a Herpes Simplex Virus 
Expressing the Green Fluorescence Protein.
3. Herpes Simplex Virus Type 1 (H SV -l) Glycoprotein K (gK) is a Structural 
Component o f Purified Virions that Functions to Modulate HveAs Receptor 
Mediated Virus Entry.
4. Genetic Analysis o f the Role o f Herpes Simplex Virus 1 (HSV-1) 
Glycoprotein K (gK) in Infectious Virus Production and Egress.
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LITERATURE REVIEW 
Historical Perspective o f Herpesviruses
The first written documentation o f human herpes infections dates back to 
ancient Greece (Nahmias and Dowdle, 1968). The herpesviruses derive their name 
from the Greek word, sproiv, meaning “creep”, which Hippocrates used to describe 
the characteristic spread of the cutaneous lesions (Wildy, 1973). However, 
throughout history the term herpes was used to describe a number o f skin ailments 
and diseases, not all o f which were associated with herpes infections. Astruc, the 
18th century physician to the king o f France, was first to draw a correlation between 
herpetic lesions and genital infections (Beswick, 1962; Hutfield, 1966). But it was 
not until 1893 that Vidal recognized the transmission o f herpes infections between 
individuals.
The beginning o f the twentieth century brought several advances in the 
recognition o f  the etiology o f herpetic lesions. First, in 1896 Unna described giant 
multinucleated cells associated with all known herpes infections (Unna, 1896). 
Second, Lownstein (1919) demonstrated the infectious nature o f fluid from herpes 
keratitis and herpes labialis by inoculating the rabbit cornea. Third, the presence of 
neutralizing antibodies in the serum o f infected patients was demonstrated by 
Andrews and Carmichael (1930). Paradoxically, only patients with neutralizing 
antibodies developed recurrent lesions, albeit less severe.
Although originally proposed by Lipschitz in 1921, it was not until the 
1960’s when the existence o f two distinct antigenic herpes simplex types, HSV type 
1 (HSV-1) and HSV type 2 (HSV-2) was discovered, each being shown to correlate
4
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to particular anatomical sites (Lipschitz, 1921). Nahmias and Dowdle (1968) 
demonstrated that HSV-1 was more frequently associated with non-genital 
infections, while HSV-2 was associated most commonly with genital disease. Since 
these initial characterizations, the biological properties o f herpesviruses have been 
an area of intense study.
Taxonomy o f Herpesviridae
The viruses which comprise the family Herpesviridae share a number o f 
common structural features which will be described in detail in subsequent sections, 
but include: 1) a core wound around which is the linear double stranded DNA 
genome; 2) an icosadeltahedral capsid; 3) a proteinacious tegument; and 4) a  cell 
derived lipid envelope (W ildy et al, 1960; Roizman and Furlong, 1974). Although 
these structural features aid in the inclusion o f virions into the family Herpesviridae, 
the various herpesviruses cannot be differentiated from one another by electron 
microscopic examination. Instead, viruses are differentiated on the basis of 
biological properties, number of base pairs in the genome, genome arrangement, 
immunological specificity, cell tropism and replication characteristics (Roizman, 
1982).
The nomenclature, which classifies the herpesviruses, was defined by the 
Herpesvirus Study Group o f the International Committee on the Taxonomy o f 
Viruses (Roizman et al, 1981). Because o f the extensive diversity o f the various 
herpesviruses, the viruses have been subdivided into three subfamilies: 1) 
Alphaherpesvirinae-Tapidly replicating, highly cytolytic herpesviruses; 2)
5
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Betaherpesvirinae-slowly replicating, cytomegalic herpesviruses; and 3) 
Gammaherpesvirinae-lymphocytc associated herpesviruses (Roizman et al, 1973; 
Roizman, 1982). Although these divisions were formulated on the basis o f 
biological properties, such as, cell tropism or replication, they do not represent an 
accurate grouping o f the relatedness o f either the characteristics o f  the viral genome 
or the structural organization o f the viral genome (Bomkamm et a l, 1976; Raab- 
Traub et al, 1980). Thus, each subfamily has been further divided into genera, 
which reflects the phylogenetic relatedness o f each virus. This relatedness is based 
on several factors including the genomic structure, sequence homology, and 
serological relationships (Roizman, 1982). A partial listing o f selected herpesviruses 
and their classifications is represented in table 1.1.
Herpesviruses are widely distributed in nature and have been found to infect 
most animal species. O f the more than eighty distinct herpesviruses described in the 
past fifty years, eight have been identified as known human pathogens (highlighted 
in bold in Table 1) and have been implicated in a number o f disease states discussed 
in the subsequent section. Despite the diversity o f the family Herpesviridae, the 
alphaherpesvirus, human herpesvirus 1 (HHV-1) (also known as herpes simplex 
virus type 1 [HSV-1]) is the prototypical herpesvirus. Its close relatedness to a 
number of other important human and animal alphaherpesvirus pathogens make it a 
fairly accurate model for studying alphaherpesvirus replication, and thus it is the 
focus of this thesis.
6
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Table 1.1. Classification o f Select Members of Herpesviridae.




Human herpesvirus 1 
Human herpesvirus 2 
Human herpesvirus 3
Cercopithecine herpesvirus 1
Cercopithecine herpesvirus 2 
Bovine herpesvirus 1
Bovine herpesvirus 2 







Cercopethicine herpesvirus 8 
Equid herpesvirus 2
Suid herpesvirus 2
Murid herpesvirus 1 
Murid herpesvirus 2 
Felid herpesvirus 2 
Human herpesvirus 6 
Human herpesvirus 7




Herpes simplex virus type 1 
Herpes simplex virus type 2 
Varicella-zoster virus 





Bovine mammillitis virus 
Dog herpesvirus 
Equine rhinopneumonitis 




Aujeszky’s disease virus 








Inclusion body rhinitis 










associated herpesvirus I 
M arek’s disease 
_______ herpesvirus_______
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Clinical Significance o f Herpes Simplex Viruses
Herpes simplex viruses are distributed worldwide in both developed and 
undeveloped countries (Black, 1975). Animal vectors for human herpesviruses have 
not been identified; therefore, man remains the only known reservoir for viral 
transmission to other humans. Because virus infection is only very rarely fatal and 
because the virus remains latent with episodes o f reactivation, the propensity for 
those infected to spread the virus is quite high (Whitley et al, 1997). The associated 
disease o f herpes simplex infections ranges from very mild, clinically undetectable 
vesicular lesions at the site o f reactivation or primary infection to a sporadic, severe, 
and sometimes life-threatening disease. Historically, herpes simplex viruses have 
garnered much biological, but little clinical interest. However, because o f the social 
significance and the pain that can be associated with the ulcerative lesions, there has 
recently been a resurgence o f investigation into possible treatments (Whitley, 1982). 
This has been further advanced by a more detailed understanding of the biological 
and structural properties o f the virus, especially with regard to virus-host 
interactions.
Epidemiology: Herpesviruses are distributed throughout the world with 
more than one-third o f the world’s population exhibiting recurrent HSV infections; 
therefore generating the capacity for transmission to susceptible individuals during 
episodes o f a productive infection. There are many factors that influence the 
prevalence o f  infection including geographic location, race, gender, socioeconomic 
status, and age (Dodd et al, 1938; Rawls and Campione-Piccardo, 198; Scott et al, 
1941; Scott, 1957). For those individuals in developing countries or from lower
8
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socioeconomic populations, approximately one-third o f  the children seroconvert by 
five years o f age and 70-80% o f the population converts by adolescence (Rawls and 
Campione-Piccardo, 1981). Middle class children five years o f age and below have 
a prevalence o f  seroconversion o f 20%, with no significant increase until their 
twenties or thirties, when the prevalence increases to 40-60%. University students 
seroconvert at about 5-10% annually (DeGiordano et al, 1970; Dunkle et al, 1979; 
Whitley et al, 1997).
Caucasians and African-Americans within the United States vary 
significantly for the prevalence o f HSV-1 infections; however, by forty years o f age, 
the differences are negligible (DeGiordano et al, 1970; Juretic et al, 1966). By the 
age of 5, >35% o f African Americans relative to 18% o f Caucasians are infected by 
HSV-1 (Rawls e ta l, 1969; Nahmias et al, 1970a; Nahmias et al, 1970b).
Throughout adolescence, the difference remains approximately two-fold higher for 
African Americans than for Caucasians (Whitley et al, 1997).
Because HSV-2 is generally acquired through intimate sexual contact, 
seroconversion is rarely found before the onset o f sexual activity. The number o f 
cases o f HSV-2 infections is estimated at over 500,000 cases annually, with 
approximately 40 to 60 million Americans latently infected with HSV-2 (Nahmias 
et al, 1973; Magder et al, 1989). The seroprevalence o f  HSV-2 infections is 10% by 
29 years o f age and 35% by 60 years o f age. While race (more African Americans 
than Caucasians), gender (more females than males), m arital status (more divorced 
than single or married), sexual preference (more homosexuals than heterosexuals), 
and residence (more city residents than suburbs) all are important factors which
9
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influence acquisition o f  HSV-2, the best indicator and correlate o f prevalence is the 
number o f sexual partners o f an individual (Whitley et al, 1997). Although much 
less prevalent, the incidence o f genital HSV-1 infections has steadily increased over 
recent years (Nahmias, 1990). HSV-1 genital infections, however, are much less 
clinically severe and are not prone to reactivation (Whitley et al, 1997).
Pathogenesis: Virus is transmitted from infected to  susceptible individuals 
(those individuals who are HSV seronegative) during close personal contact 
developing a primary infection. A recurrent infection occurs following reactivation 
within a latently infected individual and clinically is usually less severe than the 
primary infection. An initial infection occurs in individuals with preexisting 
antibodies to one type o f  HSV experiences a first infection with the opposite virus 
type (i.e. A latently infected HSV-1 infected individual is exposed to HSV-2 for the 
first time). Because o f the cross-reactivity o f many HSV antibodies, an initial 
infection is generally less severe than would be a primary infection o f the same type 
(Whitley et al, 1997).
Histopathologically, HSV infections reflect the cytopathological changes 
initiated by the virus, as well as, the associated inflammatory response to the 
infection. Viral infection produces large inflated cells, condensation of the 
chromatin, and degeneration o f nuclei within the basolateral and intermediate cells 
o f the epithelium (Roizman and Sears, 1996; Whitley and Gnann, 1993). Upon cell 
lysis, a vesicular fluid containing large numbers o f infectious virus particles is 
generated between the epidermal and dermal layers. The fluid also contains lysed 
cellular debris, multinucleated fused cells, and inflammatory cells. Because o f the
10
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recruitment o f inflammatory cells to the lesion sites, the vesicular fluid becomes 
pustular and eventually scabs, h i mucosal tissue areas, the vesicles are replaced 
with ulcerative lesions (Whitley et al, 1997).
Following a primary infection, the capsid is transported retrograde by 
neurons to the dorsal root ganglia where latency is established. Despite replication 
o f virus causing disease and much less frequently encephalitis, the predominant 
host-virus interaction in herpes infections leads to the establishment o f latency. 
Following the establishment o f latency, external stimuli such as stress or UV light, 
can cause reactivation o f the virus from its latent state, during which the virus 
particles are anterogradely transported along peripheral sensory nerves back to the 
initial site o f infection at epithelial surfaces (Roizman and Sears, 1996; Whitley et 
al, 1997).
M ucocutaneous Infections: Although herpesviruses generate a spectrum of 
disease states, asymptomatic infections are the rule rather than the exception 
(Whitley and Gnann, 1993). Incubation periods range from 2 to 12 days, with a 
mean o f 4 days. Primary infections shed virus for up to 23 days, with a mean of 7- 
10 days and are characterized by fever and intraoral gingival ulceration, but may 
also present pharyngitis and mononucleosis-like syndromes (Glezen et al, 1975).
Lip associated ulcerative lesions are indicative o f a recurrent infection.
Recurrent orolabial lesions are characterized by pain, burning, itching, and 
the appearance o f three to five vesicles within the first six hours o f onset and persist 
for only 48 hours. These lesions progress to an ulcerative stage within 72-96 hours, 
which resolves within 8-10 days. The frequency o f recurrence is variable within an
11
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individual and is dependent on several factors (Spruance et al, 1977). Other 
cutaneous HSV-1 lesions are less common and are generally either manifested as 
localized eczema herpeticum or as a disseminated Karposi’s varicella-like eruption. 
HSV lesions o f either type can trigger erythema multiforme (Whitley and Gnann, 
1993; Whitley eta l, 1997).
Genital herpetic lesions are more severe due to systemic complications. 
Primary infections are manifested as macules and papules, and are accompanied by 
fever, dysuria, malaise, and inguinal adenopathy. Systemic complications occur in 
70% of patients and are characterized by excruciating pain, aseptic meningitis, 
neuralgias, and meningoencephalitis. The more severe the primary infection, the 
more likely the severity and frequency of recurrent infections; however, recurrent 
infections usually consist o f a limited number o f vesicular lesions. W hile the 
frequency o f recurrence varies among individuals, about one-third o f the patients 
have recurrences in excess o f eight per year, one-third with 2-3 per year, and the 
other one-third will have between 4-7 recurrences per year (Corey, 1982; Corey et 
al, 1983). Although these numbers are for clinical recurrences, virus can be shed 
while asymptomatic and is readily detectable in genital secretions by PCR at a high 
frequency between clinical recurrences (Mertz et al, 1992).
Fetal and Neonatal Infections: Genital HSV infections can rarely become 
disseminated during pregnancy and result in necrotizing hepatitis, 
thrombocytopenia, encephalitis, and in greater than 50% o f the cases the fetus does 
not survive. There is also a greater than 50% m ortality for women, which acquire 
the infection during term. Primary and initial maternal genital infections pose the
12
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greatest risk o f dissemination. Therefore, identification o f  couples for which the 
mother is seronegative for HSV-2 and her partner is HSV-2 seropositive is essential 
(Whitley et al, 1997).
Nearly one in every 2,000 to one in every 5,000 deliveries results in neonatal 
HSV infection each year (Nahmias et al, 1983; Nahmias et al, 1989; Sullivan- 
Bolyai et al, 1983). Transmission to the neonate from the mother can occur via 
three routes: 1) in rare cases through in utero infection; 2) in 75 to 80% o f the cases 
through intrapartum contact o f the fetus with maternal genital secretions; 3) through 
postnatal acquisition from relatives, hospital personal, etc. containing orolabial 
herpetic lesions. Neonatal infections are invariably symptomatic characterized by a 
triad o f skin vesicles, scaring, eye infections, microencephaly, hydraencephaly and 
frequently death. Herpetic neonatal disease can be divided into the following three 
categories: 1) Localized disease with lesions in the skin, eye, and mouth occurs in 
40% o f infected neonates and presents at approximately 10 to 11 days after delivery. 
Recurrences are frequent and common, regardless o f the use o f anti-viral therapies; 
however, if  no anti-viral therapies are delivered, nearly 30% will progress to 
neurological impairment. 2) Encephalitis occurs in 35% o f neonates. Virus is 
readily cultured from cerebral spinal fluid (CSF). Clinical manifestations o f 
encephalitis include tremors, seizures, fever and/or temperature instability, 
pyramidal tract signs, poor feeding, lethargy, irritability, and bulging fontanelle. 3) 
In 25% o f neonates there is a severe disseminated infection involving multiple 
organs, the central nervous system (CNS), lungs, skin, and eyes. Encephalitis is a 
common component o f a disseminated infection occurring in 60-75% of patients.
13
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Mortality exceeds 80%; however, survivors are usually both mentally and 
physically impaired (Whitley et a l, 1988; Whitley et al, 1997).
K eratoconjunctivitis: Herpes infections o f the eye are the second leading 
infectious cause o f comeal blindness in the world. Approximately 300,000 cases o f 
HSV infections in the eye are diagnosed annually with the majority o f these 
occurring in children through neonatal transfer (Binder, 1976; Ostler, 1977; Scott, 
1957). Herpetic keratoconjunctivitis may cause tearing, photophobia, eyelid edema, 
dendretic lesions, and geographic ulceration o f the cornea. Recurrent infections are 
usually unilateral; however, a small percentage is bilateral (W hitley and Gnann, 
1993; Whitley et al, 1997).
Immunocomprimised H ost: Immunocompromised or immunosuppressed 
patients have a greatly increased risk o f severe recurrent herpetic infection (Logan et 
al, 1971; M uller et al, 1972; Pass e t al, 1978; Whitley et al, 1984). Organs and 
tissues normally not involved in recurrent or primary infections may be afflicted 
including the respiratory tract, esophagus, and gastrointestinal tract (Montgomerie et 
al, 1969; Korsager et al, 1975). Furthermore, acyclovir or other drug resistant 
strains of HSV readily evolve within these individuals (Erlich et al, 1989).
C entral Nervous System (CNS1 Infections: CNS infections by HSV which 
lead to encephalitis is the most devastating o f all infections. HSV is the most 
common cause o f sporadic fatal encephalitis, with over 70% o f untreated cases 
being fatal and only 2.5% o f survivors regaining normal neurological function 
(Ward and Roizman, 1994).
14
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Prevention and Treatment: While vaccination against viral infections 
remains the ideal method for prevention, HSV presents unique problems because o f 
its ability to recur in the presence o f both humoral and cellular immunity. Vaccines 
containing subunit glycoprotein components, which induce strong neutralizing 
antibody responses, have been extensively studied. In phase two clinical trials, a 
subunit vaccine to glycoprotein D (gD) demonstrated that the number of culture 
positive episodes could be reduced by one-third. However, no degree of protection 
to seronegative sexual partners o f persons with known HSV-2 infection was 
demonstrated during phase three clinical trials. Thus, due to the unsuccessfulness o f 
subunit vaccines, they have been largely abandoned.
Alternative approaches to subunit vaccines that are safe and efficacious are 
an area o f intense study. The popularity o f genetic immunization has spurred a new 
interest in HSV vaccine generation. Recently, genetic immunization against viral 
glycoproteins has begun phase one clinical trials. While having some advantages 
over subunit vaccines, naked DNA genetic immunization still has the problem of 
only representing a limited number o f antigens of the virus. Therefore, modified 
attenuated live vaccines, which express a large repertoire o f the viral genome, have 
also been studied. Until a vaccine has been proven effective, education and 
prophylaxis are the only prevention. For those that have already acquired herpes 
infections, there is no known cure for the infection.
Treatment is based on nucleotide analog drugs that become active only in the 
presence o f herpes infections and are based largely on the synthetic acyclic purine 
nucleoside analog, acyclovir (W hitley and Gnann, 1993). Treatment with acyclovir
15
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or derivatives thereof^ including valacyclovir and fanciclovir, is associated with very 
few adverse side effects. Furthermore, no increased risk to mothers or fetuses is 
associated w ith these drugs during pregnancy (Andrews et al, 1988). Initial 
infections can be treated through topical, oral, or intravenous delivery methods. 
Long-term preventive therapy includes daily oral doses o f acyclovir in order to 
suppress reactivation and severity of the recurrent lesions (Whitley et al, 1997).
A rchitecture o f the Herpes Virion
Inclusion o f viruses into the family Herpesviridae is based largely on the 
architecture o f  the virion. The herpes virion particle varies in size from 120nm to 
300nm in diameter and is comprised o f four concentric layers: 1) a  cylindrical core 
around which the liner double stranded viral genome is wound, 2) an 
icosadeltahedral capsid, 3) an electron dense proteinacious tegument, 4) a lipid 
bilayer envelope (Figure 1.1) (Roizman and Furlong, 1974; Roizman and Sears, 
1996; Wildy et al, 1960).
The core: The innermost core contains the liner double-stranded DNA 
genome wound in the form o f a torus and seemingly suspended by spindles 
protruding from the underlying walls o f the capsid (Figure 1.1) (Roizman and Sears, 
1996).
The capsid: The capsid is a protein shell that surrounds and protects the 
viral genome (Figure 1.1). It consists of 162 capsomeres arranged into an 
icosadeltahedran approximately lOOnm in diameter and 15nm in thickness. HSV-1 
infected cells contain three major capsid types, which can be separated by
16
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Figure 1.1. A rchitecture of Herpes V irus Particles. Cut away diagram of HSV-1 
virion particle showing the viral genomic DNA within the core, the icosahedral 
capsid, the proteinacious tegument, the lipid bilayer envelope, and the viral 
glycoproteins.
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density gradient sedimentation and differentiated by electron microscopy. These 
major capsid types correspond to the degree to which DNA has been packaged and 
have been designated “type A” (empty), “type B” (intermediate), and “type C” (full) 
capsids (Gibson and Roizman, 1972; Gibson and Roizman, 1974). The “A” capsids 
consists o f four viral proteins, viral protein 5 (VP5), VP19c, VP23, and VP26, but 
are devoid o f DNA and lack the internal torroid structure. The m ajor capsid protein 
VP5 is a  component o f both the 150 hexameric capsomeres and the 12 pentameric 
capsomeres (Heine et al, 1974; Schrag et al, 1989). VP19c is disulfide bonded to 
VP5 in an equimolar ratio and has been shown to bind to viral DNA, suggesting that 
it may play some role in anchoring the viral genome in the capsid (Braun et al,
1984). Studies have suggested that the type A capsids are not in the pathway of 
capsid maturation and may actually be a decay product (Sherman and 
Bachenheimer, 1988). Type B capsids like type A capsids are devoid o f DNA, but 
they differ in that type B capsids contain three additional proteins: VP21, VP22a, 
and VP24. VP21 and VP22a have been shown to be internal capsid proteins, while 
VP 19 and VP23 are on the surface o f capsids and may form intercapsomeric fibers 
located between each o f the capsomeres (Liu and Roizman, 1991a; Liu and 
Roizman, 1991b). Type B capsids are thought to be intermediates in capsid 
maturation as pulse chase studies have shown that “B” capsids are capable of 
packaging viral DNA to form “C” capsids (Braun et al, 1984). Type C capsids are 
the only capsid type isolated by de-enveloping intact virions and contain the entire 
linear double stranded DNA genome and an additional protein, VP22 (Gibson and 
Roizman, 1972; Schrag etal, 1989).
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The tegument: The amorphous proteinacious region between the 
undersurface o f the envelope and the outer surface o f the capsid has been designated 
the tegument (Figure 1.1). The least distinctive o f the four layers, the tegument is 
variable in both size and composition. Many regulatory structural proteins, which 
are necessary in the viral lifecycle, are contained within the tegument (Roizman and 
Furlong, 1974). Most notably, the a-Zranr-inducing factor (a-TlF, VP 16), which 
functions in transactivation o f alpha protein synthesis, and the virion host shutofF 
protein (VHS, encoded by U[41) are important constituents within the tegument 
(Read and Frenkel, 1983). Other components in the tegument include, VP 1-2 
(Ul36), VP11-12 (Ul46), VP13-14 (Ul47), and the gene product o f Usl 1 (Chou and 
Roizman, 1989; Roizman and Furlong, 1974; Roizman and Sears, 1996).
The envelope: The outermost layer o f the herpes virion is comprised of a 
bilayer lipid envelope and membrane imbedded viral glycoproteins (Figure 1.1).
The virion envelope and the imbedded viral glycoproteins are acquired at least 
initially by budding through the inner nuclear lamellae of infected cells; however, 
whether or not this initial envelope serves as the mature virus’ final envelope is still 
not known. HSV-1 specifies at least eleven glycoproteins designated as gB, gC, gD, 
gE, gG, gH, gl, gj, gK, gL, and gM, most o f which have been demonstrated to be 
structural components o f the virion (Baines and Roizman, 1993; Hutchinson et al, 
1992; Ramaswamy and Holland, 1992; Spear, 1985). These glycoproteins function 
in a number of important membrane associated events during the virus lifecycle 
including attachment, penetration, egress, and virus induced cell fusion (Spear,
1985).
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Organization o f the Viral Genome
All herpesviruses contain a linear double stranded DNA genome that can 
vary in size depending on the virus horn 120kb to 250kb in length. The HSV 
genome is approximately 150kb and is packaged in the virus in a  tightly wound 
torroid structure (Becker et al, 1968; Kieff et al, 1971; Plummer et al, 1969). The 
genome consists o f two covalently linked segments, designated as the unique long 
(U l)  and unique short (Us) sequences. Each segment contains nucleotide sequences 
distinct from the other and is bracketed on either side by inverted repeats. During 
viral replication, the U l and Us segments can invert relative to one another 
generating four possible linear isomeric forms of the viral genome (Figure 1.2) 
(Kieff et al, 1971). These isomers have been designated as P (prototype, Fig 1.2 A), 
II (Inversion o f the U l component, Fig 1.2B), Is (Inversion o f the Us component, 
Fig. 1.2C), and Isl (Inversion o f both the U l and Us components, Fig. 1.2D). 
However, all isomers o f the HSV viral genome are viable in cell culture (Hayward 
et al, 1975; Morse eta l, 1977).
Initial nucleotide sequencing of the viral genome and prediction o f putative 
open reading frames specified by these unique segments was performed by 
McGeoch et a l (McGeoch et al, 1985; McGeoch et al, 1988a). The HSV-1 genome 
specifies at least eighty-four open reading frames, o f which fourteen are located 
within the Us segment, sixty within the U l segment, four in each o f the inverted 
repeats flanking the U l segment, and one within the inverted repeat flanking the Us 
region (McGeoch et al, 1988b).
20
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Figure 1.2. Herpes Simplex Genome Inversion. A) Schematic representation of 
the arrangement o f the viral genome depicting the unique long (U l) and unique 
short (Us) regions and their prototypical (P) orientations (designated by directional 
arrows) and flanked by inverted and terminal repeats (IR and TR, respectively). B) 
IL: Inversion of the U l segment relative to prototypic arrangement. C) Is '. Inversion 
o f the Us segment relative to prototypic arrangement. D) Isl : Inversion o f both the 
U l and Us segments relative to prototypic arrangement.
21










































X) P f 1 ' 6 ?  * s f 1 ^
-J
p p p p
.f i
C8104 * °  I  p4 04 * °  I  04E—  e s  E—  e o  ■  E—  «  E—1
22





T he H erpesvirus Lifecycle
The principal events in the herpesvirus replicative cycle have been derived 
from cell culture systems. The herpesvirus lifecycle can be broken down into 
several stages as diagrammed in figure 1.3. These stages include: attachment o f the 
virion particle to the cell surface, penetration o f the nucleocapsid into the cellular 
cytoplasm, host protein synthesis shut off, transport o f the nucleocapsid to the 
nucleus, regulated cascade of gene transcription, viral DNA replication, packaging 
o f viral genomes into preassembled capsids, maturation o f virion particles, and 
translocation o f infectious particles to extracellular spaces (Roizman and Sears, 
1996). The replicative cycle within cell culture systems characteristically produces 
swollen and rounded cells, chromatin condensation and margination, and nuclear 
inclusions. In some cases limited or extensive cell-to-cell fusion is also observed 
(Roizman and Sears, 1996).
A ttachm ent: Initial virus attachment events provide loosely associated 
interactions with cells and are mediated through interactions o f virion glycoproteins 
with heparin-sulfate proteoglycan moieties found ubiquitous on cell surfaces (Fig. 
1.4) (Shieh et al, 1992; Wudunn and Spear, 1989). Binding o f virion particles to 
cell surfaces is inhibited by soluble heparin, a molecule similar in structure to 
heparin sulfate. Similarly, purified virion particles bind heparin-affinity columns 
under physiological conditions (Herold et al, 1991; M ettenleiter et al, 1990; 
Wudunn and Spear, 1989). Of the eleven glycoproteins, gC, has shown the highest 
affinity for heparin binding, indicating that it may play an important role in the 
initial attachment (Herold et al, 1991; Herold et al, 1994; Spear et al, 1989).
23
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Figure 1.3. Replicative Lifecycle o f HSV-1. The stages o f the HSV-1 lifecycle 
are diagrammed as discussed in the text, including attachment, penetration, 
coordinated sequential transcription, DNA replication, capsid assembly, packaging, 
maturation, and egress.
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Furthermore, antibodies to gC, as well as, lack o f gC abrogate virus binding to 
polarized epithelial cells (Fuller and Spear, 1985; Svennerholm et al, 1991). 
However, virions devoid o f gC still attach to non-polarized epithelial cells, 
suggesting that other virion glycoproteins participate in heparin sulfate attachment. 
HSV-1 glycoprotein B (gB) has also been shown to have heparin sulfate binding 
activity and to be responsible for cell attachment in the absence o f gC (Spear, 1993).
Receptor Facilitated Entry: Penetration o f virion particles is through pH 
independent fusion o f the virion envelope to the cellular plasma membrane or to 
early endosomes (Wittels and Spear, 1991) (Fig. 1.4). Virion glycoproteins required 
for this event include gB, gD, gH and gL (Sarmiento et al, 1979; Cai et al, 1988; 
Ligas and Johnson, 1988; Roop et al, 1993). While the initial observations of HSV 
attachment to heparin sulfate proteoglycans led many investigators to speculate that 
these molecules were the receptors for virus entry, evidence began to accumulate 
that suggested the presence of other specific receptors at cell surfaces that mediated 
virus entry. This evidence included the observation that certain cell types, such as 
Chinese hamster ovary (CHO) and swine testis (ST) cells, which exhibited 
glucosaminoglycan chains on cell surface proteoglycans that allowed virus 
attachment, but did not allow virus entry (Shieh et al, 1992; Subramanian etal, 
1994). Furthermore, normally permissive cell-lines transformed with the gD gene 
were resistant to viral infection, while gD could not be shown to exhibit any heparin 
sulfate binding activity (Campadelli-Fiume et al, 1988; Johnson and Spear, 1989). 
This data suggested that gD may sequester a  cellular receptor required for virus 
entry and that this receptor was not expressed in CHO or ST cells.
26
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Figure 1.4. Model o f Herpesvirus Attachment and Entry. The current model o f 
HSV-1 attachment and penetration is illustrated. A) Infectious virions attach in a 
“loose” association with heparin sulfate proteoglycans found ubiquitous on cell 
surfaces. B) A “tight” association between the virion and cell occurs as the virion 
glycoproteins associate with cellular herpes virus entry mediators. C) Viral 
glycoproteins mediate penetration through a pH independent fusion event of the 
herpes virus envelope with the cellular plasma membrane depositing the 
nucleocapsid into the cytoplasm of the cell. D) The nucleocapsid is actively 
transported to nuclear pores by means o f the cytoskeleton.
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Initially, the fibroblast growth factor receptor (FGFr) was implicated in 
attachment and entry o f HSV into the non-permissive CHO cells (Kaner et al,
1990); however, these results could not be confirmed by outside labs (Shieh and 
Spear, 1991; M ir da et al, 1992). Although other molecules, such as the rnannose-6- 
phosphate/ insulin like growth factor II receptor, had been reported to mediate virus 
entry into non-permissive cells, cell-lines that lacked these receptors remained fully 
susceptible to viral infection (Brunetti et al, 1995). It was not until Montgomery et 
al (1996) screened cDNA expression libraries isolated from HeLa cells that proteins 
that could definitively transfer susceptibility to  the normally resistant CHO and ST 
cells were identified. A description o f each o f these receptors follows.
H eroes V irus E ntry  M ediator A (HvcA): HveA (initially designated 
HVEM) was the first in a series o f receptors identified that rendered the normally 
resistant CHO cell-line susceptible to herpes virus infection. HveA, however, 
differs from the subsequently described receptors in its structure. HveA is a type I 
integral membrane protein with a cysteine rich extracellular domain that exhibits 
homology with the tumor necrosis factor receptor (TNFr) family. HveA was found 
to be distributed in most human tissues, including heart, lung, kidney, placenta, 
muscle, and pancreas, but not brain or other neuronal tissues. Interestingly, HveA 
expression was upregulated in activated T lymphocytes, highlighting its possible 
importance in HSV pathogenesis (Montgomery et al, 1996). It has been well 
established that HSV replicates in activated T lymphocytes (Pelton et al, 1977; 
Rinaldo et al, 1978; Teute et al, 1983) and that infected T lymphocytes could be 
isolated from biopsies o f cutaneous lesions (Boddingius et al, 1987). Because
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certain isolates o f  HSV, which specified subtle genetic alterations, were found that 
were incapable o f utilizing the HveA receptor, it may be that in the field, the 
virulence o f the virus may be directly attributable to its ability (or inability) to infect 
activated T cells.
The ability o f HveA to mediate entry o f other strains of HSV was 
determined by infecting HveA transformed CHO cells that also carried a virus 
inducible P-galactosidase gene. Although, HveA enhanced the ability o f most HSV- 
1 and HSV-2 strains, HveA failed to mediate entry o f HSV-1 mutants, HSV- 
1(ANG), HSV-l(KOS)ridl or HSV-l(KOS)rid2 (Montgomery et al, 1996). 
Moreover, soluble HveA was shown to copurify with wild-type HSV-1 (KOS) 
virions, but not HSV-l(KOS)ridl/2 mutant virions following coincubation and 
sucrose gradient centrifugation (Nicola et al, 1998). The rid mutants, HSV- 
l(KOS)ridl and HSV-l(KOS)rid2, each specify single amino acid substitutions 
within gD (Q27P or Q27R, respectively) that enable the virus to overcome the 
interference for entry that is imposed by cell-lines that express gD (Dean et al, 
1994). HSV-1(ANG) is also resistant to gD mediated interference through the same 
amino acid substitution as HSV-l(KOS)rid2, but also has other amino acid 
substitutions within gD and other proteins (Dean et al, 1994).
In this regard, HSV-1 gD was implicated as the primary virion protein that 
would physically associate with HveA. This is consistent with previous work that 
had indicated that gD was the primary virion protein involved in receptor 
recognition. Expression o f gD in normally permissive cell-lines rendered those cell 
resistant to HSV infection, presumably due to sequestration of a cellular receptor
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required for entry (Campadelli-Fiume et al, 1988). Incubation o f these cells with 
anti-gD neutralizing antibody prior to infection partially released this inhibition 
(Brandimarti et al, 1994; Campadelli-Fiume et al, 1990). A further indication o f the 
role o f gD in receptor binding was that anti-idiotypic antibodies mimicking gD 
bound cell surfaces o f normally permissive cells and blocked virus infection 
following binding (Huang et al, 1996). Moreover, soluble gD was capable o f 
binding cells in a saturable manner and could inhibit infection (Johnson et al, 1990; 
Nicola et al, 1997). Although gB, gH, and gL are essential for virus infectivity, 
similar lines o f evidence for receptor binding do not exist.
Interaction o f HSV-1 gD and HveA was shown through direct binding 
assays. Binding o f gD to HveA was conformationally dependent, but was not 
dependent on the glycosylation state o f the protein (Whitbeck et al, 1997). 
Furthermore, the complex formation appeared to occur in a 1:2 (gD:HveA) 
stoichemiotric ratio as assessed by gel filtration and SDS-PAGE analysis (Whitbeck 
et al, 1997). This stoichemiotry is consistent with receptor oligomerization 
following ligand interactions for receptors that when bound transmit signals into the 
cell (Wells, 1994; Wells, 1996). Using optical biosensor technology, the binding 
affinity o f gD with HveA was determined to be in the micromolar range (W illis et 
al, 1998). However, this interaction data may be somewhat misleading due the use 
a form o f gD that exhibits a higher affinity for HveA than its wild-type counterpart 
(Willis et al, 1998). Given the rather low affinity for HveA in these experiments, it 
is plausible that other virion proteins participate in virus binding. On the other 
hand, HveA is not the sole receptor present on cell surfaces, and it is just as
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possible, that contributions from several receptors increase the overall binding 
affinity given that different receptors appear to bind different regions o f gD 
(Krummenacher et al, 1998; Rux e t al, 1998). Another explanation is that it is not 
advantageous for the virus to exhibit high binding affinities for cell surface 
receptors because it would prevent the release of virions from cell surfaces upon 
egress.
Two cellular ligands were identified that associated with HveA, the secreted 
lymphotoxin a  (LTa) and LIGHT, a new member o f the TNF superfamily (Mauri et 
al, 1998). Each o f these proteins was shown to competitively bind HveA and to 
block the binding o f  HSV-1 gD (M auri et al, 1998). Furthermore, soluble HveA 
and antibodies to HveA inhibited a  mixed lymphocyte reaction, suggesting that 
there may be a possible role of HveA or its ligands in T cell proliferation (Harrop et 
al, 1998; Kwon et al, 1997; Mauri et al, 1998). In accordance with this, monoclonal 
antibodies to HveA prevented T cell proliferation, cytokine production, and 
expression o f activation markers following incubation with a soluble recall antigen, 
tetanus toxoid (Harrop et al, 1998).
Several lines o f  evidence indicated that HveA was not the only or the 
primary mediator o f HSV entry. Firstly, the fact that HSV is a neurotropic virus and 
that HveA was not found in neuronal tissue, indicated that other receptors remained 
to be isolated that could mediate entry into the nervous system. Secondly, although 
antibodies raised against HveA and soluble HveA blocked virus infection into CHO 
cells expressing HveA, both failed to block virus entry into normally permissive 
HeLa cells (Montgomery et al, 1996). Finally, mutant strains o f virus, such as
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HSV-l(KOS)ridl, as well as other alphaherpesviruses, such as PRV, were unable to 
enter into HveA expressing cells, but were able to enter into permissive cell-lines 
(Dean et al, 1994; Montgomery et al, 1996).
Heroes V irus E ntry  M ediator B (HvcBl: HveB was initially described as 
poliovirus receptor related protein 2 (Prr2); however, no function or ability to 
mediate poliovirus entry had been ascribed (Eberle et al, 1995). HveB is a 479 
amino acid type I integral membrane protein that is structurally similar to those 
proteins within the immunoglobulin superfamily. It contains three immunoglobulin- 
like regions in its extracellular domain and two potential sites for the addition o f N- 
linked sugars (Warner et al, 1998).
HveB was shown to mediate entry of HSV-2 and PRV-1, but not that o f 
wild-type HSV-1 or BHV-1 (Warner et al, 1998). Certain viable mutants o f HSV-1, 
namely HSV-l(KOS)ridl and HSV-l(KOS)rid2, which were unable to utilize HveA 
were capable o f utilizing HveB for virus entry (Montgomery et al, 1996; Warner et 
al, 1998). In contrast, the murine homolog of the human HveB receptor was unable 
to facilitate either HSV-1 or HSV-2 entry, but was able to mediate PRV-1 entry 
(Shukla et al, 1999). Furthermore, antibodies to this receptor were capable o f 
completely blocking PRV-1 infection into at least some normally permissive murine 
cell-lines, indicating that the murine HveB is the principal mediator o f PRV-1 entry 
into those cell-lines (Shukla et al, 1999).
Herpes V irus E ntry  M ediator C fHveCf and Herpesvirus Ig-like 
receptor fHIgRl; The HveC receptor, initially described as poliovirus receptor 
related protein 1 (P rrl), mediates entry o f all alphaherpesviruses tested to date
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including HSV-1, HSV-2, PRV-1, and BHV-1 (Geraghty et al, 1998). HveC is a 
518 amino acid type I integral membrane protein that exhibits structural properties 
similar to those proteins in the immunoglobulin (Ig) superfamily. This includes 
three Ig-like loop domains within the extracellular region (Lopez et al, 1995).
HveC mRNA was found to be distributed across tissue types, including epithelial 
and neuronal tissues, making it the prime candidate for the prim ary receptor for 
virus entry into permissive cells (Geraghty et al, 1998). In accordance with this 
observation, incubation of virus with soluble HveC blocked infection o f many 
normally permissive cell-lines (Geraghty et al, 1998). Furthermore, incubation of 
virus with either soluble HveA or HveC abrogated entry into CHO cell-lines 
expressing either HveA or HveC receptors, indicating that each entry mediator may 
recognize overlapping but distinct structural domains within gD  (Geraghty et al, 
1998; Krummenacher et al, 1998).
The HveC receptor was further shown to exist as different splice variants 
within cells. Cocchi et al (1998a) described a splice variant isoform o f HveC, 
designated HIgR, which functioned to facilitate alphaherpesvirus entry in a manner 
analogous to HveC. HIgR is a 458 amino acid protein that is structurally similar to 
HveC and specifies an ectodomain identical to HveC. The homology to HveC does 
however diverge following a splice donor consensus sequence within the HveC 
RNA resulting in a different amino acid sequence following amino acid residue 334 
(Cocchi et al, 1998a).
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Figure 1.5. M ediators of Herpesvirus Entry. The schematic represents the two 
broad families o f herpes virus entry mediating receptors, TNF-like and 
Immunoglobulin like.
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Mediators of Herpesvirus Entry
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Similar to their HveA counterpart, HveC and HIgR were shown to 
physically interact with gD (Cocchi et al, 1998b; Krummenacher et al, 1998). 
Despite the inability o f HVS-1 mutant viruses ridl and ANG mutants to bind HveA 
(Krummenacher et al, 1998; Whitbeck et al, 1997), these mutants bound HveC with 
a higher affinity than their wild-type counterpart (Krummenacher et al, 1998). 
Disruption o f the structure of gD abrogated its ability to bind HveC. Furthermore, 
whereas, mutation or deletion o f three o f the four functional domains o f gD elicited 
similar effects for both HveA and HveC binding, mutation o f the functional domain 
I had contrasting effects on HveA versus HveC binding. W hile functional region I 
is required for interaction of gD with HveA, it is not crucial for HveC binding 
(Krummenacher et al, 1998). Interaction o f gD with the ectodomain o f HveC and 
HIgR was shown to require the V domain (Figure 1.5.) o f the receptor. Moreover, 
the V domain was shown to be necessary and sufficient to mediate HSV entry into 
non-permissive cells (Cocchi et al, 1998b). Monoclonal antibodies to the V 
domain o f HveC and therefore, HIgR competed for HSV-1 gD binding and blocked 
virus infection. Additionally, chimeric receptors which specified only the V domain 
fused to a transmembrane region were shown to facilitate virus entry in the absence 
of other portions o f the receptor (Cocchi et al, 1998b). Therefore, the major 
functional region o f both gD binding and receptor facilitated entry lies within the V 
domain o f HveC and HIgR.
H eroes Virus E ntry M ediator D (HveD) and other herpesvirus 
receptors: HveD is the poliovirus receptor (Pvr) and has been shown to mediate 
entry o f PRV-1 and BHV-1 but not HSV-1 virus strains (Mendelsohn et al, 1989;
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T able 1.2. Description of herpesvirus entry mediating receptors
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Geraghty et al, 1998). Similar to the Pvr related proteins, HveB and HveC, HveD is 
a member o f the immunoglobulin superfamily (M endelsohn et al, 1989).
A number o f other receptors that mediate virus entry have been reported, but 
are yet to be described. It is however clear that a myriad o f different receptors from 
a number o f different structural families exist and that each participate in receptor 
mediated virus entry. The process by which each receptor functions in this entry 
event and the role that each may play in a biological model is still to be determined. 
A diagrammatic summary o f the described receptors is presented in Figure 1.5 and 
Table 1.2.
H ost Protein Shutoff: A distinguishing characteristic o f herpesvirus- 
infected cells is the rapid shut down o f host macromolecular synthesis machinery 
including DNA synthesis, host protein synthesis, and glycosylation/processing o f 
cellular proteins. The cessation o f host macromolecular metabolism occurs in two 
distinct stages. Initially, structural proteins within the tegument o f the virion shut 
down host protein synthesis in the absence of de novo synthesis. This occurs 
through the actions of the virion host shutoff (vhs) protein by destabilizing and 
degrading host mRNA (Kwong and Fenkel, 1987; Kwong et al, 1988; Nishika and 
Silverstein, 1977). Furthermore, VHS (Ul41) functions in downstream lifecycle 
events in the nondiscriminatory degradation and destabilization o f viral mRNA’s 
(Read and Frenkel, 1983). The second stage o f host protein shutoff requires de novo 
synthesis o f virion proteins following infection and coincides with the onset o f (3 
protein synthesis.
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V irion T ransport to the Nucleus: Due to the lack o f the necessary 
machinery for transcription and DNA replication, the nucleocapsid must be 
transported to the nucleus following penetration. The cytosolic transport o f  the 
nucleocapsid specifically to the nucleus has been reported to be mediated by 
cytoskeletal microtubules (Dales and Chardonnet, 1973; Kristensson et al, 1986). 
Depolymerization o f  microtubules prevented transport o f nucleocapsids to nuclear 
pores. Furthermore, Sodeik et al. (1997) showed by immunoelectron microscopy 
and confocal microscopy that nucleocapsids use dynenin, a  minus end directed 
microtubule dependent molecular motor, to be specifically transported through the 
cytoplasm towards the centriole. The nucleocapsid is subsequently transported to 
the nucleopore and the viral DNA unpackaged and inserted into the nucleus in a 
manner yet to be determined.
T ranscrip tional Regulation: Cellular RNA polymerase II transcribes viral 
RNA from the HSV DNA genome (Costanzo et al, 1977). Viral mRNAs are 
processed sim ilar to cellular RNAs in that they are capped, methylated, and 
polyadenylated (Bachenheimer and Roizman, 1972; Bartkoski and Roizman, 1976; 
Silverstein et al, 1973; Silverstein et al, 1976). Splicing o f viral RNA occurs in 
only six o f the open reading frames, ICPO, ICP22, ICP47, Ul15, Ul44 (gC), and 
Ul45. Genes sharing S’ and 3’ termini have been described with some genes 
utilizing several alternate initiation and polyadenylation sites (McLauchlan and 
Clements, 1982; Wagner, 1985; Wagner and Roizman, 1969). The stability o f the 
transcripts varies; however, a  and (3 gene transcripts appear more stable than y 
genes (W olf and Roizman, 1978).
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Viral gene expression is tightly regulated with respect to both abundance o f 
transcripts and timing o f expression. Transcription of viral genes is sequentially 
ordered expressing immediate early or alpha (a), then early or beta (P), and finally 
late or gamma (y) genes. The coordinate regulation o f each o f the virus gene classes 
occurs through specific viral proteins that turn on the next transcriptional class, 
while shutting down the previous transcriptional class (Roizman and Sears, 1996). 
Consequently, viral genes have been shown to have specific trans-activatable 
regulatory elements that facilitate the direct or indirect binding o f viral 
transcriptional activators (Chou and Roizman, 1986; Chou and Roizman, 1989; 
Roizman and Sears, 1996).
Classification o f  each of the kinetic classes o f transcription is dependent on 
whether or not DNA synthesis has occurred (Honess and Roizman, 1974; Honess 
and Roizman, 1975). The transcription o f a  genes occurs immediately following 
infection and does not require prior protein synthesis. Five a  genes have been 
identified, ICPO, ICP4, ICP22, ICP27, and ICP47 and have been shown to function 
in regulation o f subsequent transcriptional events. Both ICP4 and ICP27 have been 
shown to be essential for viral replication in tissue culture (Dixon et al, 1983; Sacks 
et al, 1985). Initiation o f a  gene transcription is stimulated by the virion structural 
protein a-TIF (alpha-transinducing factor) through the coordination of cellular 
transcriptional factors Oct-1, TFIED, and SP1 binding to c/J-acting sequences 
upstream of viral genes (Gerster and Roeder, 1988; Spector et al, 1990).
Accumulation o f a  gene products activates p gene transcription, many o f 
which are enzymes involved in nucleotide metabolism and DNA synthesis/
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replication (Roizman and Sears, 1996). |3 gene transcription has the capacity to be 
active in the context o f the cellular genome in the absence o f viral gene products 
(McKnight and Kingsbury, 1982; McKnight et al, 1984). However, in  the context 
o f the viral genome, (3 gene transcription is dependent on and greatly increased by a  
gene expression, especially ICP4 (Krisitie and Roizman, 1984). Trans-activation o f  
P genes involves both release from the repressive state and transcriptional 
transactivation. Production o f P gene products initiates viral DNA synthesis and 
replication (Roizman and Sears, 1996).
P gene transcription in turn leads to the final kinetic class o f gene 
transcription-the y kinetic class. The y genes can be subdivided into y 1 and y 2 gene 
types. Expression o f the yl gene products is enhanced, but not dependent, on the 
completion o f viral DNA replication; whereas, the y2 kinetic class is stringently 
dependent on viral DNA replication. Regulation o f y genes is quite complex and 
has been shown to involve: a) a  proteins; b) repression during early stages of 
infection; c) S’ response elements in transcribed coding and non-coding domains; d) 
activation of gene expression following the onset o f viral DNA synthesis. Many o f 
the HSV y gene products comprise the structural components o f virion particles. 
Therefore, y gene product accumulation leads directly to virion assembly and 
eventually to virion maturation (Roizman and Sears, 1996).
Viral DNA Replication and M etabolism : Following entry into the nucleus, 
the linear double stranded DNA viral genome circularizes into a head to tail 
concatamer (Jacob et al, 1979; Jacob and Roizman, 1977) and begins transcription 
o f a  genes; however, only a small portion o f the total input viral DNA undergoes
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replication. Viral DNA synthesis is detected as early as 3 hours post infection and 
roughly corresponds with the appearance o f P gene products. Although DNA 
synthesis occurs from 3 to 15 hours post infection, the bulk o f the viral DNA is 
made relatively late in infection.
Seven virus-specified proteins (Ul5, U l8, Ul29, Ul30, Ul42, and Ul52) are 
essential and sufficient for HSV origin dependent replication in transfection assays 
(Wu et al, 1988). The Ul30 and Ul42 gene products form a heterodimeric DNA 
dependent DNA polymerase o f which the U l.30 protein forms the catalytic subunit, 
while the double stranded DNA binding U l42 protein confers processivity to the 
complex. DNA synthesis is further facilitated by a single stranded DNA binding 
protein (Ul29), an origin o f replication binding protein (Ul9) that possesses helicase 
activity, as well as a heterotrimeric complex (Ul5, Ul8, Ul52) that possesses both 
5’ and 3’ helicase and primase activities (Crute and Lehman, 1991; Crate et al.,
1989).
The HSV genome specifies three origins (ori) o f replication. These origins 
have been deduced from the structures o f defective genomes and defined by the 
necessity o f their presence in a HSV DNA fragment to allow for DNA amplification 
in permissive cells. Two o f the three origins (orisl and oris2) map within the c 
reiterated sequences (see figure 1.2 for localization) o f the Us component, while the 
third origin (ori(.) maps in the middle o f the U l component. All three origins are 
situated between transcriptional initiation sites, suggesting that initiation o f DNA 
synthesis may be enhanced by trans-activation due to the local environment o f the 
genome during transcriptional initiation events. Replication o f the viral genome
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may originate in either direction from any o f the three origins o f replication 
(Roizman and Sears, 1996).
Early in DNA synthesis, only parental circular DNA and linear branched 
forms can be detected. These are replaced at later times in DNA synthesis by 
rapidly sedimenting tangled DNA consisting o f large tandemly repeated viral 
genomes arranged in head to tail concatamers. Circular duplex DNAs generally 
replicate in a theta (0 ) structure (Elson etal, 1995) or through a rolling circle 
mechanism (Becker et al, 1978; Jacob et al, 1979). Although rolling circle DNA 
replication may be involved in the generation o f the concatameric HSV genomic 
complex, it is also possible that HSV DNA replication occurs by an inherently 
recombinogenic mechanism. This may account for the presence o f intermediate 
structures found at early hours after infection. T4 bacteriophage DNA replication 
similarly results in intermediate branched forms o f viral DNA that are resolved prior 
to packaging by the T4 endonuclease VII (Kemper et al, 1984; Mizuuchi et al,
1988). HSV mutants defective in the alkaline nuclease (Ul12) gene, believed to 
function in a manner analogous to the T4 endonuclease VII, were defective in the 
production o f mature DNA containing capsids. Furthermore, the complex branched 
structures within the viral genomes are not resolved in Ul12 defective viruses, 
suggesting that the HSV alkaline nuclease does indeed function in resolving the 
branched DNA structures (Martinez et al, 1996).
In addition to alkaline phosphatase, there are several other virally encoded 
proteins that while not essential for DNA synthesis, undoubtedly play a role in the 
processing, cleavage, and packaging o f genomic viral DNA. These proteins include
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thymidine kinase, ribonucleotide reductase, uracil DNA glycosylase, and dUTPase 
reductase (Roizman and Sears, 1996).
Although the Ul23 thymidine kinase (TK) gene is dispensable in cell 
culture, it is vital for virus replication in natural in vivo infections (Field and Wildy, 
1978). TK functions in phosphorylation o f purine pentosides and a w ide diversity 
o f other nucleotide analogs that are not phosphorylated by cellular kinases 
(Jamieson and Subak-Sharpe, 1974; Klemperer, eta l, 1967). This unique property 
o f TK is the basis of herpesvirus antiviral treatments. Antivirals such as the 
guanosine acyclic analog, acyclovir, is mono-phosphorylated by the viral TK, 
making it susceptible to further phosphorylation by cellular kinases. Acyclovir 
triphosphate binds viral DNA polymerase and acts as a DNA chain terminator 
(Elion et al, 1977; Schaeffer et al, 1978).
The ribonucleotide reductase is a heterodimeric protein consisting o f both a 
large (U l3 9 ) and small (Ul40) subunit that together function to reduce 
ribonucleotides to deoxyribonucleotides. This process effectively creates a large 
pool o f substrates for DNA synthesis (Honess and Roizman, 1974; Honess and 
Roizman, 1975; Huszar and Bachetti, 1981; Preston etal, 1984). Deletion o f the 
HSV ribonucleotide reductase is deleterious only in non-dividing cells or in cells 
maintained above 39.5°C, indicating that actively dividing cells are capable of 
complementing this viral function (Daikoku et al, 1991; Goldstein and Weller, 
1988).
HSV also encodes for a proofreading and DNA repair enzyme, uracil DNA 
glycosylase (Ul2). Uracil DNA glycosylase functions to correct insertion o f dUTP
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and deamination o f cytosine residues in DNA, two o f  the most common mutational 
events that occur within DNA. This proofreading activity is an important element in 
the context o f  the herpes virus genome, which has an extremely high G+C content 
(Caradonna and Cheng, 1981; Caradonna et al, 1987; Mullaney et al, 1989).
The Ul50 viral dUTPase (deoxyuridine triphosphate nucleotidohydrolase) 
functions to hydrolyze dUTP to dUMP providing an additional method to prevent 
the incorporation o f dUTP into viral DNA. Furthermore, hydrolysis o f dXJTP to 
dUMP generates a pool o f dUMP for conversion to dTMP by thymidylate 
synthetase (W ohlrab and Francke, 1980).
C apsid  Assembly and Packaging: Herpes capsids are assembled and 
packaged exclusively within the host cell nucleus (Darlington and Moss, 1968; 
Schwartz and Roizman, 1969) at distinct regions o f  dense nuclear structures 
designated as “assemblons.” These regions are localized to the periphery o f the 
nucleus and are separate from the viral DNA replication centers.
Capsid assembly begins upon the transport o f  capsid proteins to the nucleus. 
Genetic and biochemical analysis suggests that seven proteins (VP5, VP 19c, VP22a, 
VP23, VP24, and VP26) encoded by six viral genes (U l19, Ul38, Ul26.5, Ul18, 
Ul26, and U l35, respectively) are necessary and sufficient for HSV capsid 
assembly. Three basic capsid forms are evident w ithin thin sections o f  infected cell 
nuclei: a) empty capsids with no internal structure (A capsids); b) intermediate 
capsids that lack DNA, but contain a proteinacious core within the outer capsid shell 
(B capsids); c) capsids which contain the viral genome (C capsids) (Roizman and 
Furlong, 1974; Roizman and Sears, 1996).
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The empty A capsids consist of four proteins, VPS, V Pl9c, CP23, and 
VP26. It has been suggested by Sherman and Bachenheimer (1988) that A  type 
capsids are not in the virion morphogenesis pathway, but rather that A type capsids 
represent a terminal decay product o f B capsids (Sherman and Bachenheimer,
1988).
B type capsids, however, are the progenitors if  both A and C type capsids, 
the latter o f which is awaiting DNA packaging. B capsids contain three additional 
proteins, VP21, VP22a, and VP24. Both VP21 and VP22a are absent from mature 
C type capsids and may account for the appearance o f the proteinacious core within 
B type capsids that form the scaffolding for proper capsid assembly.
Localization of the major capsid protein VP5 to the nucleus is dependent on 
its interaction with the scaffolding protein VP22a (Matusick-Kumar et al, 1994; 
Nicholson et al, 1994). Further association ofV P22a with itself and proteolytic 
processing form a structure to which other capsid proteins can attach and assemble 
(Thomsen et al, 199S) into large-cored B capsids. The outer icosadeltahedral shell 
is formed by VP5, VP19c, VP23, and VP26, while VP22a forms the internal 
scaffold structure. Proteolytic cleavage of VP22a yields two proteins, VP21 and 
VP24, and alters the morphology o f the capsid structure to that o f a small-core B 
capsid. C capsids are formed following the insertion o f the viral DNA genome and 
removal o f the scaffolding proteins VP22a and VP21 (Roizman and Sears, 1996).
Packaging of the viral genome into preformed B capsids occurs immediately 
following or concurrent with DNA replication. Cleavage o f concatameric DNA into 
unit length viral genomes occurs at specific recognition sequences and is intimately
47
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Figure 1.6. Packaging of U nit Length Herpes Virus Genom ic DNA. The
depicted model developed by Frenkel et al (1976) and is described in the text. A) 
Proteins attach to components o f the a  sequence and the empty capsids scan the 
genomic concatameric DNA until contact with a LTC sequence. B) The capsid is 
filled with DNA until (C) filled or contact is made with an a  sequence in the same 
orientation as the first a sequence (one unit length o f genomic viral DNA). D) Each 
strand is nicked at the packaging signal on opposite sides o f  the DR1 sequence. E) 
The juxtaposition o f the a sequences results in their reiteration.
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linked with the packaging process. The inverted repeats, present at the termini o f 
the U l and Us segments o f the viral genome, contain two highly conserved site 
specific cleavage sequence elements designated pac l and pac2 within the “a” 
sequences (Figure 1.2). The cleavage-packaging reaction involves two site-specific 
breaks on either side o f the “a” sequences producing a  net result o f a free S 
component terminus containing one “a” sequence and a free L component terminus 
consisting o f a  variable number o f repeated “a” sequences. The length o f the 
packaged DNA is therefore determined by the distance between two directly 
repeated “a” sequences (Deiss etal, 1986a; Deiss e ta l, 1986b).
Detection and monitoring of the “a” sequences within the concatameric 
DNA in order to generate unit length genomes consists o f several steps (Figure 1.6). 
a) The cleavage-packaging protein attaches to the Uc sequence within the DNA. b)
A protein or protein sequence on the surface o f the capsid complexes with the 
cleavage-packaging protein bound to the Uc sequence, c) The viral DNA is looped 
into the capsid structure by the complex and scanned from the original “a” sequence 
(a l) across the L and S components, d) A Uc domain within an “a” sequence in the 
identical orientation to a  1 is detected, e) Cleavage occurs within the shared 
juxtaposed direct repeat (DR1) regions o f the two “a” sequences and generates a 
headfull capsid containing one unit length viral genome (Roizman and Sears, 1996).
Envelopm ent, M aturation, and T ranslocation o f Infectious Virions to 
E xtracellular Spaces: The final stage in the replicative cycle o f herpesviruses is 
the process o f envelopment o f nucleocapsids, maturation o f glycoproteins on the 
virion envelope, and transport o f virions to  extracellular spaces. Several herpesvirus
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genes code for proteins that are known to be involved in HSV-1 virion envelopment 
and egress. Defects in certain tegument proteins such as U lI 1, Ul48 (a-TEF), and 
ICP34.5 inhibit virus egress (Ace et al, 1988; Baines et al, 1992; Weinheimer et al, 
1992; Browne et al, 1994); whereas, deletion of other tegument proteins do not 
affect virus maturation (Fenwick et al, 1990; Post etal, 1981; Zhang et al, 1991). In 
addition, membrane associated proteins such as Ul20 and U l53 (gK) have been 
implicated in virion egress. Deletion o f the Ul20 gene caused accumulation o f 
virions within perinuclear spaces, while deletion o f gK caused an accumulation of 
virions within the cytoplasm (Baines et al, 1992; Hutchinson et al, 1995; 
Jayachandra et al, 1997). Interestingly, mutant viruses exhibiting egress defects 
could be partially complemented by certain cellular functions, because the Ul20 null 
virus replicated well on 143TK' cells and the replication o f the gK null virus was 
enhanced in actively replicating cells (Baines et al, 1992; Jayachandra et al, 1997).
Primary envelopment occurs as nucleocapsids bud through the inner nuclear 
lamella at areas o f high electron density, which is believed to represent viral 
tegument proteins (Nii et al, 1968; Roizman and Furlong, 1974). Immature viral 
glycoproteins imbedded within nuclear membranes are initially acquired during this 
budding process. Capsids that do not contain DNA or contain only fragments of 
less than full length genomic viral DNA, rarely become enveloped (Vlazny et al, 
1982). A possible explanation for the inability of these capsids to become 
enveloped is that packaging o f full length genomic viral DNA alters the capsid 
structure or composition, which in turn alters the nucleocapsids affinity for viral 
tegument proteins. Therefore, capsids lacking this putative modification would not
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interact with the tegument proteins juxtaposed with viral membrane proteins within 
nuclear membranes.
Although there is general agreement that initial virion envelopment occurs in 
this manner, there is considerable debate as to the processes o f final virion 
envelopment, maturation and transport to extracellular spaces. While envelopment 
o f virus at the inner nuclear lamella does provide the virion with its tegument, 
envelope, and viral glycoproteins, the glycoproteins within the envelope are 
immature, as they have not yet been transported to or processed by the Golgi 
apparatus. Ultrastructural examination o f Vero cells infected with a Ul20 null virus 
indicated that enveloped capsids accumulated within the perinuclear spaces (Baines 
et al, 1991). Ul20 null virions isolated from these cells contained glycoproteins o f 
the immature type, while fully mature glycoproteins were present within Golgi or 
cell surface membranes (Avitabile et al, 1994). Mature virions present in 
extracellular fluids contain fully processed glycoproteins that have been 
significantly modified by Golgi enzymes. Therefore, virions that initially acquire 
their envelopes at the inner nuclear lamella must either acquire new envelopes at 
Golgi membranes that contain fully processed glycoproteins, or must be transported 
through the Golgi pathway for subsequent in situ processing o f viral glycoproteins. 
These hypothesizes have led to two contrasting models o f herpesvirus maturation 
and egress, known as the envelopment/de-envelopment model and the vesicular 
transport model (Fig. 1.7).
Stackpole et al (1990) originated the envelopment/ de-envelopment model o f 
herpesvirus egress wherein capsids are initially enveloped at the inner nuclear
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Figure 1.7. Diagrammatic Representation o f Models of Virion Egress. Cross- 
section o f a eukaryotic cell depicting the nucleus, endoplasmic reticulum, Golgi, and 
plasma membranes. The two models o f virus maturation and egress as discussed in 
the text are shown. A) Envelopment/ De-envelopment model. B) Vesicular 
Transport model.
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lamella, de-enveloped at the outer nuclear lamella, and finally re-enveloped at Golgi 
membranes for transport to extracellular spaces. Ultrastructural examinations o f 
infected cells have revealed the presence o f un-enveloped capsids within the 
cytoplasm juxtaposed to electron dense cytoplasmic membranes in the process o f 
envelopment. Enveloped virions within cytoplasmic vesicles were also observed 
fusing to these vesicles depositing naked capsids into the cytosol (Stackpole et al,
1990).
In this model, naked nucleocapsids within the cytoplasm represent a 
prerequisite step for budding into Golgi-derived vacuoles, generating enveloped 
virions containing fully processed glycoproteins. Enveloped virions are then 
transported to extracellular spaces within Golgi derived vesicles that fuse to the 
cellular plasma membrane depositing infectious virions into the extracellular spaces. 
In support o f this model, recombinant viruses have been constructed that specify 
virion glycoproteins modified to be retained within the endoplasmic reticulum by 
means o f the ER retention motif, KKXX. This targeting signal appended to a 
glycoprotein H (gH), conferred the predicted localization properties on gH in 
recombinant virus infected cells. Furthermore, the gH polypeptide failed to be 
processed to a mature form by Golgi modification enzymes, indicating that it was 
indeed retained within the ER (Browne et al, 1996). Glycoprotein H is an essential 
virion glycoprotein. Virus isolated from these cells was non-infectious, indicating 
that gH was not incorporated on the virion. By the envelopment/de-envelopment 
model, because gH is not transported to  the Golgi apparatus, recombinant virions 
purified from extracellular spaces should not contain gH. Consistent w ith this
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hypothesis, purified recombinant virus particles contained normal amounts o f other 
virion proteins; however, they did not contain any detectable amounts o f  gH  
(Browne et al, 1996). Targeting wild-type gH to the Golgi in trans restored virus 
infectivity, suggesting that gH was incorporated into the excreted virions (Browne et 
al, 1996). One critique o f this model is based on how cells differentiate between 
cytoplasmic capsids following an initial infection that are selectively transported to 
nuclear pores, versus de-enveloped capsids that must be transported to  G olgi 
membranes in order to acquire their envelopes.
A second model o f virus egress, designated here as the vesicular transport 
model, suggests that virions follow the cellular secretory pathway during 
translocation to extracellular spaces (Figure 1.7). The process of transport would 
therefore be similar to that described in subsequent sections o f this dissertation for 
protein transport The vesicular transport model diverges from the envelopment/de­
envelopment model following envelopment at the inner nuclear membrane.
Whereas enveloped virions are predicted to fuse to the outer nuclear lam ella in the 
envelopment/de-envelopment model, virions within the perinuclear space are 
thought to bud from the outer nuclear lamella into transport vesicles in th e  vesicular 
transport model. In a manner analogous to vesicular transport of proteins in cells 
from the ER to the Golgi, virions would then be trafficked to the Golgi fo r 
processing and modification o f immature glycoproteins in situ during translocation 
to extracellular spaces (Di Lazarro et al, 1995; Johnson and Spear, 1982; Torrisi et 
al, 1992). Fusion of the transport vesicle to Golgi membranes deposits enveloped 
virions into the lumen o f the Golgi for modification. The two models d o  however
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re-converge a t this point, as cellular vesicular transport mechanisms traffic the 
enveloped virions containing fully mature glycoproteins to cell surfaces. 
Nucleocapsids devoid o f viral envelopes, which are frequently found in  the 
cytoplasm o f infected cells, are thought to represent a nonproductive population o f 
viruses (Campadelli-Fiume et al, 1991). hi support o f this model, specific inhibitors 
of glycoprotein processing and transport, such as monensin, similarly inhibit 
infectious virus production and transport (Spear and Johnson, 1982). Furthermore, 
cells defective in the processing o f high-mannose to mature oligosaccharides 
accumulate infectious virus, but do not allow its transport to extracellular spaces 
(Banfield and Tufaro, 1990; Campadelli-Fiume et al, 1982). Opponents to this 
model suggest that it is unlikely that virions could be efficiently transported through 
a sequential Golgi system that is fragmented following viral infection. It is however 
interesting to note that in either model, cellular trafficking pathways are involved 
following processing o f virion glycoproteins.
H erpes Simplex Latency: The most unique feature o f herpes viruses are 
their ability to remain latent through the majority o f an individual’s lifetime, while 
exhibiting lim ited episodes o f recurrent lesions. Following a primary infection o f 
cells at the mucousal membranes, sensory nerves innervating mucosal tissue 
become infected and transport the virus back to the trigeminal ganglia where latency 
is established (Stevens and Cook, 1971). In latently infected neurons, the viral 
genome is maintained in a circular episomal state (M ellerick and Fraser, 1987; Rock 
and Fraser, 1983) with very little to no viral protein expression. Reactivation o f 
HSV is precipitated by several factors including, stress, fever, overexposure to
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sunlight, and the host’s immune competency (Roizman and Sears, 1996). Periodic 
reactivation o f HSV occurs in a small fraction o f neurons harboring latent virus and 
is manifested as lesions often at the same peripheral site as the primary infection 
(Goodposture, 1929; Carton and Kilboume, 1952; Roizman, 1966). The severity o f 
recurrent lesions is largely dependent on the host’s immune system, but is usually 
less severe than the primary infection (McKendall, 1979; W hitley et al, 1997).
Herpes viruses have evolved through an intimate host-virus relationship.
The major selective pressure guiding HSV evolution towards neuronal latency was 
most likely the host’s immune response. Neuronal latency provides several m ajor 
advantages in evasion o f the host’s immune system. First, during establishment o f 
latency, virus is transported intraaxonaly within cytoplasmic processes of the 
neurons to the neural bodies (Lycke et al, 1984). Therefore, the virus is not exposed 
to the immune system during transport to the sites o f latency establishment.
Second, HSV does not require replication in order for latency to be established.
This limits the availability o f antigenic markers that can be displayed by the cell to 
the immune system. Third, by definition, during latency little or no protein is 
produced and replication is silenced (Doerig et al, 1991; Rodahl and Stevens, 1992). 
Neuronal latency provides an immmunologically privileged site for maintenance o f  
the viral genome. Furthermore, the lack o f protein expression enhances the ability 
o f the virus to evade the host’s immune response by preventing or limiting the 
display o f viral antigens. Finally, even upon reactivation in the ganglion when 
infectious virus is produced, the virus remains within the cytoplasmic processes o f
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neurons and is delivered by axonal flow to target cells o f the epithelium (Cook and 
Stevens, 1973).
There are three primary animal models o f HSV latency-the mouse, the 
rabbit, and the guinea pig. hi the mouse, latency is established following 
inoculation o f the eye, footpad, or ear; however, the rate o f reactivation is extremely 
low (Hill et al, 1982). In contrast, the rabbit eye model exhibits spontaneous 
reactivation and pathogenesis similar to that o f a  natural infection (Nesbum, 1967). 
The guinea pig is used primarily for HSV-2 vaginal studies. Recurrent lesions are 
observed only with a high dose infection; however, there has been some debate o f 
whether this is a truly latent state or a festering chronic infection (Stanbury, 1982).
Following infection o f HSV in animal models, the virus replicates at or near 
the site o f inoculation ensuring entry into the innervating sensory nerve endings.
The capsid containing the viral genome is then transported by rapid retrograde 
axonal transport to the neuronal nucleus along microtubules (Kristensson et al,
1986). Drugs that either disrupt microtubule structure or inhibit retrograde transport 
similarly block the ability o f capsids to be transported to the nuclei. Replication 
often occurs within the ganglia for a short period of time; however, this may be an 
artifact o f the large amount o f virus used in infectious inoculums and most probably 
does not occur in humans (Klein et cd, 1978).
Approximately 0.1 to 1 latent viral genomes exist per 1 ganglionic cellular 
genome equivalent with only 0.1% to 3% o f neurons within ganglia harboring virus 
(Rock and Fraser, 1985; Cabrera et al, 1980). Intriguingly, neurons only account 
for about 10% o f the total cell mass o f ganglia (Rodahl and Stevens, 1992).
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Therefore, unless every cell within the ganglion, including glial cells, contains a 
viral genome, it is obvious that each latently infected neuron m ust contain more than 
one copy o f the genome. This copy number must however be reached without the 
necessity for viral genome replication by viral enzymes. Indeed, it has been shown 
that within neurons that exhibited no viral antigen expression, the copy number o f 
viral genomes was greater than twenty genomes (Roizman and Sears, 1996). Thus, 
either more than one viral genome can enter a single neuron during the 
establishment o f latency o r viral genomes can be amplified by cellular machinery 
during latency.
Two to four weeks post infection, no replicating virus can be detected within 
sensory ganglia that innervate the site o f inoculation. Co-culture o f extracted 
latently infected ganglia w ith permissive epithelial cells produces infectious virus 
only if  the ganglia are fully intact. Production of infectious virus following 
maceration indicates that infectious virus is present and the virus never truly 
established latency.
To date, no gene sequence or viral protein has been implicated in the 
maintenance o f the latent state. In fact, only one family o f transcripts, designated 
LAT (Latency Associated Transcripts), is detected during latency (Stevens et al,
1987). LAT is relatively abundant during latency and accumulates within the cell’s 
nucleus; however, the transcript does not specify a protein. LAT is a nuclear RNA 
o f approximately 2 Kb in length derived from a primary transcript o f 8.3 Kb 
(Mitchell et al, 1990). It was originally postulated that the 3’ terminus of the LAT 
transcript, which is antisense to the major regulatory ICPO gene, functioned to
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preclude the expression o f ICPO and therefore preclude the initiation of gene 
expression. Although this theory is quite logical, it did not prove to be the case. In 
the absence o f  LAT viral gene expression is still silenced and the latent state is 
similarly maintained. It is not conceivable that a  transcript with all its regulatory 
elements has been conserved throughout evolution in both HSV-1 and HSV-2 if  it 
does not perform some function. This function however, remains an enigma 
(Roizman and Sears, 1996).
External stressors, including stimuli such as physical and emotional stress, 
peripheral tissue damage, or immune suppression results in the reactivation of virus 
and transport to a site near the portal o f entry. Most commonly, reactivation is 
induced experimentally by physical trauma, iontophoresis o f epinephrine or other 
drugs, transient hyperthermia, comeal scarification, or injection o f immuno- 
supressants. Reactivation by these means allows for the detection o f infectious 
virus near the sites o f the portal o f entry. Similar to the in vivo situation, exhibited 
lesions are observed that are generally less severe than that seen upon initial 
inoculation (Roizman and Sears, 1996; Whitley et al, 1997).
G lycoprotein Processing and T ransport
N -linked glycoprotein synthesis and processing: The majority o f proteins 
directed into the rough endoplasmic reticulum are destined for the covalent addition 
o f oligosaccharides and transport to the Golgi apparatus, lysosomes, the plasma 
membrane, or the extracellular spaces. Cytosolic proteins seldom are glycosylated; 
however, those that are contain only simple oligosaccharide modifications.
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Although some O-linked glycosylation occurs at the hydroxyl group o f serine or 
threonine residues within the Golgi apparatus, the most common oligosaccharide 
modification of proteins is N-linked or Asparagine-linked (Asn-linked) 
glycosylation (Hubbard and Ivatt, 1981; Komfeld and Komfeld, 198S).
Asn-linked glycosylation consists o f the en bloc transfer o f a  preformed 
fourteen sugar residue complex to the side chain NH2  group o f  an Asn residue 
contained within the amino acid m otif Asn-X-Ser/Thr (where X is any amino acid 
except proline). The oligosaccharide complex is assembled by sequential addition 
o f sugars onto a dolichol lipid embedded within the ER membrane prior to its 
transfer to the newly synthesized protein. Attachment o f the sugar residues to the 
dolichol lipid is mediated through a high-energy pyrophosphate bond. Nucleotide- 
sugar intermediates (UDP-GlcNAc or UDP-Man) then assemble within the cytosol 
the core sugar, (GlcNAc>2(Man)s, onto the dolichol lipid in a strictly ordered fashion 
(Bergnan and Kuehl, 1978; Roberts eta l, 1978; Ronnetand Lane, 1981). Following 
assembly o f the core sugars within the cytoplasm, the dolichol-sugar complex is 
flipped into the lumen o f the ER where the sequential incorporation o f four 
additional mannose residues and three glucose residues occurs (Fig. 1.8). These 
seven sugar residues are transferred to the complex through a dolichol phosphate 
intermediate (Dol-P-Man or Dol-P-Glc). Transfer o f the complex to the newly 
synthesized protein occurs en bloc and is facilitated by the presence o f the terminal 
three glucose residues (Snider and Rogers, 1984; Snider and Robbins, 1982; Turko 
eta l, 1977; Spiro e ta l, 1979).
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Figure 1.8. Synthesis o f lipid linked oligosaccharides in the rough endoplasmic 
reticulum . Oligosaccharides are assembled on a dolichol lipid intermediate 
embedded within the membrane o f the ER in a step wise fashion prior to an en bloc 
transfer to a newly synthesized protein as described in the text
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Processing and trimming o f the primary oligosaccharide structure accounts 
for the vast diversity o f carbohydrates exhibited by glycoproteins. Initial trimming 
occurs rapidly within the ER with the removal o f  three glucose residues and one 
mannose residue (Atkinson and Lee, 1984). This process serves as a checkpoint for 
signaling that the glycoprotein is correctly folded. Removal o f these residues is 
essential for the glycoprotein to be transported from the ER to the Golgi apparatus 
where oligosaccharides are further trimmed and processed. If  however the 
glycoprotein becomes unfolded or misfolded following trimming, glucose is added 
back to the protein preventing transport from the ER. Generally, there are several 
rounds o f removal and addition o f glucose residues prior to the protein being 
properly folded and prepared for transport (Parodi et al, 1984). The ER resident 
membrane anchored chaperone protein calnexin is pivotal in assuring that the 
protein is correctly folded. Any glycoprotein within the ER that contains one or 
more glucose residues remains bound to calnexin until it is properly folded and the 
glucosylation ceases. Therefore, the final quality o f the glycoproteins being 
transported from the ER is assured (Lodish and Kong, 1984; Schlesinger et al, 
1984).
Vesicular transport, as discussed in a subsequent section o f this dissertation, 
mediates the transport o f glycoproteins from the ER to the cis phase o f the Golgi 
apparatus, as well as from the Golgi apparatus to the cellular surfaces and other 
cellular organelles (Jamieson and Palade, 1968). The Golgi apparatus consists o f 
several flattened membranous cistemae that each specify within their lumen an 
ordered and specialized oligosaccharide processing function. These cistemae can be
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differentiated into three distinct processing compartments: the cis compartment or 
face o f entry; the medial compartments or central compartments; and the trans 
compartment where glycosylation processes are completed. Furthermore, the trans 
compartment is thought to be continuous with the lumen o f the trans Golgi network, 
where proteins are segregated and sorted into vesicles for transport to their final 
destinations (Komfeld and Komfeld, 1985).
Following processing by Golgi enzymes, there are two broad classes o fN - 
linked oligosaccharide containing proteins, the complex oligosaccharide and the 
high mannose oligosaccharides containing glycoproteins. High mannose 
oligosaccharides contain two N-acetylglucosamine residues and a number o f 
mannose residues, hi contrast, complex oligosaccharides contain several N- 
acetylglucosamine residues and may further contain a  variable number of galactose, 
sialic acid, and focose residues. The structures of the complex oligosaccharides are 
generated through a combination o f both trimming and addition o f sugars.
However, despite the extensive trimming and processing that occurs within the 
Golgi, all glycoproteins maintain a common pentasaccharide core consisting o f 
three mannose residues anchored to the protein backbone by two N- 
acetylglucosamine residues (Komfeld and Komfeld, 1985).
The determination o f whether or not oligosaccharides remain high mannose 
or are subsequently processed to complex oligosaccharides is due to the 
conformation o f the protein. Inaccessibility o f oligosaccharides by Golgi processing 
enzymes prevents further trimming and additions. Therefore, it is less likely to  be 
converted to a complex form. This process accounts for the presence of both high
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mannose and complex oligosaccharides at different sites on the same glycoprotein 
(Komfeld and Komfeld, 1985).
The glycoprotein enters the cis face o f the Golgi containing two N- 
acetylglucosamine residues and eight mannose residues. If the conformational 
environment o f the protein permits, Golgi mannosidase I removes three mannose 
residues. Immediately following this removal and subsequent transport to the 
medial cistemae o f the Golgi, N-acetylglucosamine transferase I adds N-acetyl 
glucosamine allowing Golgi mannosidase II to remove an additional two mannoses. 
This generates the pentameric core sugar with an additional N-acetylglucosamine 
that is ubiquitous for all complex oligosaccharides. Moreover, the oligosaccharide 
structure is now rendered resistant to cleavage by Endoglycosidase H or F treatment 
(Komfeld and Komfeld, 1985). The oligosaccharide complex is further processed 
through the incorporation o f two additional N-acetylglucosamines, three galactose 
residues, and three N-acetylneuramic acid residues within the trans cistemae o f the 
Golgi (Fig. 1.9). Within the trans Golgi network, glycoprotein cargo is sorted and 
segregated for transport to the extracellular spaces or to other cellular organelles 
through an extensive and complex vesicular trafficking system that will be 
discussed in a subsequent section o f this dissertation.
Cargo Loading and Vesicle-Mediated Transport: Transport between 
organelles and a cellular membrane is a highly ordered and directed process that is 
dependent on an array o f proteins, lipids, and enzyme complexes. Each stage in the 
series o f transport steps requires the assembly and disassembly of complex 
structures, as well as the regulation o f their transport. This ordered process assures
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Figure 1.9. Processing of oligosaccharides within the endoplasm ic reticulum  
and Golgi apparatus. Processing o f oligosaccharides is highly ordered and follows 
a strict pathway that begins within the ER with the removal o f three glucose 
residues. The remaining steps occur within the stacks o f the Golgi apparatus as 
depicted above. Notably, removal of two mannoses by mannosidase H in the medial 
cistemae renders the bond between the two JV-acetylglucosamines resistant to 
cleavage by Endoglycosidase H.
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that cargo within vesicles reaches targeted organelles, cell surfaces, or extracellular 
spaces. During transport through the secretory pathway, each molecule passes 
through multiple cellular compartments, where the molecule can be modified in a 
series of controlled steps, stored until needed, or packaged for delivery to a specific 
site or region o f the cell surface.
Although similar transport events also occur during endocytosis, the vast 
majority o f this section will focus on the process o f transport to  and between 
organelles that eventually leads to exocytosis o f vesicular cargo. This focus is 
because during a herpes infection, the majority of the processes that are occurring 
are exocytotic in nature. This includes the transport o f virion glycoproteins to cell 
surfaces, as well as the transport o f other macromolecules, including virion particles 
to extracellular spaces. In this regard, a portion of this section may explain the 
possible mechanisms o f transport o f infectious virions to extracellular spaces, as 
discussed in an earlier section o f this dissertation. This section will however briefly 
review the mechanisms for recycling o f proteins from the cell surface. Protein 
recycling is o f recent interest as many herpesvirus proteins have been shown to be 
cycled between cell surfaces and cellular organelles through processes analogous to 
many cellular proteins. The biological relevance for this recycling during infection 
is in its infancy, but it is becoming increasingly important in understanding herpes 
viral pathogenesis.
Protein Transport between the Endoplasmic Reticulum (ER) and Golgi:
As discussed in the previous section o f this dissertation, newly synthesized proteins 
enter the biosynthetic-secretory pathway by crossing the ER membrane from the
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cytosol (Hubbard and Ivatt, 1981; Komfeld and Komfeld, 1985). All subsequent 
transport steps between organelles are facilitated through transport vesicles in a 
series o f vesicle budding and fusion events. Once a protein has entered the ER, 
transport from the ER to the Golgi and finally to the cell surface occurs without the 
requirement for specific transport signals. In contrast, proteins that are destined to 
remain within these organelles or are destined to be transported to other organelles 
specify retention or transport motifs within their amino acid sequence. Retention 
motifs therefore selectively cause the retention o f  ER resident proteins from vesicles 
when cargo is transported to the next compartment (Hardwick and Pelham, 1992). 
However, proteins that direct the vesicular transport between organelles and 
regulate the fusion process o f vesicles with the next compartment must be recycled 
in retrograde vesicles back to the previous compartment.
Two types o f protein coated vesicles shuttle cargo between the ER and Golgi 
and are defined by the type o f cytosolic proteins that are coalesced with the vesicles 
surface(Bednarek et al, 1995; Scheckman and Orci, 1995). These two distinct 
protein complexes are termed coatomer (or Coat Protein I [COPI]) and COPII. Both 
COPI and COPII coated vesicles include fiisogenic proteins designated as v- 
SNAREs (soluble NSF attachment protein receptor) that act in coordination with the 
Golgi t-SNARE or the ER t-SNARE to facilitate fusion o f the vesicle to the targeted 
organelle membrane (Lewis and Pelham, 1996; Lupashin et al, 1996). Although 
both COPI and COPII coated vesicles bud from the ER, only COPII has been shown 
to be involved in anterograde transport to the Golgi. COPI coated vesicles are 
associated with cargo that contains ER retention/retrieval motifs (KKXX, KXKXX,
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K/HDEL, where X is any amino acid). In this manner, COPI coated vesicles may 
shuttle cargo back to the ER (retrograde transport) in order to replenish proteins 
necessary for budding and fusion o f vesicles (Kuehn and Schekman, 1997).
The high concentration o f a given cargo in COPII coated vesicles favors the 
active selection o f such molecules, which would envisage specific cargo receptors 
(Balch et al, 1994; Bednarek et al, 1995; Mizuno et al, 1993;). This would entail 
cargo receptors or coat adapters interacting with one or more transport signals on 
cargo molecules; however, signals for ER to Golgi transport o f cargo have yet to be 
identified. Interestingly, cyclohexamide treatment o f cells, which inhibits protein 
synthesis and therefore depletes the available cargo, does not inhibit vesicle 
budding, suggesting that COPII vesicle formation is independent o f the presence of 
cargo (Yueng et al, 1995).
Assembly o f COPII components occurs sequentially on a specific cytosolic 
portion o f the ER, beginning with the recruitment o f a small GTP binding protein. 
Following sequential assembly o f the COPII proteins, the cargo destined for 
transportation is selected and ER resident proteins are excluded through a yet to be 
identified mechanism. Proteins necessary for recognition o f Golgi membranes as 
well as the fusion event with those membranes, such as the v-SNARE protein, are 
also included during vesicle morphogenesis (Shekman and Orci, 1996). Following 
vesicle morphogenesis, the COPII coated vesicle is directed to the cis phase o f the 
Golgi where the v-SNARE protein within the vesicle recognizes the t-SNARE 
protein o f the Golgi. Docking o f the two SNARE proteins is necessary, but not 
sufficient for vesicle fusion. A GTPase component o f the COPII protein complex,
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Rab proteins, recognize the binding o f complimentary SNARE proteins and lock the 
docked vesicle onto the target membrane by hydrolyzing the bound GTP. Fusion o f 
the vesicle to target Golgi membranes deposits the cargo into the Golgi for 
additional processing, sorting, o r transport (Shekman et al, 1995; Kuehn and 
Shekman, 1997).
Protein Trafficking between the Trans Golgi and Cell Surfaces:
Transport vesicles containing membrane proteins and lipids traffic from the trcms 
Golgi network (TGN) to cellular surfaces providing new components for the cell’s 
plasma membrane, while soluble proteins present within these vesicles are secreted 
to the extracellular spaces. This process, known as the constitutive secretory 
pathway provides for the majority o f the cell’s proteoglycans and glycoproteins o f 
the extracellular matrix. In polarized cells, a variation o f the constitutive cellular 
surface transport route occurs, such that proteins destined for basolateral delivery 
are differentially sorted from that cargo which is destined for apical surfaces 
(Cosson and Letoumeur, 1997).
Separation, sorting, and packaging o f proteins for transport to their final 
destination occurs within the trans Golgi network. Despite extensive efforts to 
characterize the pathways o f transport from the TGN to cell surfaces, sorting and 
trafficking mechanisms from the TGN have proven to be more complex and more 
numerous than initially anticipated. The process o f transport from the TGN to the 
cell surface is similar to transport from the ER to the Golgi in that coated vesicles 
mediate the transport o f the cargo. However, the composition o f the coat proteins 
remains to be established. Several coatlike proteins, including p62 (Jones et al,
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1993), p200 (Narula et al, 1992; Naiula and Stow, 1995); and p230 (Kooy e t al, 
1992), have been identified. Furthermore, these proteins have been shown to cycle 
on and off TGN membranes and are localized to coated buds and vesicles in the 
TGN region (Kooy et al, 1992; Simon et al, 1996). Unfortunately, the function o f 
these proteins in vesicle transport is yet to be identified.
Although little is known about the transport through the constitutive 
secretory pathway, there are well-identified cytosol-oriented signals that mediate the 
transport o f cargo in the selective transport pathway through the intracellular 
endosomal membrane system. Curiously, the basolateral and lysosomal targeting 
signals both contain similar tyrosine- and dileucine- based signals; however, these 
signal motifs interact with the coat proteins with different affinities. Therefore, 
minor differences within these signals separate proteins selectively either into 
basolateral-destined vesicles or lysosomal destined vesicles. Moreover, these same 
motifs function in the recycling o f cell surface proteins back to the TGN and prevent 
the delivery o f these proteins to clathrin coated lysosome-destined vesicles.
In fact, the p. subunits o f AP-1, AP-2, and AP-3 (adapter proteins 1, 2, and 3) 
do exhibit different binding affinities for certain sorting signals (Ohno, et al, 1995; 
Ohno et al, 1996). In this manner, adapter proteins (AP) interact with cargo directly 
and facilitate the coalescence o f specific coat proteins on the emerging vesicle. 
Therefore, it is the cargo that selects for the type o f coated vesicle that w ill be 
formed and by this selection the destination o f the vesicle (Cosson and Letoumeur, 
1997). It is however not yet possible to assign specific coats to a specific sorting 
route from the TGN. Moreover, it is apparent that vesicular trafficking is subject to
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additional levels o f  regulation, including protein phosphorylation (Simon et al, 
1996a; Simon eta l, 1996b).
Proteins Recycle from the Cell Surface via Endocytosis: Internalization 
o f proteins from the cellular surface occurs in a manner analogous to endocytosis o f 
extracellular materials, except that the signals required for internalization are 
different. Cytosolic signals direct the rapid internalization, as well as the 
intracellular targeting to specific membranes. Two common signal motifs contain a  
critical tyrosine residue (YXX0, where 0  is any bulky hydrophobic amino acid) or 
a dileucine m otif (Trowbridge etal, 1993; Mellman 1996; Marks eta l, 1997). 
Although these signals function in internalization from the plasma membrane, 
subsets o f these signals are involved in the targeting of proteins to lysosomes, the 
TGN, basolateral surfaces o f the plasma membrane, and endosomal/lysosomal 
compartments (Mellman, 1996; Marks e ta l, 1997).
The tyrosine-based signal motif, Y X X 0, has shown a high affinity for the 
adapter protein (AP) family of proteins. As would be expected for interactions 
reliant on a limited number of recognition molecules, internalization through these 
signals is a saturable process (Marks et al, 1996). Phosphorylation abrogates the 
ability o f the AP2/p2 subunit to bind to the tyrosine-based motif. Thus, 
phosphorylation provides a means to regulate the interactions and subsequent 
vesiculation (Shiratori et al, 1997). Regulation o f p2 interactions is regulated by 
other methods as well. Phosphorylation o f residues adjacent to the signal modifies 
the local environment and the conformational context o f the signal, making the 
signals more or less accessible for interaction with the adapter proteins. Another
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important determinant in these interactions is the oligomeric state o f the membrane 
proteins. Oligomeric complexes o f proteins, which may occur at a  greater frequency 
when being localized into coated pits prior to internalization, would be expected to 
dramatically increase the avidity for the adapter proteins.
Clathrin-based vesiculation from the plasma membrane is the best described 
system for internalization o f plasma membrane receptors. Binding o f adapter 
proteins to the signal motifs within membrane  proteins facilitates clathrin coat 
assembly and regulates the recruitment o f other coat components. Membrane 
proteins specifying internalization motifs are concentrated within coated pits at the 
surface of the cell. The main structural component o f these pits is clathrin, a 
trimeric scaffold protein organized into cagelike lattices on cytosolic surfaces of the 
plasma membrane (Kirchhausen, 1993). Clathrin functions as the organizing 
framework for proteins that facilitate the sorting, membrane budding, and other 
steps in vesicle assembly, uncoating and fusion.
Although most adapter proteins recruit clathrin as the framework for 
vesiculation, other adapter proteins, such as AP3, are non-clathrin associated 
(Dell’Angelica et al, 1997; Simpson et al, 1997). The process o f transport is further 
complicated by similar adapter protein complexes mediating transport from the 
TGN to cellular surfaces, as well as from cellular surfaces back to the TGN. In 
either process, during or after signal-adapter interaction, the coat is assembled in a 
coordinated manner; however, the precise sequence o f events in vesicle formation is 
still largely unknown.
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Herpes Simplex Glycoproteins and their Putative Functions
The herpes simplex virus genome specifies at least eleven glycoproteins, 
designated gB, gC, gD, gE, gG, gH, gl, gJ, gK, gL, and gM (Figure 1.10). These 
glycoproteins function in a number o f important events during the virus replicative 
cycle including virus attachment, penetration, cell-to-cell spread, egress, and virus 
induced cell-to-cell fusion. This section w ill summarize the important features o f 
these glycoproteins and briefly describe the putative functions associated with each. 
Conspicuously absent from this discussion is glycoprotein K (gK), which will be 
discussed extensively in the subsequent section.
Glycoprotein B (gB): Glycoprotein B, encoded by the U l27 ORF, is the 
largest glycoprotein specified by HSV-1. The precursor 904 amino acid polypeptide 
contains a cleavable 30 amino acid signal peptide (Claesson-Welsh and Spear,
1987) and three putative transmembrane regions (Gilbert et al., 1994). The 
transmembrane regions anchor and orient gB such that 696 amino acids are located 
extracellularly and encode five potential sites for N-linked glycosylation (Cai et al.,
1988), while a relatively large 109 amino acid carboxyl terminus faces the lumen or 
intracellular regions o f the cell. (Pellet et al., 1985). Following synthesis, gB forms 
homodimers within the endoplasmic reticulum (ER) through interaction o f two 
regions of the polypeptide at amino acid residues 92-282 and 596-711 (Highlander 
etal., 1991; Quadrieta l., 1991).
Glycoprotein B initially functions with gC in virus attachment to heparin 
sulfate containing proteoglycans on the surfaces o f permissive cells. Although 
virions deficient for gB are capable o f attaching to cell surfaces, these virions can
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Relative Positions of HSV Glycoproteins in the Genome
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Figure 1.10. Relative Positions of HSV Glycoproteins in the Genome. A) The prototypical 
arrangement of the HSV-1 genome is depicted with the Ul and Us regions highlighted. B) The 
relative positions within the viral genome of each of the eleven HSV-1 glycoproteins are shown.
not penetrate cells. However, addition o f fusogenic reagents, such as polyethylene 
glycol (PEG), following attachment allows the virus to enter cells and initiate a 
productive infection. Collectively, these experiments indicate that gB is required 
for the virion to cell fusion event in virus penetration.
Glycoprotein C (gC): The U[44 gene specifies the 511 amino acid 
precursor o f gC, that contains a 25 amino acid signal peptide, a 435 amino acid 
extracellular domain, a  23 amino acid transmembrane region, and a 28 amino acid 
cytoplasmic domain (Fink et al., 1983; Homa et al., 1986; Holland et al., 1984). 
Although gC has a predicted molecular mass of only 55 kDa, gC migrates at 120- 
130 kDa on SDS-PAGE due to extensive N-linked and O-linked glycosylation 
(Kikuchi et al., 1987).
While not essential for a productive infection in tissue culture cells, gC is 
believed to function in the initial attachment of virion particles to cells through 
interactions with heparin sulfate moieties ubiquitous on cell surfaces (Wudunn and 
Spear, 1989). This attachment event can however be mediated by gB in the 
absence o f gC.
Glycoprotein D (gD): The 394 amino acid precursor o f gD is specified by 
the US6 ORF and contains three sites o f N-linked glycosylation to generate a 52kD 
precursor gD molecule (Watson et al, 1982). Cleavage o f a 25 amino acid signal 
peptide, as well as conversion o f the carbohydrate additions to complex forms 
through further glycosylation and sialylation, yields a protein with an apparent 
molecular weight o f 59kD. The cytoplasmic carboxyl terminus is 32 amino acids in 
length specified by amino acids 338-369 (Minson e t al, 1986). The majority o f
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neutralizing antibodies to HSV-1 and HSV-2 react strongly with several 
discontinuous epitopes o f gD- In accordance with this, gD has been shown to be 
essential for virus entry into permissive cells. Furthermore, gD mediated entry is 
through receptor specific interactions, as gD has been shown to interact both with 
the HveA and HveC receptors (Krummenacher, 1998). Although no syncytial 
mutations have been mapped to gD, it may also function in membrane fusion 
events, hi the absence o f gD, virus mediated or in vitro initiated syncytia formation 
does not occur.
G lycoproteins E and I (gE and gl): Herpes simplex virus gE and gl are 
encoded by the neighboring US8 and US7 genes, respectively. In infected cells, 
they form a single membrane anchored heterodimeric complex. Virions deficient in 
the gE/gl complex formed small plaques on epithelial cells, but showed no defect in 
virus entry or infectious virus production indicating a possible role o f these proteins 
in cell to cell spread (Dingwell et al, 1994). Accordingly, infections o f in vitro 
cultured trigeminal ganglionic neurons with gE/gl mutants indicated that there was a 
defect in virion crossing o f cytoplasmic membranes (Dingwell et al, 1995). 
Corresponding results were observed w ith in vivo neural pathway models (Racjcani 
et al, 1990; Kudelova et al, 1991). The gE/gl complex is also capable o f binding 
the Fc portion o f IgG antibodies, providing the virus an in vivo evasion mechanism 
from specific antibody action. More recently, gE and gl have been shown to 
localize to tight junctions o f cellular membranes, presumably to facilitate virus 
spread to adjacent cells (Dingwell and Johnson, 1998).
78
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Glycoprotein G (gG): The product o f  the US4 gene, gG is localized to both 
nuclear and cytoplasmic membranes (Ackeman et al., 1986; Frame et al., 1986; 
Sullivan and Smith, 1987). In tissue culture, gG is not essential for virus entry or 
translocation o f virus to extracellular spaces; however, virions devoid o f gG are 
arrested through an unknown mechanism post-adsorbtion (Roizman and Sears, 
1996).
Glycoproteins H and L (gH and gL): The products o f  the UL22 and UL1 
genes, gH and gL respectively, form a heterodimeric complex that is essential for 
virus cell-to-cell spread, egress, and entry (Hutchinson et al, 1992a). Expression o f 
gH in the absence o f gL results in a polypeptide that is both incorrectly folded and 
processed due to its inability to be transported from the endoplasmic reticulum. 
Interestingly, expression o f the gL monomer results in its secretion from cells to 
extracellular spaces (Hutchinson et al, 1992a; Roop etal, 1993). Therefore, gL 
appears not to be an integral membrane protein, but one that is dependent on 
interactions with gH for its anchoring to membranes (Dubin et al, 1995). Virions 
devoid o f gH and gL can attach but not enter into permissive cells. Attachment o f 
these virions blocked superinfection by wild type virus, indicating that gH was 
involved in membrane fusion, but not receptor binding (Forrester et al, 1992).
Glycoprotein J (gJ): Glycoprotein J is encoded by the US5 gene and is the 
most recently described and characterized o f the HSV glycoproteins. Baculovirus 
expressed gJ exhibited an apparent m olecular weight o f 10 kD and 16-17kD and 
was shown to be glycosylated. Moreover, gJ was expressed at cellular surfaces and
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was incorporated into mature virion particles (Ghiasi et al, 1998). There has been 
no functional data described for this protein to date.
G lycoprotein M  (gM ): Glycoprotein M  is a highly hydrophobic 
glycoprotein specified by the UlIO gene. Once synthesized, the protein is tightly 
associated with membranes transversing the membrane eight times (Baines and 
Roizman, 1993). Glycoprotein M has been shown to be a component o f the virion 
particle and has been shown to be expressed a t cell surfaces. Deletion mutant 
analysis has suggested that gM functions in cell-to-cell spread as deletion of gM 
produced a virus that replicated to lower titers in certain cell lines and exhibited a 
small plaque phenotype (MacLean et al, 1993; Davis-Poyter et al, 1994).
C haracterization o f Glycoprotein K  (gK)
The vast majority o f this dissertation will focus on understanding the 
structure and function o f a single glycoprotein encoded by HSV. Therefore, it is 
only fitting that this section provides a detailed overview of the experimental work 
to date on glycoprotein K (gK). The Ul53 open reading frame (ORF) was initially 
described nearly fifteen years ago and was predicted to encode a putative 
glycoprotein with multiple hydrophobic regions. It garnered much research interest 
because o f the propensity for mutations that caused extensive cell-to-cell fusion 
(syncytia) to map to the gK gene. However, despite extensive efforts to characterize 
the Ul53 gene product and its functions, until recently gK has remained quite 
elusive.
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The U l53 ORF: The Ul53 ORF coding sequences have a GC content o f 
61%, which is relatively similar to the 67% GC content o f the viral genome (Kieff et 
al, 1971). The coding sequences o f the Ul52 and Ul53 ORFs overlap within the 
viral genome, in that the Ul52 ORF runs through the first 43 nucleotides o f U l53. 
Contained within the Ul52 ORF are several putative transcriptional signals 
including a TATA box, a CAAT signal, and a GGGCGG signal (McKnight et al, 
1984; Gidoni et al 1984), as well as two copies o f  its complement (CCCGCC). 
Approximately 10 nucleotides upstream of the predicted start codon, there is a 
sequence that is similar to the ribosomal binding sequences (TCCTCCTACA). 
Ninety-one nucleotides downstream o f the putative termination sequence there is a 
consensus polyadenylation addition signal sequence that may function to signal 
polyadenylation for both the Ul52 and Ul53 transcripts (Debroy et al, 1985).
There are conflicting reports as to which kinetic class (P or y) the transcript 
of the U l53  gene belongs. Initial reports by Debroy et al. (1985) showed that U l53 
mRNA could not be detected in infected cells in the presence o f phosphonoacetic 
acid (PAA), a  potent viral DNA synthesis inhibitor. This would tend to indicate that 
the kinetics o f  transcription for the U l53 gene would be within the y  class due to its 
dependence on viral DNA replication. However, Hutchinson et al. (1992b) reported 
that transcription o f the U l53 gene was not sensitive to PAA treatment, and thus, it 
was most likely regulated as a p class protein.
C haracteristics o f the U|.53-gK protein: The U l53 ORF is predicted to 
encode a 338 amino acid protein (Figure 1.11/ primary sequence) with very 
hydrophobic characteristics (Figure 1.12). In vitro transcription/translation analysis
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HS V-1 gK Primary Sequence
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Figure 1.11. Predicted primary sequence for HSV-1 (KOS) gK. The primary amino acid sequence of gK was deduced ftom the 
HSV-1 UL53 gene as published by Debroy et al (1985). Also shown are the relative positions of the signal sequence, sites for N- 
linked glycosylation, and four putative hydrophobic domains.
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Figure 1.12. Predictions o f hydrophilicity, surface probability, flexibility, and 
antigenic index fo r HSV-1 glycoprotein K. Analysis was performed using the 
protein analysis tool box o f the MacVector software (IBI-Kodak). A) 
Representation o f the hydrophilic profile o f gK. B) Prediction o f the surface 
probability of gK. C) Diagram ofthe relative flexibility o f HSV-1 gK. D) 
Presentation o f the antigenic index o f gK.
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8
revealed that the Ul53 gene product had characteristics o f an integral membrane 
glycoprotein including: 1) a 30 amino acid signal sequence on the amino terminus 
that was shown to be cleaved between the Gly and Ala residues following 
translation; 2) two potential sites for N-linked glycosylation within the amino 
terminal one-third o f the protein at amino acids 48 and 58; 3) four hydrophobic 
domains that have potential for transversing membranes and thus, anchoring the 
glycoprotein to the cellular membranes. However, it was recently determined by 
membrane protection assays that for in vitro transcribed/translated gK only three of 
the four hydrophobic domains transversed membranes (Mo et al, 1997). This was 
consistent with computer predictions and experimental data from our laboratory 
generated during the course of these investigations. Analysis o f the predicted 
secondary structure o f gK reveals much information as to its topology and possible 
mechanisms o f function in infected cells (Figure 1.13). A modification of the 
original Chou-Fasman prediction by Debroy et al. is schematically presented in 
Figure 1.14 and discussed later in this dissertation. We have operationally divided 
gK into four specific domains, each separated physically by transmembrane regions 
of the protein. In this modified representation, the amino and carboxyl terminuses 
of gK are placed on opposite sides o f the cellular membranes (Figure 1.14). An 
interesting consequence o f this model is that syncytial mutations that map within gK 
fall within two specific domains (I and II) and are localized to the same side o f the 
membrane (lumen/extracellular). Previously, mutations mapped to opposite sides o f 
the membrane. Therefore, for alteration o f amino acids within intracellular/ 
cytoplasmic domains to induce syncytia formation, the mutation would have to
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Figure 1.13. Prediction o f helix, sheet, and secondary structure from the 
prim ary amino acid sequence o f gK. Analysis was performed using the protein 
analysis tool box o f the Mac Vector software (IBI-Kodak). CF: Chou Fasman 
secondary structure predictions. RG: Robson-Gamier secondary structure 
prediction. Schematic o f these results are presented in Fig. 1.14.
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Figure 1.14. Schematic model of the predicted secondary structure of gK. The
gK model o f Debroy et al (1985) was modified to have three instead o f four 
membrane spanning domains are shown as embedded within the membrane (lines). 
Syncytial mutations that map to gK are indicated by asterisks.
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somehow transduce a  signal to extracellular domains. In our revised model o f gK, 
all known syncytial mutations now map to  the two extracellular domains of gK. 
Therefore, it can more easily be envisioned that either mutations directly participate 
in causing syncytia formation or alternatively, that the two domains (domain I and 
domain HI) cooperate in the regulation o f syncytia formation. An extensive review 
of HSV induced cell fusion will be presented within the next section to further 
define the current knowledge o f the role o f gK in cell fusion.
The gK polypeptide has been difficult to characterize because o f the lack o f 
immunological reagents (see antigenic index, Figure 1.12) and the high 
hydrophobicity o f the protein (Figure 1.12). Therefore, characterization of gK has 
been for the most part done by assessing the properties o f in vitro 
transcribed/translated protein (Hutchinson et al, 1992b; Mo and Holland, 1997; 
Ramaswamy and Holland, 1992). In vitro translation o f the Ul53 ORF indicated 
that the gene product was unable to enter the separating gel o f an SDS-PAGE 
following heat treatment at 100°C; however, the protein samples could be 
successfully separated in the absence o f boiling. Aggregation o f the protein products 
was abrogated by truncation o f the carboxyl terminal one-third (truncation at amino 
acid 239) of the polypeptide indicating that the domain that affected aggregation 
following heating resided between amino acids 240-298 (Ramaswamy and Holland, 
1992).
Glycoprotein K contains two possible sites (amino acid residues 48 and 58) 
for the addition o f N-linked carbohydrates (Figure 1.14). Addition o f canine 
pancreatic microsomal membranes to in vitro translated protein reactions increased
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the molecular weight o f the polypeptide by approximately 9000 Daltons relative to 
the unprocessed forms. Endoglycosidase treatment o f microsomally treated 
peptides produced similar albeit not identical banding patterns to that ofthe 
unprocessed forms. Furthermore, truncation o f these peptides to  as little as 170 
amino acids did not affect the relative shift due to glycosylation, demonstrating that 
glycosylation only occurred within the amino terminal one-third o f the protein 
(Ramaswamy and Holland, 1992).
Treatment o f microsomally processed in vitro translated protein with sodium 
carbonate results in conversion o f the closed vesicles to open sheets o f membranes 
(Fujiki et al., 1982). As a consequence, membrane associated proteins remain 
membrane bound, while soluble proteins enclosed within the microsomes are 
released. Membranes and associated proteins can be isolated by high-speed 
centrifugation, while soluble proteins can be precipitated with trichloroacetic acid. 
Therefore, by this method it can be readily assessed whether or not a protein is 
membrane associated. In vitro translated Ul53 protein and all truncated forms 
greater than 170 amino acids were shown to associate with membranes. However, 
truncation of the peptide to 112 amino acids resulted in a soluble form o f the protein 
indicating that at least one transmembrane region resided between amino acid 
residues 112 and 170 (Ramaswamy and Holland, 1992; Mo and Holland, 1997). 
Furthermore, because the 112-residue protein was soluble in these fractions, an 
amino terminal signal cleavage must have occurred to release the protein, as the 
signal sequence is a transmembrane domain prior to cleavage (Shaw et al., 1988).
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N-terminal sequencing demonstrated that this cleavage had occurred between the 
Gly and Ala residues o f the polypeptide (Ramaswamy and Holland, 1992).
Hutchinson et al. (1992b) were successful in generating antipeptide antisera 
in rabbits to three stretches o f linear amino acids within gK. To date, these sera 
have been the sole method for characterizing gK in infected cells (Hutchinson et al, 
1992b; Hutchinson et al, 1995). However, this methodology and the results derived 
from them have several disadvantages. Firstly, all antipeptide sera were generated 
within rabbits. Herpes virus glycoproteins gE and gl are notorious for binding the 
Fc portion o f rabbit antibodies. Thus, sera generated within rabbits are cross- 
reactive and non-specific in herpes infected cells-a problem easily visualized in all 
radioimmunoprecipitations (RIPS) published to date. Secondly, reaction o f these 
antibodies with protein is poor at best. This may be due to several factors including 
the relatively low levels o f expression for gK, the inability o f the protein to enter 
into SDS-PAGE, inaccessibility o f the protein due to the hydrophobic nature ofthe 
protein, and/or a low affinity o f these antibodies to their target epitopes.
In any case, the use o f antipeptide sera was essential for the initial 
characterization o f infected cell protein (Hutchinson et al, 1992b; Hutchinson et al, 
1995). In contrast with the in vitro translated gK protein, infected cell gK detected 
with antipeptide sera was not sensitive to heating. Furthermore, infected cell gK had 
an apparent molecular weight o f approximately 40 kDa compared to 36 kDa for in 
vitro translated and microsomally processed protein. This difference could not 
however be attributed to Golgi modification within infected cells as the peptide was 
endoglycosidase H/F sensitive, indicating that contrary to all other HSV
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glycoproteins, gK had not undergone extensive golgi processing. Moreover, using 
antipeptide sera, gK could not be detected as a structural component from purified 
virion extracts (Hutchinson et al, 1992b; Hutchinson et al, 1995).
Localization of HSV-1 gK: All HSV glycoproteins except gK appear as 
two protein species by SDS-PAGE analysis, differing in the composition o f N- 
linked and O-linked oligosaccharides. The feet that gK was shown to exist as a 
single 40 kDa species and to be endoglycosidase H/F sensitive indicated that gK 
was neither processed to a mature form during transit through the Golgi apparatus 
nor transported to the surface o f cells (Hutchinson et al, 1992). This assessment 
was, however, somewhat paradoxical to the role o f gK in the regulation o f syncytia 
formation. Hutchinson et al. (1995) demonstrated by immunofluorescence assays 
(IFA) using anti-peptide sera that gK did not localize to cell surfaces. Instead, gK 
was only detected in perinuclear and nuclear membranes. In contrast, all other HSV 
glycoproteins have been shown to be distributed throughout cytoplasmic and surface 
membranes. Interestingly, localization o f  gK did not change if syncytial mutations 
were introduced into gK. Thus, the effect exerted by gK in the formation o f cell to 
cell fusion would most likely be a regulatory one.
Ghiasi et al. (1994) generated antisera to gK expressed in baculovirus 
infected cells. Although not discussed by the authors, IFA’s o f either gK expressing 
baculovirus infected cells or HSV-1 infected cells appear to depict gK distributed 
throughout the cytoplasm and at cell surfaces. This localization pattern is consistent 
with the architecture and the cell fusion characteristics o f the protein, and the lack of 
endoplasmic reticulum (ER) retention signals within the gK polypeptide. Although
90
Reproduced with permission o fthe copyright owner. Further reproduction prohibited without permission.
this scenario seems most plausible, proper controls were not provided for the needed 
assessment and this antisera has not been made available for testing.
Despite initial indications to the contrary, HSV gK has been reported not to 
be a structural component o f the virion (Hutchinson et al, 1994; Hutchinson et al, 
1995). Therefore, gK cannot function in membrane fusion events other than 
syncytia formation, during entry o f the virion into cells. However, gK has been 
detected as a structural component o f several other closely related herpes viruses, 
including pseudorabies virus (PRV) (Klupp et al., 1998) and varicella-zoster virus 
(VZV) (Mo et al, 1999). It is possible that the observed differences in detection o f 
gK in PRV and VZV but not HSV, are solely dependent on the availability of 
quality immunological reagents. Detection o f gK as a structural component o f both 
PRV and VZV was achieved using sera generated in mice against bacterially 
expressed gK protein (Klupp et al., 1998; Mo et al, 1999). However, expression o f 
HSV-1 gK in bacterial systems prior to this dissertation has not been possible.
Function o f gK in the HSV-1 Lifecycle: Although the lack o f 
immunological reagents has placed limitations on the characterization o f gK, recent 
genetic studies have begun to unravel the mystery ofthe function o f gK. Initial 
attempts to isolate Ul53 null virions were unsuccessful leading many to theorize 
that the Ul53 gene was essential for virus replication in tissue culture (MacLean et 
al., 1991). Similarly, Hutchinson and Johnson (1995) isolated the mutant virus, 
designated FgK(3 that contained an insertionally inactivated Ui,53-gK gene which 
was unable to efficiently replicate in cell culture. The FgKP virus was constructed 
through the insertion o f a P-galactosidase gene cassette within the coding region o f
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the UL53-gK gene; however, the design o f this insertion allowed the amino terminal 
one-third of the gK protein to be expressed. Electron microscopic examination of 
infected Vero cells revealed unenveloped capsids dispersed throughout the 
cytoplasm indicating that gK most likely functions during egress o f virion particles 
(Hutchinson and Johnson, 1995).
Concurrent with these investigations, Jayachandra et al (1997) constructed 
the gK-null virus AgK, in which the entire coding region o f Ul53 was deleted. 
Although the AgK virus was significantly inhibited in both infectious virus 
production and virion egress, the virus was still capable o f being propagated on the 
non-complementing Vero cell line, indicating that gK was not essential for 
infectious virus production. The difference in results between these two viruses was 
attributed to the expression o f the amino terminal one-third o f gK in the FgKp virus. 
In support of this hypothesis FgK(3 produced large syncytial plaques on 143TK' 
cells, while the AgK virus did not. Furthermore, melitin a specific inhibitor of gK 
mediated syncytia formation, inhibited FgK(3 syncytia formation (Jayachandra et al, 
1997).
Glycoprotein K  and V iral Pathogenesis: There has been very little work 
done to characterize the function o f gK in HSV pathogenesis. Furthermore, 
although some o f the work arrives at very interesting conclusions, the premise of 
many o f those conclusions is questionable. Moyal et al. (1992) reported that 
mutations that mapped within the Ui.53-gK gene abolished neurovirulence in mice 
that were infected by an intracerebral route. The authors’ conclusions were based 
on sequence comparisons o f two strains o f HSV, R15 (apathogenic) and R19
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(pathogenic). Four mutations within the Ul53 gene were found that were thought to 
be responsible for the apathogenic phenotype o f HSV strain R15. Moyal et al. 
failed to sequence the pathogenic controls, but instead compared the apathogenic 
sequences to those o f published wild-type (wt) pathogenic virus strain sequences.
Of those four mutations, three were described within the Debroy et al. (1985) 
reference as “either/or” due to compressions on the sequencing gel that made 
determination of the exact sequence difficult. This sequence was subsequently 
corrected to the exact sequence, which Moyal et al. mistakenly described to be the 
changes that abolish neurovirulence. The fourth and final mutation was not a 
determinate o f neuro virulence, as other apathogenic strains also specify this 
mutation.
Recently, Ghiasi et al. (1994; 1996; 1997) have used baculovirus expressed 
HSV-1 gK to investigate the role gK plays in HSV pathogenesis. Although 
im m unization of mice with baculovirus expressed gK did not elicit neutralizing 
antibodies to gK, mice were protected against lethal intraperitoneal (i p ) challenge. 
Immunization did not however protect against establishment o f latency within the 
trigeminal ganglia (TG) (Ghiasi et al., 1994). Following intraocular infection with 
HSV, latency is established within, the TG resulting in the absence o f detectable 
infectious virus (need reference here). Because the virus within the TG is normally 
latent (existing in an episomal DNA state), reactivation following co-cultivation of 
the TG with Vero cells usually takes a week or more to detect. Mice immunized 
with gK were shown to constantly shed infectious virus; therefore, co-cultivation 
with Vero cells resulted in cytopathic changes within the first three days. Moreover,
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incubation o f TG cellular extracts from gK-immunized mice resulted in similar 
cytopathic effects (CPE); whereas, cellular extracts from the TGs o f mock 
vaccinated mice produced no cytopathic changes (Ghiasi et al., 1996). These results 
indicate that following immunization with HSV-1 gK, clearance o f virus from the 
TG is impaired resulting in a  chronic productive infection.
It could only follow that if there is constant shedding of virus from gK- 
vaccinated anim als, that there would be a significant exacerbation ofthe disease 
state. In accordance with this, Ghiasi et al. (1994) demonstrated that the severity o f 
HSV-1 induced eye disease in vaccinated mice was exacerbated relative to that o f 
control vaccinated mice. Challenge of gK vaccinated BALB/c mice with KOS 
resulted in comeal scarring, despite the fact that KOS does not normally produce 
any comeal scarring. Furthermore, challenge o f gK vaccinated C57BL/6 mice, 
which are normally refractory to HSV induced comeal scarring, with HSV-1 
McKrae strain produced significant comeal scarring. The increased severity o f 
HSV-1 induced comeal scarring was attributed to non-neutralizing antibodies 
against gK; therefore, total anti-gK mouse sera or purified anti-gK mouse IgG was 
passively transferred to BALB/c mice four hours prior to ocular challenge. 
Following challenge, anti-gK sera recipient mice exhibited increased comeal 
scarring relative to either those mice that received transfer from naive an im als or 
those that received transfer from KOS vaccinated animals. As had been 
demonstrated previously, mice that had received passive transfer from HSV KOS 
strain (live avirulent virus) vaccinated an im als  exhibited no comeal scarring 
indicating that the passive transfer was effective. While adoptive transfer o f T cells
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from mice vaccinated with KOS showed complete protection from comeal scarring, 
adoptive transfer o f T cells from gK vaccinated mice neither protected nor 
exacerbated the disease state (Ghiasi et al., 1997).
Virus Induced Syncytia Formation
Both HSV-1 and HSV-2 cause infected cells to round up and adhere to one 
another in tissue culture; however, some mutant viruses induce extensive cell-to-cell 
fusion forming large polykaryocytes. Although syncytia formation by wild-type 
virus strains does not usually occur in cell culture, syncytia formation within in vivo 
herpetic lesions is common. The specific mechanism by which herpes viruses elicit 
polykarocytosis is largely unknown. Some have suggested that the observed cell 
fusion may be a biologically irrelevant event, elicited by herpes expressed 
membrane proteins with altered structure or conformation causing an aberrant 
manifestation o f the interactions o f juxtaposed membranes. Others have argued that 
the syncytia formation is biologically relevant, providing a manner in which the 
virus can avoid the host’s immune response and insure virion spread to adjacent 
cells. In either case, virus induced cell fusion is studied for a number o f reasons: as a 
probe into the structure and function of cellular membranes, as a tool to analyze the 
structure and function o f cellular and viral membrane proteins, and as a model of 
virus to cell fusion events during virus entry and egress.
In contrast to most other viruses that induce cell fusion, herpes viruses have 
a number of proteins that the syncytial phenotype is associated. Whereas expression 
o f the fusogenic protein from other viruses generally has the propensity to cause cell
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fusion to occur, expression o f a single or several herpes virus syncytial proteins does 
not elicit syncytia formation. Therefore, it has been postulated that a complex o f 
proteins function collectively as fusion machinery, opening a fusion pore between 
adjacent cells.
Mutations, which cause extensive virus induced cell-to-cell fusion can arise 
in at least four genes of the HSV genome: the Ui.53-gK gene (Bond and Person, 
1984; Debroy e t al, 1985; Pogue-Geile et al, 1984), the UL27-gB gene (Bzik et al, 
1984; Pellet et al, 1982), the Ul20 gene (Baines eta l, 1991; MacLean eta l, 1991), 
and the Ul24 gene (Jacobson eta l, 1989; Sanders et al, 1982). However, syncytial 
mutations within the UL53-gK gene are more frequently isolated than any other gene 
(Bond and Person, 1982; Bond and Person, 1984; Dolter et al, 1994). HSV-1 gB, 
gD, gH, gL, and Ul45 have all been shown to be required for syncytia formation to 
occur, while other viral glycoproteins including gl, gE, and gM may enhance 
syncytia formation. In contrast, gC may inhibit syncytia formation o f some cultured 
cells and this may account for the absence or altered expression of gC by many 
syncytial mutants.
Glycoprotein K and HSV-1 Induced Cell Fusion: Although mutations that 
cause extensive virus induced syncytia formation map to the U[.53-gK gene more 
than any other gene, little is understood o f how gK participates in the fusion event. 
The story has become even more complicated by studies indicating that gK is absent 
from the surface o f infected cells (Hutchinson et al, 1995). It is difficult to 
contemplate how a membrane-associated protein, such as gK, can induce cell-to-cell 
fusion if  it does not localize to juxtaposed regions o f cell surfaces. Due to the
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hydrophobic nature and intimate membrane association o f  gK. (Fig. 1.12), it is a 
prime candidate for the fusogenic protein in a multiple protein complex. Therefore, 
it is more likely that the lack o f adequate gK-specific reagents has limited 
characterization o f the role o f gK plays in this process.
Amino acid changes within the gK polypeptide that result in virus induced 
syncytia formation are concentrated to two domains o f gK, domain I and domain EH 
(Fig. 1.14). Initial topology predictions localized each to opposite sides o f  cellular 
membranes with domain I localized to the luminal/extracellular sides o f membranes, 
while domain HI localized to cytoplasmic/intracellular sides o f membranes (Debroy 
et al, 1985). Consequently, mutations within domain HI could not directly 
participate in the fusion event, but rather, those mutations would have to initiate a 
conformational change within domain I that then could induce cell fusion. Thus, 
domain HI would only play a regulatory role in gK mediated cell fusion.
More recent topological studies have repredicted the structure o f gK to that 
shown in Figure 1.14. Whereas, domain I and m were first proposed to lie on 
opposite sides o f cellular membranes, the new model depicts these domains on the 
same side o f membranes (Mo and Holland, 1997). This orientation allows the 
ability for direct interaction between these two domains either through disulfide 
linkages or protein-protein interactions. Direct interaction between domains I and 
HI may be involved in the regulation o f fusion events. Indeed, mutations within a 
cysteine residue o f domain IQ has been shown to elicit gK mediated cell fusion.
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CHAPTER n
EXPRESSION OF THE ENHANCED GREEN FLUORESCENT 
PROTEIN BY HERPES SIMPLEX VIRUS TYPE 1 (HSV-1) AS 
AN IN  VITRO OR IN  VIVO MARKER FOR VIRUS ENTRY AND
REPLICATION1
INTRODUCTION
Herpes simplex virus type I (HSV-1) specifies at least 11 glycoproteins: gB, 
gC, gD, gE, gG, gH, gl, gJ, gK, gL, and gM, which are expressed during productive 
virus replication. These glycoproteins function during virus entry, cell-to-cell 
spread, and egress o f infectious virion particles (Spear, 1993a; Spear, 1993b; 
Roizman and Sears, 1996). Syncytial mutations (syn) that cause extensive virus- 
induced cell fusion can arise in at least four different regions o f the viral genome 
including the UL20 gene (Baines et al, 1991; MacLean et al, 1991); the UL24 gene 
(Jacobson et al, 1989; Sanders et al, 1982); the UL27 gene encoding glycoprotein B 
(gB) (Bzik et al, 1984; Pellett et al, 1985) and the UL53 gene coding for 
glycoprotein K (gK) (Bond and Person, 1984; Pogue-Geile et al, 1984; Ryechan et 
al, 1979; Debroy et al, 1985). Syncytial mutations in the UL53 (gK) gene are more 
frequently isolated than syncytial mutations in any other genes (Ryechan et al,
1979; Read et al, 1980; Bond et al, 1982; Bond and Person, 1984; Pogue-Geile et 
al, 1984; Debroy et al, 1985; Dolter et al, 1994). Recently, it was shown that gK is 
involved in infectious virus production and virion egress (Jayachandra et al, 1997). 
Furthermore, domains o f gK, which are involved in infectious virus production and 
egress, were delineated through the construction and characterization o f mutant 
viruses expressing sequential gK truncations (Foster and Kousoulas, 1999).
1 Reprinted from Journal ofVirological Methods, Vol 75, Foster T. P., G.V. 
Rybachuk, and K.G. Kousoulas, ppl51-160, Copyright 1998, with permission from 
Elsevier Science.
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The p-galactosidase (p-gal) gene has been used for insertional inactivation of 
HSV-1 genes (Goldstein and Weller, 1988), for monitoring the kinetics o f HSV 
virus infection and spread in cell culture (Montgomery et al, 1996), as well as for 
tracing H SV -l infections in vivo. (Ho and Mocarski, 1988). However, p-gal 
detection requires the addition of exogenous chromophoric reagents, and 
quantitative spectrophotometric measurements o f p-gal expression requires lysis o f 
cells. In general, detection o f fluorescence is more sensitive than spectrophotometric 
methods and enables convenient quantitation, analysis and sorting o f labeled cells 
using fluorescent activated cell sorting (FACS) instruments. Recently, a PRV 
recombinant virus was constructed which carried the green fluorescence protein 
(GFP) gene under the promoter control o f glycoprotein gG. PRV infected cells 
emitted green fluorescence, which enabled the detection o f virus plaque formation, 
but the fluorescence did not appear to be stable over time (Jons and Mettenlieter, 
1997).
The green fluorescent protein was first isolated from the jellyfish Aequorea 
victoria and has since been modified through codon optimization for use in 
eukaryotic mammalian systems (Zolotukhin et al, 1996). The enhanced green 
fluorescent protein (EGFP) chromophore can form a either a monomer, dimer or 
trimer and fluorescence emission is dependent upon proper folding and oxidation. 
The critical amino acid sequence for fluorescence emission is a Ser65-Tyr66-Gly67 
peptide (Cody et al, 1993). The fluorescence o f GFP is independent o f  co-factors, 
substrates, or other cellular gene products (Chalfie et al, 1994; Chalfie, 1995; Cubitt 
et al, 1995). The EGFP is a modified (S e r^  replaced with Thr) 238 amino acid 
peptide, which exhibits excitation maxima at 488 nm and emission maxima at 511 
nm and fluoresces 35 times more intensely than that o f its GFP counterpart (Cubitt 
et al, 1995; Zolotukhin etal, 1996). These modifications facilitate EGFP detection
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by fluorescent microscopy, plate fluorometry, and FACS, using standardized FTTC 
filter sets (Cormack et al, 1996).
To assess the role o f gK in virus entry, virus spread, and in the in vivo 
pathogenicity o f HSV-1, we constructed a recombinant virus expressing the EGFP 
gene under the control o f the cytomegalovirus (CMV) immediate early promoter. 
This virus expressed relatively large amounts o f EGFP causing infected cells to emit 
bright green fluorescence.
MATERIALS AND METHODS
Cells and viruses. African green monkey kidney (Vero) cells were obtained 
from ATCC (Rockville, MD). Cells were propagated and maintained in Dulbecco’s 
Modified Eagles Medium (DMEM; Sigma Chemical Company, St. Louis, MO) 
containing sodium bicarbonate, 15mM Hepes and supplemented with 7% heat 
inactivated fetal bovine serum (FBS). The VK302 cell-line (Hutchinson and 
Johnson, 1995) is a gK transformed cell line obtained from Dr. D.C. Johnson, 
Oregon Health Sciences University. These cells were propagated in DMEM lacking 
histidine (GIBCO-BRL Laboratories, Grand Island, NY) supplemented with 7%
FBS and 0.3mM histidinol (Sigma Chemical Co., St. Louis, MO). The ICP27 
transformed cell-line, V27 (Rice and Knipe, 1990) was provided by Dr. DAI. Knipe 
and was passaged in DMEM with 7% FBS. All cells were passaged in DMEM with 
7% FBS without selection prior to virus infections. The parental wild-type strain, 
HSV-1 (KOS), was originally obtained from Dr. PA . Schaffer (Dana-Faber Cancer 
Institute, Boston, MA). Virus d27-l (Rice and Knipe, 1990), which contains a 1.6kb 
deletion o f the ICP27 gene, was provided by Dr. D.M. Knipe, Harvard Medical 
School, and was propagated in V27 cells. Recombinant viruses were propagated in 
VK302 cells.
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Reagents. Restriction enzymes and DNA modification enzymes were 
obtained from New England Biolabs (Beverly, MA). Prep-a-gene gel fragment 
purification matrix and buffers were purchased from BioRad (Hercules, Calif.). 
Sequenase and dideoxynucleotides for dideoxy chain termination sequencing 
reactions were obtained from United States Biochemical (Cleveland, Ohio). 35S- 
dATP was obtained from Dupont/NEN (Wilmington, Dela.). Amplitaq, XL 
Polymerase, and deoxynucleotide triphosphates were purchased from Perkin Elmer 
(Foster City, Calif.). All synthetic oligonucleotide primers were synthesized in our 
laboratory using phosphoramidite chemistry on an Applied Biosystems A B I394 
DNA/RNA synthesizer utilizing Perkin Elmer reagents.
Plasmids. The cytomegalovirus (CMV) immediate early promoter was 
polymerase chain reaction (PCR) amplified from the plasm id vector pcDNA3.1 
(Invitrogen, Carlsbad, Calif.) using primer CMVEcoRI (5’CTCTCCGAATTC 
GCGTT11GCGCTGCTTC3’) as the sense primer and primer CMVBamHI 
(5’CTCTCCGGATCCTCTCCCTATAGT GAGTCG3’) as the antisense primer.
The PCR product was digested with EcoRI and BamHI and cloned into the similarly 
restricted promoteriess plasmid pEGFP-1 (Clontech, Pala Alto, Calif.) generating 
plasmid pGR8000. PGR8000 was digested with BamHI and T4 polymerase was 
used to fill in overhangs and inactivate the BamHI restriction site. This plasmid was 
designated pTF9200. Primers CMVEcoRI and EGFPBamHI (5’GCGCGGATCC 
TTACTTGTACAGCTC3’), which flank the upstream and downstream regions of 
the CMV-EGFP gene cassette respectively, were used in PCR. The final product 
was restricted with Spel and BamHI and cloned into the previously described 
plasmid pSJ1723 (Jayachandra et al, 1997), which was also digested Spel and 
BamHI, generating plasmid pTF9201.
101
Reproduced with permission o fthe copyright owner. Further reproduction prohibited without permission.
Virus C onstruction. Plasmid pTF920l specifying the CMV-EGFP gene 
cassette flanked by homologous HSV-1 sequences was transfected into 50% 
confluent VK302 cells using Lipofectamine (GIBCO-BRL, Gaithersburg, Md.) as 
per the manufacturer’s instructions. Twenty-four hours post transfection (h.p.t.), the 
cells were infected at an MOI of 10 with d27-l virus (ICP27 null) as described 
previously for the generation of the gK null virus, AgK (Jayachandra et al, 1997).
At forty-eight hours post infection (h.p.i.), the cells were lysed by three freeze-thaw 
cycles and the resultant virus stocks were plated onto VK302 cells and overlaid with 
agarose. Virus plaques were visualized by fluorescent microscopy, picked and 
plaque purified five times on VK302 cells.
Diagnostic PCR. Primers UL52KpnI2 (5 ’TAGTCGCGTGCATCGAAA 
CCC3’) and gKTr2 (5’ATCACATACCCCGTTCCGCTTCCG 3’) were used to 
amplify the region o f the UL53 gK gene locus containing the CMV-EGFP gene 
cassette. To confirm the EGFP gene cassette insertion into the gK gene, the 
UL52KpnI2 primer was used in conjunction with the EGFPBamHI primer to 
confirm the isolated virus construction. Reaction conditions for both primer sets 
were 98°C for 3 sec., 72°C for 2 min, for 30 cycles.
W estern immunoblots. Vero cells were infected at an MOI o f 1. At 24 
h.p.i., infected cells were collected by centrifugation and cell pellets were 
resuspended in SDS-PAGE sample buffer (0.1M Tris, 5% SDS, 20% glycerol,
0.2% bromophenol blue, 10% (3-mercaptoethanol). Samples were heated for 10 
minutes at 100°C and electrophoretically separated in a 10% SDS-polyacrylamide 
gel (Laemmli, 1970). Following separation, the proteins were electrotransferred to 
nitrocellulose membranes, visualized with Ponceau S (0.1% Ponceau S in 3% 
trichloroacetic acid), and destained. Blots were blocked against non-specific
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binding for 2 hours using 10% skim milk in TBS. Blots were then incubated with 
anti-GFP monoclonal (Clontech, Pala Alto, Calif.) overnight a t a 1:5,000 dilution in 
TBS with 0.1% Tween 20 (TBS-T), washed five times for ten minutes each with 
TBS-T, incubated for 1 hour with horse radish peroxidase conjugated goat anti­
mouse secondary antibody (Pierce, Rockford, IL) at a 1:50,000 dilution in TBS-T, 
and washed five times in TBS-T for 15 minutes each. Blots were visualized by 
autoradiography using the Pierce Super Signal chemiluminescent detection kit 
(Pierce, Rockford, IL) as per the manufacturer’s instructions.
Fluorescent Microscopy. Subconfluent Vero cell monolayers in 24-well 
plates were infected with AgK-EGFPl at an MOI o f 0.01. After one hour room 
temperature adsorption, cells were overlaid with DMEM containing 2% FCS and 
0.5% methylcellulose and incubated at 37°C for the times indicated. Infected cells 
were visualized directly by epi-fluorescence using a standardized FITC filter set on 
a Nikon Optiphot-2 fluorescence microscope. Phase-contrast microscopy was also 
used to visualize plaque morphology in the absence of fluorescence.
FACS Analysis. Vero cells were infected at an MOI o f 3 with either KOS 
or AgK-EGFP. Forty-eight h.p.i. cells were pelleted, washed in PBS, and either fixed 
in 3% paraformaldehyde for five minutes or resuspended in PBS without fixation. 
All samples were analyzed using a Becton Dickinson FACScan flow cytometer 
equipped with a 15-mW air-cooled 488-nm argon ion laser. The green fluorescence 
from the GFP was detected with a 530/30-nm band pass filter. FACS data was 
acquired and analyzed on a Hewlett-Packard (San Diego, Calif.) 340 computer. Log 
green fluorescence histograms were illustrated using the Lysys H software package 
(Becton Dickinson, San Jose, Calif.).
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Figure 2.1. Construction schematic of the plasmid used to transfer the CMV- 
EGFP gene cassette into the d27-l viral genome, (a) PCR amplification o f the 
CMV promoter with primers CMVEcoRI and CMVBamHI. (b) Construction o f the 
CMV-EGFP gene cassette by cloning the CMV promoter upstream o f the EGFP 
gene to create plasmid pGR8000. (c) Elimination o f the BamHI site and 
amplification of the CMV-EGFP gene cassette with primers CMVEcoRI and 
EGFP BamHI. (d) Insertion o f CMV-EGFP gene cassette within the gK gene to 
create plasmid pTF9201.
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RESULTS
Construction o f the AgK-EGFP recom bination plasmid. To facilitate the 
insertion o f the EGFP gene cassette within the AgK viral genome by homologous 
recombination, a recombinant plasmid was engineered in which the EGFP gene 
cassette was cloned between UL52 and UL54 DNA sequences. The HCMV 
immediate early promoter sequences from plasmid pcDNA3.1 were PCR amplified 
using primers CMVEcoRI and CMVBamHI (Fig. 2.1a). The PCR product was 
restricted with EcoRl and BamHI, cloned into plasmid pEGFP-1 generating plasmid 
pGR8000 (Fig. 2.1b). Subsequently, the BamHI site was deleted using T4 
polymerase after BamHI restriction creating plasmid pTF9200, and the CMV-EGFP 
gene cassette was PCR amplified using primers EGFPBamHI and CMVEcoRI and 
restricted with Spel and BamHI (Fig. 2.1c). Plasmid pSI1723 containing the UL52, 
UL53, and UL54 open reading frames (ORF) was as described previously 
(Jayachandra et al, 1997). The CMV-EGFP cassette was cloned into the plasmid 
pSJ1723 to create plasmid pTF9201 (Fig. 2 .Id). Plasmid pTF9201 was confirmed 
to contain the EGFP gene cassette inserted within the UL53 gene with multiple 
restriction endonucleases and PCR. Transfection o f plasmid pTF9201 into Vero 
cells resulted in bright fluorescence emission (data not shown).
Isolation of the recom binant virus AgK-EGFP. HSV-1 (KOS) d27-l 
carries a deletion in the essential ICP27-UL54 gene rendering the virus unable to 
replicate in Vero cells; however, it can replicate in the complementing cell line V27, 
which is transformed with the ICP27 gene (Rice and Knipe, 1990). A 
recombination system was designed to transfer the CMV-EGFP gene cassette into 
the gK locus o f the d27-l viral genome by rescuing a deletion within the ICP27- 
UL54 gene. Successful rescue of the deleted ICP27-UL54 region o f the d27-l viral
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Figure 2.2. Schematic o f AgK-EGFP virus construction, (a) The top line 
represents the prototypic arrangement o f the HSV-1 genome with the unique long 
(UL) and unique short (Us) regions flanked by the terminal (TR) and internal (IR) 
repeat regions and marked in map units, (b) The region of the mutant virus HSV-1 
d27-l genome (between map units 0.7 and 0.8) containing the Ul52, Ul53, and the 
partially deleted Ul54 open reading frames with relevant restriction endonuclease 
sites, (c) Plasmid pTF9201 (Fig. Id) containing the CMV-EGFP gene cassette 
within the gK gene and bracketed by the Ul52 and Ul54 genes. This plasmid was 
used to rescue the ICP27-Ul54 deletion o f virus d27-l via homologous 
recombination as shown. Represented on the HSV-1 (d27-l) genome are the 
relative positions of PCR primers, UL52KpnI2/gKTr2, used to detect the gene 
insertion. Represented on the pTF9201 schematic are the relative positions o f PCR 
primers UL52KpnI2 and EGFPBamHI used to detect the CMV-IE-EGFP cassette 
within the gK gene.
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genome by plasmid pTF9201 ensures that recombinant viruses that form  plaques on 
Vero or VK302 cells contain the CMV-EGFP gene cassette (Fig. 2.2b, c). A similar 
method was used to construct the gK-null virus AgK (Jayachandra et al, 1997). 
Purified pTF9201 plasmid was transfected into VK302 cells, and the cells were 
subsequently infected with d27-l virus. Virus stocks were collected and individual 
viral plaques formed on Vero cells were plaque purified and tested by PCR for the 
presence o f the EGFP gene cassette. Several viral isolates expressing EGFP were 
picked, plaque purified five tim es, and final virus stocks were made for further 
analysis. Overall, this recombinational scheme transferred the EGFP gene cassette 
into the d27-l viral genome with 100% frequency as evidenced by the fact that all 
virus plaques formed on Vero cells expressed bright fluorescence.
Genetic characterization o f recombinant viruses containing EGFP gene
cassettes. Viral DNA from the HSV-1 wild-type strain KOS or the plaque purified 
recombinant virus AgK-EGFPl was isolated and used in a diagnostic PCR to 
determine the presence or absence o f the EGFP gene cassettes within the UL53-gK 
gene. Primer pair UL52Kpnl2/ gKTr2 was designed to amplify the UL53 gene 
region (Figure 2.2b). The insertion o f the EGFP gene cassette was predicted to 
produce a PCR product o f 1865 base pairs (bp) (Fig. 2.3, lane 3) instead o f the 1569 
bp predicted to be produced by PCR amplification o f the wild-type genome (Fig.
2.3, lane 2). Furthermore, the EGFP specific primer, EGFPBamHI (Fig. 1, panel e), 
and the HSV-1 specific primer, UL52KpnI2, (Fig. 2.2d) yielded an expected PCR 
product o f 1759 bp for the AgK-EGFPl viral genome (Fig. 2.3, lane 5), whereas, no 
PCR product was visualized with HSV-1 KOS viral DNA as the PCR template (Fig.
2.3, lane 4). The precise insertion o f the EGFP gene cassette was confirmed by 
dideoxy-nucleotide DNA sequencing o f DNA sequences bracketing the EGFP gene 
(data not shown).
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Figure 2.3. D iagnostic PCR of plaque purified EGFP recom binant viruses.
Agarose gel electrophoresis o f double-stranded DNA PCR products with the 
UL52KpnI2/gKTr2 primer pair (lanes 2, 3) or the UL52KpnI2/EGFPBamHI primer 
pair (lanes 4, 5) used to detect the EGFP gene insertion within the UL53 (gK) gene. 
Lane 1: lambda phage DNA digested with HindHI (marker); Lanes 2 and 4: KOS 
viral DNA; Lanes 3 and 5: AgK-EGFP viral DNA; Lane 6: 1 kbp molecular weight 
ladder marker.
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Figure 2.4. W estern im m unoblot analysis of recom binant EGFP viruses. Anti- 
GFP monoclonal antibody was used to detect EGFP expression in virus-infected cell 
extracts. Lane 1: KOS, lane2: AgK-EGFPl, and lane 3: AgK-EGFP2. Molecular 
mass standards are as indicated.
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Detection o f EGFP expression by w estern im m onoblot analysis. Anti- 
GFP monoclonal antibody (Clontech, Pala Alto, Calif.) was used in western blots o f 
infected cell lysates to detect EGFP expression by recombinant viruses. Vero cells 
were infected with KOS (Fig. 2.4, lane 1), AgK-EGFP 1 (Fig. 2.4, lane 2), and AgK- 
EGFP2 (Fig. 2.4, lane 3) at an MOI o f 1. Twenty-four hours post infection, cellular 
extracts were prepared and EGFP expression was detected by western immunoblot 
analysis using anti-EGFP monoclonal antibody. The enhanced green fluorescent 
protein is expressed in cells as a 27 kDa monomeric protein which forms post- 
translationally an extremely stable homotrimeric complex (Cody et al, 1993). EGFP 
was detected as a 27-kDa protein (Fig. 2.4, lanes 2 and 3), as well as a protein 
species with an apparent molecular weight corresponding to the predicted trimeric 
form (Fig. 2.4, lanes 2 and 3) in AgK-EGFP virus infected cell lysates. In contrast, 
the anti-GFP antibody did not detect any proteins in KOS infected cellular extracts 
(Fig. 2.4, lane 1).
Fluorescence and phase contrast microscopy of AgK-EGFP infected 
Vero cells. Vero cells were seeded in 1S.5 mm culture dishes and infected at an 
MOI o f 0.01. Cells were monitored by either fluorescence or phase contrast 
microscopy at different times post infection. Four to five h.p.i., individual cells 
emitted fluorescence, while there were no apparent cytopathic effects (CPE) 
including non-adherent cells or cell rounding. Fluorescence intensity increased 
drastically at later times after infection achieving a maximum intensity at 12-18 
h.p.i. (not shown). All cells recruited into viral plaques emitted bright green 
fluorescence at 24 or 48 h.p.i. (Fig. 2.5: a, b). At 24 h.p.i., fluorescence microscopy 
detected viral plaque formation readily, while plaques were not discernible by phase 
contrast microscopy (Fig. 2.5: a, a '). A t 48 h.p.i., cells within the center o f viral
i l l
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Figure 2.5. Autolluorescence and phase contrast m icroscopy of EGFP 
expressing viruses. Vero cells were infected with AgK-EGFP 1 and analyzed by 
either fluorescence microscopy (panels: a, b) or phase contrast microscopy (panels: 
a’, b’) at 24 hours post infections (panels: a, a’) or 48 hours post infection (panels: 
b, b’). The same virus plaque is shown in panels a and a* and a different plaque is 
shown in both panels b and b’.
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Figure 2.6. F luorescent cytom etry profiles of KOS and AgK-EGFP infected 
Vero cells. Vero cells were infected with either KOS (unshaded histogram) or AgK- 
EGFP 1 (shaded histogram) at a multiplicity of infection o f  3. Cytometric profiles 
were determined at 48 hours post infection using either unfixed infected Vero cells 
(panel a) or cells fixed with 3% paraformaldehyde (panel b).
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plaques emitted bright green fluorescence, while newly infected cells in the 
periphery o f viral plaques appeared to fluoresce less intensely (Fig. 2.5: b, b ').
FACS analysis of AgK-EGFP-1 infected cells. EGFP has a single red- 
shifted excitation peak at 488 nm, which is ideal for automated analysis by 
fluorescence-activated cell sorting (FACS) instruments utilizing argon ion lasers 
and standard FTTC filter sets (Cormack et al, 1996). To assess the ability o f 
recombinant virus infected cells to be detected by FACS analysis, Vero cells were 
infected at an MOI o f 3 with either KOS or AgK-EGFP 1 viruses. Forty-eight h.p.i., 
the cells were pelleted by centrifugation, washed with PBS, and analyzed either 
directly (Fig. 2.6, panel a), or after fixation with 3% paraformaldehyde (Fig. 2.6, 
panel b). Overlay o f histograms produced by KOS (unshaded histograms) and of 
AgK-EGFP 1 infected cells (shaded histograms) (Fig. 2.6, panels a and b) revealed 
that greater than 97% of the EGFP-1 cells were intensely stained with EGFP, while 
KOS-infected cells appeared unstained. Paraformaldehyde fixation (panel b) did 
not significantly diminish fluorescence intensity relative to the unfixed cells 
(panel a).
DISCUSSION
Recombinant viruses were constructed expressing the EGFP gene cassette 
under the promoter control of the HCMV immediate early promoter. High levels o f 
EGFP expression were achieved in virus-infected cells, which was easily detected 
by fluorescence microscopy and quantified by FACS analysis.
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EGFP is capable o f emitting bright green fluorescence within cells in cell 
culture or within animals under physiological conditions without the requirement o f 
exogenous substances. In addition, EGFP is highly stable under varying pH 
conditions, detergents and reducing agents enabling the direct measurement of 
EGFP expression (Chalfie et al, 1994; Chalfie, 1995). Most importantly, EGFP 
labeling o f infected cells did not affect the production o f infectious HSV-1. These 
EGFP characteristics provide significant advantages over the detection of 
conventional enzymatic reactions such as that produced by the widely used (3-gal 
protein, which requires the addition o f toxic chromophoric substrates and other 
reagents that inactivate cells and viruses.
Recently, a PRV recombinant virus was constructed expressing the EGFP 
gene under the promoter control of the PRV G glycoprotein. It is important to note 
that there are significant differences in the amount and intensity o f EGFP 
fluorescence reported for the PRV virus in comparison to the AgK-EGFP virus. The 
PRV EGFP cassette enabled the detection o f  newly infected cells during plaque 
formation, while initially infected cells ceased to fluoresce at later times after 
infection. This loss o f fluorescence was probably due to down regulation o f the PRV 
gG promoter at later times post infection. In contrast, EGFP expressed by the AgK- 
EGFP virus recombinant was detected early and increased at later times after 
infection without any loss of fluorescence intensity. This increased fluorescence 
emission must be due to high levels o f EGFP expression under the HCMV-IE 
promoter control. The HCMV-IE promoter functions constitutively expressing 
EGFP immediately after the delivery o f viral DNA into the nuclei of infected cells. 
EGFP expression by surrounding cells indicates viral replication into newly infected 
cells, and provides a sensitive monitoring method for virus spread. Alternatively, 
productive infection within individual cells could be achieved by the use o f 
promoter sequences controlling the expression o f structural proteins. It is worth
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noting that EGFP gene cassettes under different HSV-1 promoter controls would be 
a valuable tool for the assessment o f differential promoter utilization during viral 
infection in vitro and in vivo.
The AgK-EGFP virus as well as other viruses constructed in this laboratory 
expressing EGFP genes will be instrumental in determining the role o f gK and other 
glycoproteins in virus attachment, entry, virion maturation and egress. Furthermore, 
virions capable o f expressing high levels o f EGFP should be valuable tools in the 
tracing of viral infections in animals. In this regard, it is important to note that gK 
has been implicated in neurovirulence and increased herpetic keratitis disease 
(Moyal et al, 1992; Ghiasi et al, 1996). EGFP expression should enable the 
monitoring o f viruses with or without gK in animal infections and the determination 
o f the role o f gK in neuroinvasiness and herpetic eye disease.
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CHAPTER m
FUNCTIONAL CHARACTERIZATION OF THE HVEA 
HOMOLOG SPECIFIED BY AFRICAN GREEN MONKEY 
KIDNEY CELLS THROUGH THE USE OF A  HERPES 
SIMPLEX VIRUS EXPRESSING THE GREEN 
FLUORESCENCE PROTEIN2
INTRODUCTION
Early steps during productive infection o f eukaryotic cells by herpes simplex 
virus include initial binding o f virions to cell surfaces mediated by binding o f viral 
glycoproteins gB and gC onto glycosaminoglycan chains that are ubiquitous on 
most cell surfaces (Spear, 1993). Virion penetration into cells occurs via the pH- 
independent fusion o f the viral envelope with the cell membrane or an early 
endosome (Wittels and Spear, 1991) and is mediated by at least viral glycoproteins 
gB, gD and gH-gL hetero-oligomers (Cai et al., 1988; Forrester e t al., 1992; Ligas 
and Johnson, 1988; Roop et al., 1993; Sarmiento et al., 1979).
A gD receptor for virus entry, HveA, is an additional member of the tumor 
necrosis factor receptor family (Geraghty et al., 1998; Montgomery et al., 1996; 
Whitbeck et al., 1997). HveA is expressed in various tissues, including liver, lung, 
kidney, spleen, and peripheral leucocytes, and it is the principal receptor for entry 
into human lymphoid cells but not into other cell types (Montgomery et al., 1996). 
The cytoplasmic region o f HveA binds to several members o f the tumor necrosis 
factor-associated factor (TRAF) family, such as TRAF1, TRAF2, TRAF3, and 
TRAF5, but not to TRAF6. Transient transfection o f HveA into human 293 cells 
causes activation o f nuclear factor-kB (NF-kB), a transcriptional regulator of 
multiple immunomodulatory and inflammatory genes as well as activation o f the
2 Reprinted by permission o f  Virology.
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Jun-containing transcription factor AP-1, a regulator o f cellular stress-response 
genes. These results suggest that HveA is associated with signal transduction 
pathways that activate the immune response (Marsters et al., 1997).
A second receptor for virus entry, HveB, is the poliovirus receptor-related 
protein 2 (Prr2). HveB mediates HSV-2, but not wild-type HSV-1 viral entry 
(Eberle et al., 1995). Apparently, certain mutants o f HSV-1 utilize HveB for viral 
entry, and HveB but not HveA mediates pseudorabies virus entry. A third receptor, 
HveC, is the poliovirus receptor-related protein (P rrl), which is a human member o f 
the immunoglobulin superfamily (Lopez et al., 1995). HveC mediates entry o f 
several alphaherpesviruses, including HSV-1 and -2, pseudorabies virus (PRV) and 
bovine herpesvirus-1 (BHV-1). HveC is expressed in human cells o f epithelial and 
neuronal origin, and is the primary candidate for the coreceptor that mediates HSV- 
1 and -2 viral entry into epithelial cells on mucosa surfaces and virus spread to cells 
of the nervous system (Geraghty et al., 1998). A fourth receptor, HveD, is the 
poliovirus receptor Pvr (Mendelsohn et al., 1989). HveD mediates the entry o f PRV 
and BHV-1 but not o f HSV-1 (Geraghty et al., 1998).
African green monkey kidney (Vero) cells are commonly used for the 
propagation of HSV-1 in many herpesvirus laboratories as well as for the 
determination o f HSV-1 virus entry and egress. Therefore, we cloned, sequenced, 
and characterized the Vero HveA homolog, designated here as simian HveA 
(HveAs). Functional characterization o f HveAs for HSV-1 virus entry was 
accomplished through the construction and use o f  a recombinant virus constitutively 
expressing the enhanced green fluorescence protein (EGFP), while retaining wild- 
type KOS-like characteristics. Our results indicate that HveAs is the functional 
homolog o f HveA.
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MATERIALS AND M ETHODS
Cells and viruses. African green monkey kidney (Vero) ceils were obtained 
from ATCC (Rockville, MD). Cells were propagated and maintained in Dulbecco’s 
Modified Eagles Medium (DMEM; Sigma Chemical Co., St. Louis, MO) containing 
sodium bicarbonate, IS mM Hepes, and supplemented w ith 7% heat inactivated 
fetal bovine serum (FBS). V27 cells carry a stably integrated copy o f the HSV-1 
(KOS) ICP27 gene and were kindly provided by Dr. D. M . Knipe, Harvard Medical 
School. These cells were cultured in DMEM supplemented with 7% FBS (Rice and 
Knipe, 1990). HSV-1 (KOS), the parental wild-type strain used in this study, was 
originally obtained from Dr. P. A. Schaffer (Dana-Faber Cancer Institute, Boston, 
MA). HSV-1 (KOS) d27-l which has a 1.6 kb BamHI-StuI deletion o f the ICP27 
gene was kindly provided by Dr. D. M. Knipe, Harvard Medical School and was 
propagated in V27 cells (Rice and Knipe, 1990).
Reagents. Restriction and DNA modification enzymes were obtained from 
New England BioLabs (Beverly, MA). RNase and Proteinase K were purchased 
from Boehringer Mannheim (Indianapolis, IN). Gel fragment purification matrix 
and buffers (Prep-a-gene) were obtained from BioRad (Hercules, CA). Sequencing 
grade [35S] dATP was obtained from DuPont/NEN (Wilmington, DE). Amplitaq, 
rTth XL Polymerase, and deoxynucleotide triphosphates were purchased from 
Perkin Elmer (Foster City, CA.). All synthetic oligonucleotide primers were 
synthesized by the LSU Gene Probes and Expression Systems Laboratory 
“GeneLab” using phosphoamidite chemistry on an Applied Biosystems ABI394 
DNA/RNA synthesizer with Perkin Elmer (Foster City, CA) reagents.
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Isolation o f the HveAs gene and construction o f plasmids. Total RNA 
was extracted from Vero cells using TRIReagent (Molecular Research Center, Inc., 
Cincinnati, OH). A cDNA library was constructed using Ready-To-Go You-Prime 
First-Strand Beads (Pharmacia Biotech Inc., Uppsala, Sweden). All PCR 
amplifications were performed using the Gene-Amp PCR system 9600, AmpliTaq, 
and other Perkin Elmer reagents (Perkin-Elmer, Norwalk, CT). PCR products were 
derived using HveA-specific primers (Montgomery et al., 1996), and were cloned 
into plasmid pCR2.1 using the TA-cloning kit (Invitrogen Inc., Carlsbad, CA) 
producing plasmid pCR/HveAs. The cloned HveAs gene was sequenced using 
dideoxy-chain termination methodology, and the predicted primary structure o f the 
protein was obtained (GeneBank Accession number AF147720). The HveAs gene 
was isolated from plasmid pCR/HveAs after restriction with EcoRl and cloned into 
plasmid pcDNA3.1Zeo+ in the coding and non-coding orientations producing 
plasmids pCMV/HveAs and pCMV/sAevH, respectively. The extracellular domain 
of HveAs (first 202 amino acids) was fused to a DNA fragment specifying the Fc 
portion o f the mouse IgG heavy chain using PCR-assisted splice-overlap-extension 
(Chouljenko et al., 1996), and cloned into plasmid pCR3.1 using the eukaryotic TA- 
cloning kit (Invitrogen, Inc.) producing plasmid pCR/HveAs:Fc. This portion o f the 
HveAs gene was also cloned into plasmid pMALc2 (NEB, Beverly, MA) producing 
plasmid pMAL/HveAs. Plasmid pTF9202 was constructed by inserting the gK gene, 
after amplification with primer pair UL52KpnI2/gKSpeI (5 '-AACACCAACACT 
AGTGGTGGATGTCCTTATACC-3'), into the unique Kpnl and Spel sites o f
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pTF9201(Foster e t al, 1998). This plasmid was used to transfer the EGFP gene into 
the d27-l viral genome.
Construction o f the HSV-1 (KOS)/EGFP recombinant virus. Plasmid 
pTF9202 specifying the CMV-EGFP gene cassette flanked by homologous HSV-1 
sequences was transfected into 50% confluent Vero cells using Lipofectamine 
(GIBCO-BRL, Gaithersburg, MD) according to the manufacturer’s instructions. 
Twenty-four hours post transfection (h.p.t.), the cells were infected at a  multiplicity 
o f infection(MOI) o f 10 with d27-l virus (ICP27- null) as described previously for 
the generation o f the gK null virus, AgK (Jayachandra et a l, 1997). At forty-eight 
hours post infection (h.p.i.), the cells were freeze-thawed three times, and the 
resultant virus stocks were plated onto Vero cells and overlaid with agarose. Virus 
plaques were visualized by fluorescent microscopy, individual virus plaques were 
isolated, and virus was plaque purified five times on Vero cells.
Diagnostic PCR. Primer pairs UL52KpnI2/gKTr2, and 
UL52KpnI2/CMVBamHI were used to confirm the EGFP gene insertion as 
described previously (Foster et al, 1998). Primer pair UL52KpnI2/d27-la was used 
to detect the presence o f contaminating d27-l viral DNA. Reaction conditions for 
UL52KpnI2/gKTr2 and UL52KpnI2/d27-la pairs were 98°C for 3 sec., 72°C for 7 
min, repeated for 30 cycles using rTth XL-Polymerase (Perkin-Elmer, Inc.). 
Reaction conditions for the UL52KpnI2/CMVBamHI primer pair were 98°C for 3 
sec. and 72°C for 3 min, repeated for 30 cycles using rTth XL-Polymerase.
Construction o f Chinese hamster ovary (CHO) cell lines transformed 
with the HveAs or HveAszFc genes. Plasmid pCMV/HveAs, pCMV/sAevH, and 
pCR/HveAs:Fc were transfected into CHO cells using LipofectAmine™ and
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transformed cells were selected using Zeocin for the first two plasmids (Invitrogen, 
Carlsbad, CA) and G418 (Sigma, Inc.) for the pCR/HveAs:Fc plasmid. Individual 
CHO colonies were isolated, expanded, and tested for the presence o f the HveAs 
gene using PCR and Southern blotting.
Production o f anti-HveAs-specific antibodies. Plasmid pCMV/HveAs was 
used to  generate mouse anti-HveAs antibodies by direct injection into mice (genetic 
immunization). Purified plasmid DNA was inoculated intramuscularly into mice 
five times approximately every four weeks. HveAs was expressed in E. coli as a 
fusion protein with the maltose binding protein (MBP) by plasmid pMAL/HveAs 
and purified according to the manufacturer’s instructions (New England Biolabs, 
Beverly, MA). Anti-HveAs antibodies were tested in immunoblots against the 
MBP/HveAs fusion protein essentially as described previously (Foster et al., 1998).
Production o f HveA: Fc by CH O -transform ed cells. HveAs :Fc protein 
secreted in supernatant fluids o f approximately 107 CHO/HveAs:Fc-transformed 
cells was purified using protein A sepharose beads. Samples were resuspended in 
SDS-PAGE sample buffer and electrophoretically separated in a 10% SDS- 
polyacrylamide gels. Following electrophoretic separation, proteins were 
electrotransferred to nitrocellulose membranes. Blots were blocked against non­
specific binding and incubated with horseradish peroxidase conjugated goat anti­
mouse secondary antibody (Pierce, Rockford, IL) at a 1:50,000 dilution in TBS-T. 
Blots were visualized by autoradiography using the Pierce SuperSignal
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chemiluminescent detection kit (Pierce, Rockford, EL) as per the manufacturer’s 
instructions.
Phase-contrast and fluorescent microscopy. Subconfluent ceil monolayers 
in 24-well plates were infected with the KOS/EGFP virus at an MOI o f 0.02 for 
visualization o f  individual viral plaques by either phase contrast or fluorescence 
microscopy essentially as described previously for the AgK/EGFP virus (Foster et 
al., 1998). Viral entry experiments were performed at an MOI o f  10 and visualized 
by fluorescence microscopy at 24 h.p.i.
FACS analysis. CHO-transformed cells expressing HveAs or Vero cells 
were fixed w ith paraformaldehyde and incubated with anti-HveAs antibody for 1 
hour at 4°C. Next, cells were washed three times with PBS buffer, incubated with 
goat-anti-mouse FITC-conjugated secondary antibody (Sigma, Inc.), and analyzed 
by FACS. KOS and KOS/EGFP-infected Vero cells were analyzed by FACS at 24 
h.p.i. as described previously (Foster e t al., 1998).
Inhibition o f virus entry by anti-HveAs antibody and soluble HveA-Fc 
protein. CHO/HveAs cells were incubated with either pre-immune or anti-HveAs 
serum for 1 hour at room temperature immediately prior to infection with 
KOS/EGFP at an MOI o f 10. One ml o f supernatant fluids from either 
CHO/HveAs:Fc or CHO cells transformed with pCR3.1 (control) was mixed with 
one ml o f KOS/EGFP virus stock (1 x 108 PFU/ml) and incubated at 4°C for 1 hour
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immediately prior to  infection. The amount o f virus used in  these experiments was 
approximately 106 PFU per 105 CHO/HveAs cells.
RESULTS
Construction and genetic characterization of the recombinant virus 
HSV-1 (KOS)/EGFP. Recently, we constructed the recombinant virus AgK/EGFP 
expressing an engineered enhanced green fluorescent protein (EGFP) from a gene 
cassette inserted in place o f the glycoprotein K (gK) gene (Foster et al., 1998). To 
facilitate our studies on HSV-1 entry, we engineered the virus KOS/EGFP 
constitutively expressing EGFP, by inserting the HCMV-EGFP gene cassette into 
the intergenic region between the UL53 (gK) and the UL54 (ICP27) genes. First, 
plasmid pTF9202 was constructed to contain the HCMV-EGFP cassette in the 
intergenic region between the UL53 and UL54 genes. Next, the deleted ICP27- 
UL54 region o f the 62.1-1 viral genome was rescued by plasm id pTF9202, while 
simultaneously transferring the CMV-EGFP gene cassette into the viral genome 
(Fig. 3.1). Similar methodologies were used to construct the AgK virus (Jayachandra 
et al., 1997) and the AgK/EGFP virus (Foster et al., 1998). Virus stocks from 
marker-rescue experiments were collected, individual virus plaques were plaque 
purified five times, and virus isolates were tested by diagnostic PCR. Primer gKTr2 
is located within the deleted portion o f the UL54 gene (Fig. 3.1c). Amplification 
with this primer is possible only if the UL54 gene has been rescued by the pTF9202 
plasmid. Complementary DNA sequences to primer gKTr2 are present in plasmid
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Figure 3.1. C onstruction o f recom binant KOS and AgK viruses constitutively 
expressing the EG FP gene, (a) The top line represents the prototypic arrangement 
o f the HSV-1 genome indicating approximate map units, (b) The region o f the 
mutant virus HSV-1 d27-l genome containing the Ul52, Ul53, and partially deleted 
Ul54 genes with relevant restriction endonuclease sites, (c) Plasm id pTF9201, 
which contains the CMV-IE-EGFP gene cassette in place o f the gK gene (Foster et 
al, 1998). (d) Plasmid pTF9202 was produced by inserting the gK gene within the 
unique KpnI/Spel sites o f plasmid pTF9201. The approximate location of PCR 
primers UL52KpnI2, gKTr2, and CMVBamHI are shown (b-d).
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pTF9202 immediately upstream and downstream o f the CMV/EGFP gene cassette. 
(Fig. 3.1: c, d). Therefore, amplification with primer pair UL52KpnI2/gKTr2 
generated two DNA fragments o f 1,569 bp and 3,261 bp against KOS/EGFP viral 
DNA (Fig. 3.2, lane 3), while only the 1,569 bp DNA fragment was generated 
against KOS viral DNA (Fig. 3.2, lane 2). Primer pair UL52KpnI2/CMVBamHI 
detected the presence o f the EGFP gene cassette within the KOS/EGFP viral 
genome as evidenced by the PCR-amplified DNA fragment o f 2,401 bp (Fig. 3.2, 
lane 5), whereas it did not produce a PCR product against the KOS viral genome 
(Fig. 3.2, lane 4). Additional PCR testing was performed to ensure that the 
KOS/EGFP virus was not contaminated with the d27-l virus using primer pair 
UL52KpnI2/d27-la (Fig. lb). This primer pair produced the predicted size DNA 
fragments o f 3,241 bp and 1,613 bp against KOS and d27-l viruses (Fig. 3.2, lanes 
6, and 8, respectively), and the predicted DNA fragment o f4,889 bp against the 
KOS/EGFP virus (Fig. 3.2, lane 7). A second DNA fragment o f 650 bp was of non­
specific origin.
Plaque phenotype, EGFP expression, and growth characteristics of the 
KOS/EGFP virus. The KOS/EGFP virus produced viral plaques similar in 
appearance to those produced by the wild-type virus KOS (Fig 3.3: a, c). Bright 
green fluorescence was detected in all infected cells, when viral plaques were 
examined under the fluorescent microscope (Fig. 3.3b). Fluorescence from Vero 
cells infected with either KOS or KOS/EGFP viruses at an MOI o f 5 was detected 
using FACS at 24 h.p.i. Nearly, all KOS/EGFP-infected cells emitted bright
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Figure 3.2. Diagnostic PCR of plaque purified KOS/EGFP recom binant virus.
DNA PCR products with the UL52KpnI2/gKTr2 primer pair (lanes 2 and 3) or the 
UL52KpnI2/CMVBamHI primer pair (lanes 4 and 5) used to detect the EGFP gene. 
Lanes 6-8: PCR diagnostic with primer pair UL52KpnI2/d27-1 a  used to determine 
the purity o f viral stocks. Lanes 2 ,4 , and 6: KOS viral DNA. Lanes 3,5, and 7: 
KOS/EGFP viral DNA. Lane 8: d27-l viral DNA. Lane 1: lambda phage DNA 
digested with HindUI (marker). Lane 9: 1 kb molecular weight ladder (marker).
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Figure 3.3. M orphology and fluorescence detection o f KOS/EGFP virus 
infections. Vero cells were infected with either KOS (c) or KOS/EGFP virus (a and
b) at a multiplicity o f infection o f 0.001 in 24 well plastic tissue culture plates. 
Individual viral plaques were photographed through the use o f phase-contrast (a and
c) and epi-fluorescence (b) microscopy under live conditions at 48 hours post 
infection. FACS analysis o f KOS- and KOS/EGFP-infected cells (MOI o f 5) was 
performed at 48 h p.i. (d) as described previously (Foster et al, 1998).
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fluorescence, whereas KOS-infected ceils did not emit any fluorescence (Fig. 3.3d). 
To determine the replication characteristics o f the KOS/EGFP virus, Vero cell 
monolayers were infected in triplicates with either KOS or KOS/EGFP virus at an 
MOI o f 10, and virus stocks were prepared at 12, 24,36, and 48 h.p.i. The 
KOS/EGFP virus replicated to high titers approaching those of the KOS parental 
virus (Table 1).
Isolation of the gene coding fo r the Vero HveA homolog (HveAs) and 
com parison o f the HveA and HveAs predicted amino acid sequences. Primers 
specific for the HveA gene were used to isolate and clone the HveAs cDNA 
specified by Vero cells. Translation o f the largest open reading frame o f the HveAs 
cDNA sequence produced a putative protein o f283 amino acids sharing a high 
degree o f homology with the previously described HveA receptor gene 
(Montgomery et al., 1996). On the basis o f the homology to HveA, this protein was 
designated the HveA simian homolog (HveAs). A comparison of the predicted 
amino acid sequences o f HveA and HveAs is shown in Figure 3.4. The two proteins 
were o f equal length (283 amino acids), but contained a number of amino acid 
differences including: i) Forty-one amino acid substitutions of which twenty-four 
were to similar amino acids and seventeen were to dissimilar amino acids; ii) Amino 
acid deletions and insertions principally located within the intramembrane 
sequences. Specifically, HveAs contained a single amino acid insertion (aa 187 of 
HveAs) and a single amino acid deletion (aa 212 o f HveA), and a segment o f 
deleted amino acids (aa 216-218 o f HveA) and inserted amino acids (aa 216 and aa
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Table 3.1. V iral yields o f KOS and  KOS/EGFP viruses.
______________________T iter_(PFU/ml)___________________
Virus 12 h p i________ 24 h p i_______ 36 h p i________ 48 hpi
KOS 5.0 x l0 ; 1.5 xlO8 2.0 xlO* 2.0 xlO*
KOS- 3.0 xlO7 1.0x10* 1.4 x10s 1.5x10*
EGFP
Note: Subconfluent Vero cell monolayers (approximately 8x10s cells) were infected 
with each virus at an MOI o f 5 and at 12,24, 36, and 48 hours post infection the 
total number o f infectious virions was determined. Viral titers represent one o f 
three experiments in which individual numbers varied by less than 2-fold.
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Figure 3.4. Comparison of the amino acid sequences o f HveAs and HveAh.
The HveAs (top lines) and HveAh (bottom lines) amino acid sequences were 
aligned through the use o f computer assisted algorithms and visual inspection. Both 
proteins are 283 amino acids long. Relevant structural features are marked as 
indicated.
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222-226 o f HveAs). Characteristically, the carboxyl terminus o f HveA contained 
three extra amino acids (P-N-H) in comparison with HveAs.
Functional characterization o f the HveAs receptor. The ability o f HveAs 
to mediate HSV-1 virus entry was assessed through the use o f HveAs-transformed 
CHO cells, anti-HveAs antibody, and soluble HveA protein. Anti-HveAs serum was 
produced by genetic immunization using plasmid pCMV/HveAs, and it was tested 
for its ability to react with HveAs expressed in E. coli as a  fusion protein with the 
maltose-binding protein (MBP). Anti-HveAs serum reacted with a protein species 
migrating with an apparent molecular mass of 70 kDa in agreement with the 
expected apparent molecular mass o f  electrophoretically separated MBP/HveAs 
fusion protein (Fig. 3.5a, lane 2 o f immune samples). Anti-HveAs serum did not 
react against MBP expressed in E. coli (Fig. 3.5a, lane 1 o f immune samples). 
Similarly, pre-immune sera did not react with either MBP or MBP/HveAs proteins 
(Fig. 3.5a, lanes 1 and 2, respectively, o f pre-immune samples).
Next, CHO cells were transformed with either pCMV/HveAs or 
pCMV/sAevH. Plasmid pCMV/sAevH contains the HveAs gene in the opposite 
(noncoding) orientation. HveAs expression by CHO/HveAs and Vero cells was 
assessed using anti-HveAs serum and FACS analysis. Anti-HveAs serum reacted 
strongly with paraformaldehyde-fixed Vero cells and CHO/HveAs cells (Fig. 3.5, 
solid histograms in panels b and c, respectively). No background fluorescence was 
observed in control experiments, in which Vero cells were incubated with pre- 
immune sera prior to incubation with goat-anti-mouse FITC-conjugate (Fig. 3.5,
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Figure 3.5. Detection of HveAs expression in £  coli., Vero, and HveAs- 
transform ed CHO cells using anti-HveAs serum , (a) Immunoblot o f 
electrophoreticaily separated HveAs/MBP fusion protein after expression in E. coli 
using anti-HveAs serum produced by genetic immunization. Pre-immune and 
immune sera were tested as shown. Lanes labeled 1: MBP control. Lanes labeled 2: 
MBP/HveAs fusion protein, (b) Vero cells were analyzed by FACS after reaction 
with either anti-HveAs antibody followed by reaction with anti-mouse-IgG labeled 
with fluorescein (filled histogram) or with pre-immune sera as the primary antibody 
(unfilled histogram), (c) CHO-HveAs- (filled histogram) and CHO/sAevH- 
(unfilled histograms) transformed cells were analyzed by FACS to detect HveAs 
expression using anti-HveAs antibody.
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Figure 3.6. Im m unoblot detection o f HveAs:Fc expression from 
CHO/HveAs:Fc transform ed cells. Supernatants from either HveAs:Fc 
transformed CHO cells or naive CHO/sAevH control cells were subjected to protein 
A sepharose purification and prepared for immunoblot analysis, hnmunoblots were 
reacted with goat-anti-mouse HRP reagent. Lane 1: reaction with supernatant 
concentrate from control CHO cells. Lane 2: reaction with supernatant concentrate 
from HveAs:Fc-transformed CHO cells.
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unfilled histogram o f panel b). Anti-HveAs antibody did not react with CHO/sAevH 
cells (Fig. 3.5, unfilled histogram o f panel c).
To facilitate virus entry blocking experiments, soluble HveAs protein was 
produced by first, constructing a gene cassette coding for the extracellular portion o f 
HveAs fused to the Fc portion o f mouse IgG. Next, CHO cells were transformed 
with plasmid pCR/HveAs:Fc capable o f constitutively expressing HveAs rFc protein, 
and HveAsrFc protein was purified from supernatant fluids o f these cells using 
protein A sepharose beads (see Materials and Methods). The authenticity o f 
HveAsrFc protein was tested in immunoblots using anti-mouse-IgG antibody. A 
protein species with an apparent molecular mass o f approximately 60 kDa was 
detected in immunoblots o f electrophoretically separated HveAsrFc protein (Fig.
3.6, lane 2), while anti-mouse IgG antibody did not react with supernatants from 
CHO/sAevH control cells (Fig. 3.6, lane 1). The HveAsrFc purified protein was 
sensitive to digestion by PNGase F, indicating that it contained N-glycosylated 
carbohydrates (not shown). A glycosylated protein with similar apparent mass was 
produced by a HveArFc fusion protein (Montgomery e t al., 1996)
Virus entry experiments were performed by monitoring EGFP expression 
specified by KOS/EGFP virus. KOS/EGFP infection (M O I5) o f CHO/HveAs cells 
resulted in most cells emitting green fluorescence at 24 h.p.i. indicating successful 
viral entry (Fig. 3.7A). In contrast, practically none o f the KOS/EGFP-infected 
CHO/sAevH control cells emitted fluorescence (Fig. 3.7B). Next, experiments were 
performed using the soluble HveAsrFc protein. Pre-incubation of KOS/EGFP 
virions with supernatant fluids from CHO/sAevH control cells did not reduce the 
number o f fluorescent cells, while pre-incubation with purified HveAsrFc protein
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Figure 3.7. Blocking of virus en try  by HveAs:Fc soluble protein and by anti- 
HveAs antibodies. (A and C-F) CHO/HveAs cells infected with KOS/EGFP virus 
at an MOI o f 10. (A) Untreated control. (B) CHO/sAevH control cells (transformed 
with the HveAs gene in the noncoding orientation). (C and D) CHO/HveAs cells 
were pretreated with pre-immune or anti-HveAs serum, respectively, for 30 minutes 
at room temperature prior to infection. (E and F) KOS/EGFP virus was pre-treated 
with CHO/sAevH control supemates and soluble HveAsrFc, respectively, for 30 
minutes at 4° C prior to infections.
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reduced the number o f fluorescent cells substantially (Fig. 3.7: C , D, respectively). 
Similarly, treatment o f the CHO/HveAs cells with pre-immune control serum prior 
to infection with KOS/EGFP virus did not reduce the number o f  fluorescent cells, 
while treatment with anti-HveAs antibody serum caused a substantial decrease in 
the number o f fluorescent cells (Fig. 3.7: E, F, respectively).
DISCUSSION
We report here the functional characterization o f the herpes simplex HveA 
receptor homolog specified by African green monkey kidney cells, designated here 
as HveAs. These studies were undertaken because Vero cells constitute our primary 
cells in which virus entry and egress are studied. Investigation o f  the ability o f 
HveAs to mediate HSV-1 virus entry was achieved through the use of a novel wild- 
type KOS-like herpesvirus constitutively expressing the EGFP protein immediately 
after viral entry into cells.
The KOS/EGFP virus. We inserted the EGFP gene cassette within the 
intergenic region between the UL53 and UL54 genes, immediately after the poly-A 
sequence o f the UL53 gene. The purpose o f this construction was to enable the 
monitoring o f viral entry through the detection o f EGFP fluorescence. In addition, 
EGFP could serve as a fluorescent marker for the isolation o f recombinant viruses 
containing gK mutations by simultaneously transferring the mutated gK genes and 
the EGFP gene cassette to viral genomes. EGFP was selected because this protein is 
capable o f emitting bright green fluorescence within cells in cell culture under 
physiological conditions without the requirement of exogenous substances, hi
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addition, EGFP is highly stable under varying pH conditions, detergents and 
reducing agents enabling the direct measurement of EGFP accumulated expression 
(Chalfie, 1995; Chalfie et al., 1994). In this regard, EGFP detection provides a  
useful alternative to p-galactosidase and other enzyme detection method because it 
does not require addition o f toxic reagents that inactivate cells and viruses.
The growth characteristics and plaque morphology o f the resultant 
KOS/EGFP virus were similar to wild-type KOS virus, indicating that insertion o f 
the EGFP gene cassette between the two essential genes, UL52 and UL54 as well as 
expression o f the EGFP proteins did not adversely affect virus replication. High 
levels o f EGFP expression were achieved in KOS/EGFP virus-infected cells that 
was easily detected by fluorescence microscopy and quantified by FACS analysis. 
KOS/EGFP fluorescence was detected through the use o f a fluorescent microscope 
as early as 5-6 hours post infection and fluorescent plaques were readily visualized 
at 12 h.p.i. Fluorescence emitted from cells located within the center o f each plaque 
increased with time, whereas newly recruited cells appeared weakly fluorescent 
until EGFP accumulated at later times. This radial feature o f fluorescence emission 
enables an improved, time-dependent visualization of KOS/EGFP plaque formation 
in comparison to phase-contrast microscopy.
HveAs m ediates HSV entry. The functionality o f the HveA receptor was 
demonstrated principally by showing that CHO/HveA-transformed cells facilitated 
HSV-1 entry, and that HSV-1 entry into these cells was blocked by either soluble 
HveA:Fc protein or anti-HveA antibodies (Montgomery et al., 1996). We performed 
similar experiments with the exception that viral entry into cells was monitored 
through fluorescence detection of the EGFP protein specified by the KOS/EGFP 
virus. Collectively, these experiments showed that HveAs mediates HSV virus entry 
in a specific manner. Undiluted amounts o f anti-HveAs antibody and CHO cell
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supernatants containing soluble HveAsrFc protein reduced viral entry by 
approximately 40%, and 20%, respectively, as measured by FACS (not shown). The 
inability of anti-HveAs antibody and soluble HveAsrFc to fully inhibit virus entry 
into Vero cells is either due to the use o f the blocking reagents at non-saturating 
conditions or the presence o f the HveC and other receptors on Vero cell surfaces 
(Geraghty et al., 1998).
The HveAs protein. Comparison o f the cDNA-predicted amino acid 
sequences o f HveA and HveAs proteins revealed conservation o f all cysteine 
residues with the exception of a single cysteine missing in the membrane-spanning 
portion of HveAs with respect to HveA. Furthermore, overall structural features, 
which identified the HveA protein as a homolog to the TNF family o f proteins, were 
conserved (Montgomery et al., 1996). However, there was a significant divergence 
at the amino acid level between the HveA and HveAs proteins. Most amino acid 
substitutions were concentrated within specific regions of the amino terminus o f the 
molecule and were to similar amino acids that are not expected to drastically alter 
the secondary structure o f the molecule. However, certain amino acid substitutions 
were to dissimilar amino acids, which may alter structural properties o f the protein. 
These were: S9 to P9, R12 to W12, P14 to S14, T22 to R22, S33 to P33, Q70 to 
L70, S79 to P79, T113 to R113, A115 to E l 15, AMO to R140, S172 to P172, G182 
to Q182 and N 183 to T183 in the extracellular portions o f the proteins, and S233 to 
P230,1256 to T253, T258 to 1254, and E276 to 1273 in the cytoplasmic portions o f 
the proteins. Significant insertions and deletions were noted in the predicted 
intramembranous sequences of the HveAs and HveA proteins including a deletion, 
which eliminated one cysteine residue in the HveAs sequence in comparison to the 
HveA sequence. However, both intramembranous sequences exhibited similar 
hydrophobic potential indicating that both proteins should be effectively anchored
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into membranes. The carboxyl terminus o f HveA ended in amino acids P-N-H, 
which were not present in the carboxyl terminus o f the HveAs protein. Deletion o f 
the terminal 26 amino acids o f the HveA protein did not adversely affect the ability 
o f this protein to mediate herpes simplex virus entry (Montgomery et al., 1996); 
therefore, the carboxyl terminal differences between HveAs and HveA are not 
expected to significantly alter the ability o f HveAs to mediate HSV virus entry in 
comparison to HveA.
The primary sequences o f gD specified by HSV and simian herpes B virus 
(SHBV) are 58% identical. However, regions o f gD that are important for HSV-1 
virus entry into Vero cells are highly conserved in HSV-1, HSV-2, and SHBV 
(Bennett et al., 1992; Chiang et al., 1994). Furthermore, anti HSV-1 gD monoclonal 
antibodies that block HSV-1 binding to soluble HveA recognize epitopes that 
overlap or are adjacent to these conserved regions (Nicola et al., 1998). HSV enters 
into both HveA and HveAs-transformed cells efficiently, suggesting that conserved 
domains in the extracellular portions o f  HveA and HveAs proteins may serve as 
common functional sites for binding gD during viral entry.
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CHAPTER IV
HERPES SIMPLEX VIRUS TYPE 1 (HSV-1) 
GLYCOPROTEIN K (gK) IS A STRUCTURAL COMPONENT 
OF PURIFIED VIRIONS THAT FUNCTIONS TO MODULATE 
HVEAS RECEPTOR MEDIATED VIRUS ENTRY
INTRODUCTION
Herpes simplex virus type I (HSV-I) encodes eleven glycoproteins, 
designated gB, gC, gD, gE, gG, gH, gl, gJ, gK, gL, and gM, that function at various 
stages during a productive infection o f eukaryotic cells (Roizman and Sears, 1996). 
At least four o f these glycoproteins, gB, gD, and the gH/gL hetero-oligomer, 
participate in HSV-1 entry into cells (Cai et al, 1988; Forrester et al, 1992; Roop et 
al, 1993). Initial binding o f virions to cell surfaces is mediated through the 
interactions o f viral gC and/or gB with heparin sulfate proteoglycans found 
ubiquitous on most cell surfaces; however, binding o f virus to cells is not sufficient 
to facilitate penetration (Herold et al, 1991; Herold et al, 1994). Binding events that 
lead to virus penetration and uncoating can be distinguished experimentally as 
heparin sulfate sensitive (initial binding) and heparin sulfate resistant (stable 
attachment) (WuDunn and Spear, 1989; Lycke et al, 1991; Shieh et al, 1992).
Stable attachment therefore requires additional non-heparin sulfate receptors found 
at cell surfaces.
Several human cellular receptors have been identified as herpesvirus 
receptors by their ability to mediate virus entry into normally HSV resistant Chinese 
hamster ovary (CHO) cells. These receptors include HveA, a member of the tumor
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necrosis factor receptor family (Montgomery e t al, 1996), as well as several 
members o f the immunoglobulin superfamily, HveB, HveC, HveD, and HIgR 
(Cocchi et al, 1998a; Geraghty et al, 1998; Warner etal, 1998). Various homologs 
o f some o f these receptors have also been isolated from other cell-types (Foster et 
al, 1999; Shukla et al, 1999). HveA is expressed in various tissues including liver, 
lung, kidney, spleen, and peripheral leukocytes, and it is the principal mediator for 
HSV-l entry into human lymphoid cells, but not other cell types. However, HveA 
failed to mediate the entry o f certain viable mutants o f HSV-1 (those carrying 
mutations in gD), as well as other alphaherpesviruses (Montgomery et al, 1996). 
HveC and the splice variant isoform o f HveC, HIgR, are capable o f mediating entry 
o f human and animal alphaherpesviruses, including HSV-1 and -2 , 
pseudorabiesvirus (PRV-1), and bovine herpesvirus (BHV-1). HveC and HIgR are 
expressed in human cells o f epithelial and neuronal origin and are therefore the 
primary candidates for co-receptors that mediate entry into epithelial cells at the 
initial site o f infection and into neuronal cells for the establishment o f latency 
(Cocchi e ta l, 1998a; Geraghty et al, 1998).
Soluble forms o f HveA, HveC, and HIgR have all been shown to bind to 
HSV-1 gD (Cocchi et al, 1998b; Krummenacher et al, 1998; Nicola et al, 1998; Rux 
et al, 1998; W illis et al, 1998). However, whereas the amino terminal o f gD was 
important for interaction with HveA, it was not directly involved in HveC binding 
(Krummenacher et al, 1998), indicating that different regions o f  gD are capable o f 
interacting with different receptors. Although interaction o f  gD with these receptors 
does facilitate stable attachment of virions, the molecular mechanisms that dictate
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virus penetration following receptor interaction remain obscure. Penetration of 
virion particles into cells occurs through a pH-independent direct fusion o f the virus 
envelope with cellular membranes and is mediated by viral glycoproteins gB, gD, 
and gH/gL, although other viral glycoproteins may also be involved.
Despite being two distinct processes, fusion of the virion particle to cell 
surfaces is often paralleled with virus induced cell-to-cell fusion. This correlation is 
drawn due to the involvement o f many o f the same viral and cellular components in 
each of these processes and because both involve membrane fusion. Mutations, 
which cause extensive virus induced cell-to-cell fusion can arise in at least four 
genes o f the HSV genome: the Ul53 (gK) gene (Bond and Person, 1984; Debroy et 
al, 1985; Pogue-Geile et al, 1984), the Ul27 (gB) gene (Bzik et al, 1984; Pellet et 
al, 1982), the Ul20 gene (Baines et al, 1991; MacLean et al, 1991), and the Ul24 
gene (Jacobson et al, 1989; Sanders et al, 1982). HSV-1 gB, gD, gH, gL, and Ul45 
have all been shown to be required for syncytia formation to occur, while other viral 
glycoproteins including gl, gE, and gM may enhance syncytia formation. In 
contrast, gC may inhibit syncytia formation o f some cultured cells and this may 
account for the absence or altered expression o f gC by many syncytial mutants. 
Although little is known about its function in cell-to ceil fusion, syncytial mutations 
within the Ul53 (gK) gene are more frequently isolated than any other gene (Bond 
and Person, 1982; Bond and Person, 1984; Doiter etal, 1994).
HSV-1 gK has characteristics o f a membrane-spanning protein including an 
N-terminal signal sequence, two potential sites for N-linked glycosylation, and three 
putative membrane spanning domains (Debroy eta l, 1985; Mo and Holland, 1997;
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Ramaswamy and Holland, 1992). Glycoprotein K exists as a single 40 kDa species 
in infected cells (Hutchinson et al, 1992), while gK translated in vitro had an 
apparent molecular mass o f  36 kDa and N-linked glycosylation occurred within the 
first 112 amino acids, consistent with glycosylation at residues 48 and 58 
(Ramaswamy and Holland, 1992). Although gK has been described as a structural 
component o f other alphaherpesviruses including PRV-1 (Klupp et al, 1998) and 
varicella-zoster virus (VZV) (Mo etal, 1999), detection o f HSV-1 gK in purified 
virions has been elusive. Recombinant viruses that lack gK or that contain 
mutations within critical amino acid motifs replicated inefficiently and were unable 
to egress from infected cells, indicating that gK plays a crucial role infectious virus 
production and translocation o f infectious particles to extracellular spaces (Foster 
and Kousoulas, 1999; Hutchinson and Johnson, 1995; Jayachandra et al, 1997).
African Green Monkey Kidney (Vero) cells constitute the primary cell-line 
for propagation o f HSV-1, as well as the determination o f virus entry and egress. 
Recently, we described the isolation from Vero cells o f a simian homolog (HveAs) 
to the human HveA (HveAh) receptor (Mongomery et al, 1996) that was capable o f 
mediating entry o f wild-type HSV-1 that expressed the enhanced green fluorescent 
protein (Foster et al, 1999). Although there was significant amino acid homology, 
the HveAs specified several amino acid substitutions, deletions, and insertions 
relative to HveAh (Foster et al, 1999; Montgomery et al, 1996). In this study, we 
generated antibodies against domains o f gK and identified HSV-1 gK as a structural 
component o f purified virions. To characterize the role o f gK in virus entry, we 
tested the ability o f gK null viruses to enter into Vero cells, as well as to utilize
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various cellular receptors. Our results indicate that in the absence o f  gK, the 
kinetics o f HSV-1 entry into Vero cells are delayed. Furthermore, gK null virions 
cannot efficiently utilize currently characterized individual HSV-1 receptors for 
virus entry.
MATERIALS AND METHODS
Cells and V iruses. African green monkey kidney (Vero) cells were obtained 
from ATCC (Rockville, MD). Cells were propagated and maintained in Dulbecco's 
Modified Eagles Medium (DMEM; Sigma Chemical Co., St. Louis, MO) containing 
sodium bicarbonate, 15 mM Hepes, and supplemented with 7% heat inactivated 
fetal bovine serum (FBS). The gK-transformed cell line VK302 was obtained from 
D. C. Johnson, Oregon Health Sciences University, and was maintained in DMEM 
lacking histidine (GIBCO Laboratories, Grand Island, NY) supplemented with 7% 
FBS and 0.3 mM histidinol (Sigma Chemical Co. St. Louis, MO) (Hutchinson and 
Johnson, 1995). CHO cells that were transformed with HveAh, HveB, and HveC 
were a gift of P.G. Spear, University o f Northwestern, Chicago, IL and were 
maintained in Ham’s F12 supplemented with 10% FCS, 500pg/ml G418, and 
75pg/ml purimycin. CHO cells transformed with the HveAs gene were described 
previously (Foster et al, 1999). All cells were passaged once in the absence of 
selection prior to infection. The parental wild-type strain used in this study HSV-1 
(KOS) was originally obtained from P. A. Schaffer (Unversity o f Pennsylvania, 
Philadelphia, PA). The gK-null virus AgK was propagated either on Vero cells and
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was as described previously (Jayachandra et al, 1997). KOS-EGFP and AgK-EGFP 
are viruses that express the enhanced green fluorescent protein upon entry and were 
described previously (Foster et al, 1998; Foster et al, 1999).
Construction o f expression plasmids. The sequence coding for domain II o f 
gK (amino acids 140 to 225) or domain m  o f gK (amino acids 240 to 310) (Figure 
4.1) were amplified by PCR using the primer pairs gKdom25’ (5’TTCTTCGGA 
TCCCACCAACGCCGATGTAT3 ’)/gKdom23 ’ (5’TTCTTCGAATTCGC 
GTAGCATCAACTCGCA3’) and gKdom35’ (5’TTCTTCGGATCCCGGGGGGC 
ATGTGCG3’)/ gKdom33’ (5’TTCTTCGAATTCTCGCATTGCGATGCC3’) 
respectively. The 5’ primers, gKdom25’ and gKdom35\ included BamHI 
restriction sites; whereas, the 3’ primers, gKdom23’ and gKdom33’, included EcoRI 
restriction sites. The amplified PCR fragments were restriction digested with 
BamHI and EcoRI (New England Biolabs) and cloned into the BamHI and EcoRI 
sites o f pGEX2T (Pharmacia) generating pGEX-dom2 and pGEX-dom3. Plasmids 
pGEX-dom2 and pGEX-dom3 specified GST fusions with domainll and domainin 
o f gK, respectively. Each DNA construct was varified by dideoxy chain termination 
sequencing to ensure that the gK gene fragments were in frame with the GST 
peptide coding sequence.
Expression and purification o f fusion proteins. Escherechia coli (E. coli) 
strain DH5a (GIBCO-BRL) was transformed with either pGEX2T or the pGEX-gK 
derivatives pGEX-dom2 or pGEX-dom3. A single colony o f each was inoculated 
into 5ml LB broth (ampicillin lOOpg/ml) and grown overnight at 37°C. The
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Figure 4.1. Domains o f gK expressed as fusion products w ith GST.
Schematic diagram depicting the predicted secondary structure o f HSV-1 gK as 
described previously (Foster and Kousoulas, 1999). Domains II and HI o f gK that 
were expressed as a fusion with GST are shaded.
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overnight culture was diluted 1:100 into a to tal o f SO ml fresh culture media and 
incubated at 37°C until A6oo=0.500. Protein expression was induced with 0.5mM 
IPTG (isopropyl-P-D-thiogalactopyranodise) fo r 3h at 37°C. Cells were harvested 
by centrifugation, and the pellets were resuspended in Tris buffered saline (TBS). 
Cell lysates were aliquoted for SDS-PAGE analysis.
Inclusion body purification and production o f antisera. GST-gKdomain2 
and GST-gKdomain3 were expressed as insoluble inclusion bodies in E. coli. 
Pelleted bacteria was centrifuged and incubated in a 10 % lysis bufier (lOOmM 
NaCl, lmM  EDTA, 50 mM Tris, and 1 mg/ml lysozyme) at room temperature for 
20 minutes. Pelleted spheroplasts were resuspended in ice cold solution (lOOmM 
NaCl, lmM  EDTA, 0.1% deoxycholate, 50 mM  Tris) and incubated on ice for 10 
min. MgCl2 (final concentration o f 8mM) and DNase I (final concentration 
lOpg/ml) were added and allowed to incubate until viscosity disappeared. Inclusion 
bodies were removed by centrifugation at 8,000 g for 10 min and washed five times 
in 2M urea, 2% SDS, 50mM Tris followed by a final wash in lOOmM NaCl, lmM 
EDTA, 50mM Tris. Hyperimmune sera were generated against GST-gKdomain2 
and GST-gKdomain3 by im m unizing mice w ith four doses of purified inclusion 
body protein. Freund’s complete adjuvant supplemented the first injection, while 
Freund’s incomplete adjuvant supplemented each subsequent injection. Injections 
were administered subcutaneously and intramuscularly at approximately two and 
one half week intervals.
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G radient Purification o f HSV-1 virions. Vero cells were infected with KOS 
and AgK viruses at an MOI o f 10 and prepared for density gradient centrifugation. 
Cultures were scraped into medium and both extracellular and intracellular virions 
were harvested from infected cells by three fteeze-thaw cycles and sonication. Cell 
debris was pelleted at 2,000 g for 30 min and discarded. The virus within 
supernatants was pelleted at 25,000 g for 2 hours through a 10% sucrose cushion. 
Virus was resuspended in TBS and double gradient purified on 15-60% continuous 
sucrose gradients. Final purified virus stocks were concentrated by centrifugation 
through a 10% sucrose cushion.
SDS-PAGE and immunoblotting. Cell lysates were placed in  sample buffer 
and heated for 5 minutes at 100°C prior to electrophoretic separation in a 10% SDS- 
polyacrylamide gel (Laemmli, 1970). Following separation, the proteins were 
stained with G el Code-Blue (Pierce, Rockford, IL) or electrotransferred to 
nitrocellulose membranes, visualized with Ponceau S (0.1% Ponceau S in 3% 
trichloroacetic acid), and destained. Blots were blocked against non-specific 
binding for 2 hours using 10% skim milk in TBS and incubated with the primary 
antibody indicated for 1 hour. The blots were washed five times for ten minutes 
each with TBS-Tween (TBS-T), incubated for 1 hour w ith horse radish peroxidase 
(HRP) conjugated secondary antibody at a 1:50,000 dilution in TBS-T and washed 
five times in TBS-T for 15 minutes each. Blots were visualized by autoradiography 
using the Pierce Super Signal chemiluminescent detection kit (Pierce, Rockford, IL) 
as per the manufacturer’s instructions.
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Kinetics o f V irus E n try  into Vero (VK302) cells. VK302 cells were 
seeded at 3.5 x 10s cells/cm2 in 6 well plates. Subconfluent monolayers were 
infected in multiples o f six with 200-300 plaque forming units per well o f  AgK 
propagated on Vero, AgK propagated on VK302, or KOS propagated on Vero and 
incubated at 4°C for 2 hours. Following adsorbtion, cells were washed with pre­
warmed media, overlaid with DMEM with 2% FCS, and shifted to 34°C for the 
times designated. A t each time point extracellular virions were inactivated in 
triplicate using a low pH buffer (0.1M glycine in TBS, pH3.0) wash, as described 
previously (Huang and Warner, 1964; Highlander et al, 1987). The other three 
wells were mock treated with media and served as a control for the determination o f 
percent survival. Subsequently, plates were washed with media and monolayers 
were overlaid with DMEM, 2% FCS, 1% methylcellulose. Plates were incubated at 
37°C for forty-eight hours, at which time the number o f plaques in each well was 
determined and the % survival at each time point was calculated as the average of 
the number o f plaques formed in inactivated wells divided by the number o f plaques 
formed in mock treated wells.
Fluorescent M icroscopy of Infected Cells. Subconfluent cell monolayers 
in 24-well plates were infected with AgK/EGFP or KOS/EGFP at an MOI o f 5.
After a two-hour adsorption at 4°C, cells were washed, overlaid with DMEM 
containing 2% FCS and 0.5% methylcellulose, and incubated at 37°C. Infected 
cells were visualized directly by epi-fluorescence using a standardized F1TC filter 
set on a Nikon Alphaphot-2 fluorescence microscope.
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Polyethylene Glycol (PEG) Induced V irus E n try . Subconfluent cell 
monolayers were infected with AgK/EGFP or KOS/EGFP at an MOI o f 5 and 
allowed to adsorb at 4°C for two hours. Following attachment, cells were washed 
with medium, and treated with polyethylene glycol solutions to facilitate entry 
essentially as described previously (Cai et al, 1988). Cells were exposed briefly to 
PEG 8000 (50% in TBS or lg/2 ml), then washed twice in TBS and treated again 
with PEG (33% in TBS o r lg/3ml). Control cells were treated identically except for 
exposure to PEG. Finally, cells were washed with media, and overlaid with DMEM 
supplemented with 2% FBS and 1% methylcellulose. At the indicated time points, 
ceils were observed by fluorescent microscopy for virus penetration.
Construction o f Chim eric HveAh/HveAs expressing CHO cell-lines.
HveaH/HveAs chimeric genes were generated by splice overlap extension PCR 
essentially as described previously (Choljenko et al, 1996; Foster et al, 1999; Foster 
and Kousoulas, 1999). Briefly, primers HveA5’ and HveA3 ’ that recognize specific 
sequences within the amino and carboxyl termini, respectively of both HveAs and 
HveAh were used in PCR reactions against HveAs or HveAh template DNA with 3’ 
and 5’ primers that represented the sites at which chimeras were to be generated. 7 
pi o f PCR product from the coding regions o f HveAs or HveAh were mixed with 7 
pi o f PCR product from the carboxyl coding regions o f HveAh or HveAs, 
respectively and extended with 10 cycles: 96°C 30 sec; 72°C 10 min. The chimeric 
genes from this extension were amplified by PCR utilizing primers HveA5’ and 
HveA3’. Final chimeric PCR products were cloned into pcr3.1TA (Invitrogen) and
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checked for orientation relative to the CMV promoter. Chimeric expression 
plasmids were introduced into CHO-IEP8 cells (Montgomery et al, 1996) by 
Lipofectamine (GIBCO-BRL) transfection. Forty-eight hours post transfection, 
cells were selected in Ham’s-F12, 75mg/ml puromycin, 500mg/ml G418, and 10% 
FCS as described previously (Foster et al, 1999).
RESULTS
Expression and purification o f fusion proteins. Fusion proteins (GST- 
gKdomainll and GST-gKdomainlll) and GST were expressed in bacterial cells 
transformed with the recombinant plasmids (GSTdom2 and GSTdom3) or with 
parental plasmid vector pGEX2T. Transformed cells were induced with 0.5mM 
EPTG at 37°C for 3 hours. Protein bands corresponding to the respective expressed 
protein products were observed by Gel-Code Blue stained SDS-PAGE (Fig. 4.2A). 
Expression o f GST (»26kDa), GSTgKdomain2 (»35.5kDa), and GSTgKdomain3 
(»33.8kDa) were readily detected by SDS-PAGE and were further confirmed by 
western immunoblot analysis using anti-GST antibodies (Fig. 4.2B). Analysis o f 
soluble and insoluble proteins following sonication indicated that under these 
conditions the expressed protein products were insoluble (data not shown).
Attempts to solubilize expressed protein products proved unsuccessful; 
however, inclusion bodies are easily purified and particulate antigens make
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Figure 4.2. SDS-PAGE and western analysis o f the expression o f GST, GST- 
gKdomain2 and GST-gKdomain3 proteins. Bacterial lysates were separated on 
an SDS-PAGE and either A) stained with Gel-Code blue to visualize protein bands 
or B) electrotransferred to nitrocellulose for immunoblotting with anti-GST 
antibody. Lane 1: GST expression; Lane 2: GST-gKdomain2; Lane 3: GST- 
gKdomain3; M: Low molecular weight marker.
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Figure 4.3. SDS-PAGE and western analysis o f the purification o f GST- 
gKdomain2 and GST-gKdomain3 inclusion bodies. Purified GST-gKdomain2 
and GST-gKdomain3 were separated on an SDS-PAGE and proteins were either A) 
visualized by staining with Gel-CODE or B) electrotransferred to nitrocellulose for 
western analysis using anti-GST antibody. Lane 1: GST-gKdomain2; Lane 2: GST- 
gKdomain3.
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excellent immunogens. Therefore, proteins within inclusions were purified by 
solublizing the bacterial proteins, while the expressed fusion products within the 
inclusions remained in an insoluble pellet. Analysis by SDS-PAGE indicated that 
these protein products were purified to near homogeneity (Fig. 4.3 A). The purified 
proteins were again confirmed by western immunoblots using anti-GST antibodies 
to be GST fusion proteins (Fig. 4.3B).
Detection of gK as a structural com ponent o f purified virions.
Glycoprotein K has been characterized as a structural component o f other 
alphaherpesviruses, including PRV-1 and VZV (Klupp etal, 1998; Mo etal, 1999). 
To determine if  gK was a structural component o f HSV-1 virions, AgK and KOS 
viruses were double purified on continuous sucrose gradients. The virion protein 
content was normalized by the amount o f gD detected through immunoblot analysis 
with an anti-gD monoclonal antibody (data not shown). Utilizing a pool of the anti- 
GST-gKdomain2 and anti-GST-gKdomain3 antibodies, we detected a 40-kDa 
protein species for KOS but not AgK electrophoretically separated normalized 
virions (Fig. 4.4). This 40 kDa species appeared to correspond to the predicted and 
previously described glycosylated gK (Ramaswamy and Holland, 1992; Hutchinson 
et al, 199S) and was not detected with pre-immune or anti-GST sera. A second 
protein species o f approximately 80 kDa could also be faintly visualized in these 
immunoblots. This protein species may represent gK homodimers as it was not 
detected in gK-null virion preparations and the protein products could not
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Figure 4.4. Detection o f HSV-1 gK as a structural component o f purified
virions. Purified HSV-1 KOS or AgK virions were normalized to gD protein 
content and separated on an SDS-PAGE. Proteins were electrotransferred to 
nitrocellulose and probed with anti-GSTgKdomain2 and anti-GSTgKdomain3 sera 
pools.
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be fully dissociated due to problems with protein aggregation upon heating 
(Ramaswamy and Holland, 1992).
E ntry of AgK and KOS viruses into Vero (VK302) cells. Glycoprotein K 
null virions were tested for their ability to enter into normally permissive Vero cells. 
Classical pH inactivation entry kinetics were performed to determine the kinetics o f 
virus entry into Vero (VK302) cell-lines. Although HSV-1 virions are capable of 
attachment to cell surfaces at 4°C, virus cannot enter into these cells (Huang and 
Warner, 1964). Therefore, shifting o f cultures to an entry permissive temperature 
(i.e. 34-37°C) following attachment synchronizes virus penetration and thus allows 
for the quantitative measurement o f virus entry. Because extracellular virus are 
inactivated by low pH buffers, low pH treatment o f cells at various tim e points post 
adsorbtion shift generates the kinetics o f virus entry by the number o f  plaques 
formed (i.e. those virus particles that were capable o f entry at the given time point) 
(Highlander et al, 1987). AgK virions entered into VK302 cells in a  delayed manner 
relative to that o f wild-type KOS virus (Fig. 4.5). Furthermore, at the farthest time 
point (180 min), AgK has not yet achieved an equivalent entry efficiency compared 
to KOS. It does however appear that entry is still occurring, since the slope o f the 
line has not reached a plateau (Fig. 4.5). AgK virions propagated on the gK-null 
complimenting VK302 cells had entry kinetics that were similar to those o f wild- 
type KOS (Fig. 4.5), indicating that tram  complementation o f gK restored the 
defect in entry caused by deletion o f gK.
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Entry Kinetics a t  34'C






AgK grown on Vero 
AgK grown on VK302 
KOS grown on Vero
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Time of pH inactivation, hours post adsorption
Figure 4.5. Kinetics o f HSV-1 AgK (Vero), AgK (VK302), and KOS virus entry 
into Vero (VK302) cells. Classical low pH inactivation of extracellular virions was 
employed to determine entry kinetics at 34°C. All experiments were done in 
triplicate.
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Despite the delay in entry kinetics, we had previously observed that AgK 
virions are capable of entering into Vero cells. Therefore, to assess the ability o f 
these viruses to penetrate Vero cells rather than establish a productive infection, 
Vero cells were infected at an MOI of 5 by viruses that constitutively express the 
enhanced green fluorescent protein (EGFP) (Foster et a /, 1998; Foster et al, 1999). 
Consistent with previous observations, AgK/EGFP virus propagated on Vero cells 
(Fig. 4.6B) penetrated cell surfaces as efficiently as AgK propagated on VK302 
(Fig, 4.6C) and wild-type KOS/EGFP virus (Fig. 4.6A).
Receptor mediated entry  of gK null virions. To investigate if  the delayed 
entry kinetics exhibited by AgK were due to failure to utilize different Hve 
receptors, AgK/EGFP virus stocks were prepared in both Vero and VK302 cells.
An equal number of infectious virions were used to infect CHO-Kl cells 
transformed with HveAs (Fig. 4.7A, B, C), sAevH (Fig. 4.7D), HveAh (Fig. 4.7F), 
HveB (Fig. 4.7E), or HveC (Fig. 4.7G). AgK/EGFP virus prepared in Vero cells did 
not enter into CHO/HveAs cells (Fig. 4.7C); whereas, AgK/EGFP virus propagated 
on VK302 cells (Fig. 4.7B) entered at a similar efficiency to that of KOS/EGFP 
(Fig. 4.7 A). Interestingly, the human homolog o f the HveAs receptor, HveAh, did 
facilitate AgK/EGFP virus entry, albeit inefficiently (Fig. 4.7F). The AgK/EGFP 
virus propagated on Vero cells was then tested for its ability to utilize other Hve 
receptor expressing cell-lines. As expected, AgK/EGFP did not enter into either the 
control CHO/sAevH cells or the CHO/HveB cells (Fig. 4.7. D and E, respectively).
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Figure 4.6. Entry o f AgK/EGFP (Vero), AgK/EGFP (VK302), and  KOS/EGFP 
virus into Vero cells. Vero cells were infected with KOS/EGFP (A), AgK/EGFP 
propagated on Vero cells (B) or AgK/EGFP propagated on VK302 cells (C) at an 
MOI o f 10 and visualized under fluorescent microscopy at 12 hours post infection.
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However, AgK/EGFP did enter into CHO/HveC cells with some efficiency (Fig. 
4.7G).
Mutant viruses that are capable o f attachment, but defective in penetration o f 
cell surfaces are enhanced by PEG, an agent that promotes fusion between 
membranes. KOS/EGFP enters into CHO cells expressing various Hve receptors 
with 100% efficiency and as expected KOS/EGFP entry was neither enhanced nor 
inhibited by PEG treatment (Fig. 4.8A). Contrastingly, the gK null virus 
AgK/EGFP, which was unable to utilize the HveAs receptor for virus entry, was 
enhanced several fold by PEG treatment (Fig. 4.8B). Similarly, inefficient entry into 
CHO cell-lines expressing other Hve receptors could be enhanced by PEG treatment 
(Fig. 4.8C). Hence, it gK-null viruses are able to attach to CHO cells expressing 
receptors at their surfaces, but are defective in virus penetration and entry.
Domains o f HveAh/s that facilitate AgK entry. Recently, our 
characterization o f  the HveAs receptor revealed that although there was significant 
homology to HveAh, there were several amino acid substitutions, deletions, and 
insertions (Foster et al, 1999). Thus, we investigated whether these differences 
accounted for the inability o f HveAs to facilitate AgK virus entry. Genes that 
specified chimeric proteins were generated that when expressed in CHO cells could 
be used to rapidly identify regions o f the HveAh receptor that mediated AgK/EGFP 
virus entry. Chimeric proteins were designed to address specific regions o f HveA 
where the greatest differences in amino acid composition resided. Furthermore, for
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Figure 4.7. KOS/EGFP and AgK/EGFP entry  into CHO cells transform ed w ith 
Hve receptors. CHO-K1 cells transformed with HveAs (panels A, B, C), sAevH 
(opposite orientation o f HveA (panel D), HveB (panel E), HveAh (panel F) or HveC 
(panel G) were infected with EGFP expressing viruses and analyzed for entry 12 
h.p.i. Panel A: KOS/EGFP infected cells. Panel B: AgK/EGFP virus propagated on 
gK null complementing VK302 cells. Panels C-G: AgK/EGFP virus propagated on 
non-complementing Vero cells.
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Figure 4.8. Polyethylene glycol m ediated penetration o f gK null viruses into 
CHO cell-lines expressing Hve receptors. 5 PFU/cell KOS/EGFP (A) or 
AgK/EGFP (B and C) were absorbed at 4°C for 2 hours on HveAs (A and B) or 
HveAh (C) transformed CHO cell-lines. Following adsorption, virus was treated 
with PEG to mediate entry.
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each chimeric receptor generated, a reciprocal was similarly generated, which in 
theory should always function in contrast to its sister receptor. Chimeric receptors 
were generated to isolate: 1) the signal peptide m otif (11 amino acid substitutions); 
2) the transmembrane and carboxyl terminus (9 amino acid substitutions, 4  amino 
acid deletions, 6 am ino acid insertions, and a 3 amino acid shorter carboxyl 
terminus); 3) the amino terminus prior to amino acid 100 (8 amino acid 
substitutions); 4) the amino terminus between amino acids 100 and 203 (13 amino 
acid substitutions and 1 insertion).
All HveAh amino terminal chimeric receptors containing HveAs after amino 
acid 100 functioned to facilitate AgK/EGFP virus entry in a similar manner to 
HveAh (Fig. 4.9A); however, the HveAh signal peptide attached to HveAs did not 
mediate AgK/EGFP virus entry (Fig. 4.9B). Conversely, all HveAs amino terminal 
chimeric receptors containing HveAh after amino acid 100 did not facilitate 
AgK/EGFP virus entry (Fig. 4.9C); whereas, addendum o f the HveAs signal peptide 
to HveAh receptor did mediate AgK/EGFP virus entry (Fig. 4.9D). All chimeric 
receptors facilitated KOS/EGFP virus entry, indicating that chimeric receptors did 
not adversely affect their ability to mediate HSV-1 entry.
DISCUSSION
Although many o f the alphaherpesvirus glycoproteins are well characterized, 
information on gK is limited. Due to the highly hydrophobic nature o f gK and the 
lack o f immunological reagents, structural studies o f gK have been mostly limited
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Figure 4.9. AgK/EGFP entry  into HveAs/HveAh and HveAh/HveAs chim eric 
receptors. HveAh amino terminal/HveAs carboxyl terminal chimera 
(representative in panel A), HveAs amino terminal/ HveAh carboxyl terminal 
chimera (representative in panel B), HveAh signal/ HveAs chimeric protein (panel 
C) or HveAs signal/ HveAh chimeric protein (panel D) expressing CHO cell-lines 
were infected with AgK/EGFP at an MOI o f 10. Cells were visualized by 
fluorescent microscopy 24 hours post infection.
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to characterization o f in vitro translated and processed protein products. However, 
recent genetic studies have begun to unravel the mysteries o f  HSV-1 gK function. 
Previously, we showed that the gK-null virus AgK replicated inefficiently and failed 
to be translocated through the cytoplasm o f infected cells to extracellular spaces 
(Jayachandra et al, 1997). We recently extended these observations by generating a 
series o f truncations and mutations within the Ul53 gK gene. Many o f  these 
mutations indicated that gK may function in vesicular transport events from the 
Golgi apparatus to the cellular plasma membrane (Foster and Kousoulas, 1999). 
Consistent with the original theories o f HSV-1 gK functioning in multiple 
membrane fusion events within the herpesvirus lifecycle, in this study we report that 
gK is a structural component o f purified virions that appears to function in entry by 
modulating receptor mediated penetration events.
S tructural characterization o f HSV-1 gK. Glycoprotein K has been 
characterized as a structural component o f other alphaherpesviruses, including PR.V- 
1 and VZV (Klupp et al, 1998; Mo et al, 1999); however, according to Hutchinson 
et al (1995) it did not appear to be present in purified virion preparations. This was 
in contradiction to the popular belief that HSV-1 gK functioned in multiple 
membrane fusion events during HSV-1 infection, based in large part on earlier 
studies describing several mutations in the Ul53 (gK) gene that resulted in syncytial 
phenotypes (Dolter et al, 1994). Moreover, viruses that specified mutations in gK 
exhibited delayed entry into non-complementing cells (Pertel and Spear, 1996).
Prokaryotically expressed proteins o f GST fused with domains o f HSV-1 gK 
were used to generate monospecific anti-gK sera. Pools o f these sera detected a 40
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kDa protein species in gradient purified KOS virions, but not purified AgK virions. 
Furthermore, a second protein species was detected at approximately 80 kDa, the 
expected molecular mass of a gK homodimer. Thus, HSV-1 gK clearly represents a 
virion structural component that may function in virus entry events. Considering 
our observations, it is possible that the lack o f reactivity o f previously generated 
anti-gK peptide sera or that low levels o f  gK present in purified virions prevented 
detection. Alternatively, the inability o f peptide antisera to recognize homodimeric 
protein complexes, as gK appears to exist as in purified virions, may have accounted 
for this oversight. In either case, the presence o f gK as a structural component o f 
virions can now account for the phenotypic alterations in penetration exhibited by 
viruses that contained mutations in the Ul53 (gK) gene (Dolter et al, 1994; 
Hutchinson et al, 1993; Pertel and Spear, 1996).
E n try  profiles and receptor utilization of the AgK virion. Although 
KOS/EGFP virions were capable o f utilizing all herpes simplex virus entry 
mediating receptors at 100% efficiency, AgK/EGFP was capable o f only using a 
limited subset o f these receptors. Specifically, while HveAh and HveCh were 
capable o f mediating AgK/EGFP virus entry, HveAs was not. Despite the ability o f 
these two receptors to mediate AgK/EGFP virus entry, they did so at a lower 
efficiency relative to KOS/EGFP virus entry. Complementation o f AgK/EGFP virus 
through propagation on a cell-line that expressed gK in trans, restored the ability o f 
the gK-null virion to efficiently utilize these receptors, indicating that gK and not 
another virion component was most likely responsible for this phenotype.
Moreover, the inability of the gK null virus to utilize the HveAs receptor was shown
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not to be attributable to an inability o f the virus to attach to cell surfaces as PEG 
mediated virus entry. Therefore, gK may function in coordination with HveAs in 
either receptor-mediated attachment or more likely in gK/HveAs receptor mediated 
virus to cell fusion during penetration. There is some evidence for the latter 
scenario. The HveA receptor has been shown to be essential for virus mediated 
cell-to-cell fusion for viruses that specified a syncytial mutation in glycoprotein K.
Domains o f HveA involved in AgK/EGFP entry . Although our recent 
characterization o f the simian homolog o f the HveAh receptor revealed a high 
degree o f homology between the two proteins, there were several amino acid 
substitutions, deletions, and insertions. Specifically, HveAs contained: 1)41 amino 
acid substitutions o f which 24 were to similar amino acids and 17 were to dissimilar 
amino acids; 2) amino acid deletions within the transmembrane sequence; 3) amino 
acid insertions within the transmembrane sequence and the amino terminal (Foster 
et al, 1999). The inability o f the HveAs receptor to mediate AgK/EGFP virus entry, 
while the HveAh receptor was able to facilitate virus AgK/EGFP penetration, 
indicated that the amino acid differences between these two receptors were critical 
to its function. A panel o f chimeric HveAh/HveAs and HveAs/HveAh protein 
expressing CHO cell-lines were generated in order to  map the functional region o f 
HveA that facilitated AgK/EGFP virus entry. From these results, it can be inferred 
that the domain o f HveAh, which mediates entry o f gK null viruses, lies between 
amino acids 38 o f the signal peptide and 100 o f the amino terminus. Moreover, due 
to the significant homology o f these proteins, this region can be further narrowed to
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8 amino acid substitutions between amino acids 59 and 87. These amino acid 
substitutions are: G58 to S58, F61 to Y61, H62 to R62, R64 to K64, Q65 to E65, 
Q70 to L70, S80 to P80, and F87 to L87. O f these 8 amino acid substitutions, only 
Q70 to L70 and S80 to P80 represent changes to dissimilar amino acids and 
therefore, are the m ost likely candidates to function in AgK/EGFP virus receptor 
mediated entry.
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CHAPTER V
GENETIC ANALYSIS OF THE ROLE OF 
HERPES SIMPLEX VIRUS 1 (HSV-1) 
GLYCOPROTEIN K (gK) IN INFECTIOUS VIRUS 
PRODUCTION AND EGRESS3
INTRODUCTION
Glycoproteins specified by herpes simplex virus (HS V) are synthesized in 
the endoplasmic reticulum (ER) and are thought to be transported to the plasma 
membrane via the Golgi apparatus (Roizman and Sears, 1996; Spear, P.G., 1993a; 
Spear, P.G., 1993b), presumably following cellular vesicular transport pathways 
(Griffiths et al, 1986; Palade, G, 1975; Pfeffer etal, 1987; Rothman, J.E., 1996; 
Rothman et al, 1996). Herpes virions assemble their nucleocapsids within the 
nucleus and acquire an envelope containing viral glycoproteins by budding through 
the inner nuclear lamellae (Morgan et al, 1959; Roizman and Sears, 1996; Schwartz 
et al, 1969; Torrisi et al, 1992). The process by which enveloped virions are 
transported from the perinuclear spaces through the cytoplasm to extracellular 
spaces and adjacent cells is not completely understood. According to  one 
hypothesis, virions are transported as enveloped particles from the ER to the Golgi 
within vesicles derived from the outer nuclear lamellae and from the Golgi to 
extracellular spaces via Golgi-derived vesicles in a manner analogous to vesicular 
transport o f viral and cellular glycoproteins. In this model, viral glycoproteins are 
modified in situ during transport before they are released to extracellular spaces
3 Reprinted by permission o f the Journal o f  Virology.
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(Campadelli-Fiume et al, 1991; Di Lazzaro et al, 1995; Johnson et al, 1982; 
Roizman and Sears, 1996; Spear, P.G., 1993a; Spear, P.G., 1993b; Torrisi et al, 
1992). Nucleocapsids devoid o f viral envelopes, which are frequently found in the 
cytoplasm o f infected cells, are thought to represent a non-productive population o f 
viruses (Campadelli-Fiume etal, 1991). An alternative model suggests that after 
virions acquire their envelopes from the inner nuclear membrane, they fuse with the 
outer nuclear lamellae releasing unenveloped nucleocapsids into the cytoplasm o f 
infected cells (Browne et al, 1996; Gershon et al, 1994; Granzow et al, 1997; Klupp 
et al, 1998; Whealy et al, 1992). In contrast to the previous model, free 
nucleocapsids in the cytoplasm represent a prerequisite step for subsequent budding 
into Golgi-derived vacuoles, generating enveloped virions containing frilly 
processed glycoproteins. In both egress models, virions are released from the 
infected cells via fusion o f vacuoles containing enveloped virions with the plasma 
membranes (Komuro etal, 1989; Roizman etal, 1996; Stackpole, C.W., 1969).
At least three genes, UL11, UL20 and UL53 (glycoprotein K [gK]), code for 
proteins that are known to be involved in HSV type 1 (HSV-1) virion egress (Baines 
et al, 1992; Baines et al, 1991; Hutchinson et al, 1995; Jayachandra et al, 1997). 
Deletion o f the UL20 gene caused accumulation o f enveloped virions within the 
perinuclear spaces (Baines et al, 1992), while deletion o f the gK gene led to 
accumulation of enveloped virions within the cytoplasm (Jayachandra et al, 1997). 
Both UL20- and gK-null mutant viruses were partially complemented by cellular 
factors, because the UL20-null virus replicated in 143 TK' cells, and the replication
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of the gK-null virus was enhanced in actively replicating cells (Baines et al, 
Jayachandra et al, 1997).
HSV-1 gK is encoded by die UL53 open reading frame (Debroy et al, 1985; 
McGeoch et al, 1988), and it has characteristics o f a membrane protein, including a 
N-terminal signal sequence, and two potential sites for N-glycosylation 10 amino 
acids apart (Debroy et al, 1985; Pogue-Geile et al, 1987). It exists as a  single 40 
kDa protein species in infected cells (Hutchinson et al, 1992), while gK translated in 
vitro had an apparent molecular mass o f 36 kDa, and N-linked glycosylation 
occurred in the first 112 residues o f the protein consistent with glycosylation at 
residues 48 and 58 (Ramaswamy et al, 1992). Initially, gK was predicted to have 
four membrane spanning regions (Debroy et al, 1985); however, recent, 
experiments with in v/Yro-translated gK in the presence of microsomal membranes 
suggested that gK contained three instead o f four membrane-spanning regions (Mo 
and Holland, 1997).
To investigate the role o f gK in infectious-virus production and virion 
egress, we constructed mutant viruses containing stop codons within the gK gene 
immediately after gene segments coding for each o f the four putative hydrophobic 
domains (hpd) predicted by Debroy et al (1985) as well as mutant viruses 
containing mutated codons causing single amino acid changes within gK amino acid 
motifs conserved among all alphaherpesviruses. Characterization o f these viruses in 
cell culture revealed structural features o f gK that are important for infectious virus 
production and egress.
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MATERIALS AND METHODS
Cells and viruses. African green monkey kidney (Vero) cells were obtained 
from American Type Culture Collection (Manassas, Va.). The cells were 
propagated and maintained  in Dulbecco's Modified Eagle’s Medium (DMEM; 
Sigma Chemical Co., St. Louis, Mo.) containing sodium bicarbonate and IS mM 
HEPES and supplemented with 7% heat-inactivated fetal bovine serum (FBS). V27 
cells carry a stably integrated copy o f the HSV-1 (KOS) ICP27 gene and were 
kindly provided by D. M. Knipe, Harvard Medical School. These cells were 
propagated in DMEM supplemented with 7% FBS and 500pg/ml o f G418 (Rice and 
Knipe, 1990). The gK-transformed cell line VK302 was obtained from D. C. 
Johnson, Oregon Health Sciences University, and was maintained in DMEM 
lacking histidine (GIBCO Laboratories, Grand Island, N.Y.) supplemented with 7% 
FBS and 0.3 mM histidinol (Sigma Chemical Co.). All cells were passed once in 
DMEM plus 7% FBS without selection prior to infection with virus (Hutchinson 
and Johnson, 1995). HSV-l(KOS), the parental wild-type strain used in this study, 
was originally obtained from P. A. Schaffer (University o f Pennsylvania, 
Philadelphia). HSV-1 (KOS) d27-l, which has a 1.6 kb BamHI-StuI deletion of the 
ICP27 gene, was kindly provided by D. M. Knipe and was propagated in V27 cells 
(Rice and Knipe, 1990). The AgK virus was propagated on VK302 cells and was as 
described previously (Jayachandra et al, 1997).
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Reagents. Restriction enzymes and DNA modification enzymes were 
obtained from New England BioLabs (Beverly, Mass.). RNase and proteinase K 
were purchased from Boehringer Mannheim (Indianapolis, Ind.). Gel fragment 
purification matrix and buffers (Prep-a-gene) were obtained from BioRad (Hercules, 
Calif.). Sequencing grade [35S] dATP was obtained from DuPont/NEN 
(Wilmington, Del). AmpliTaq, XL Polymerase, and deoxynucleotide triphosphates 
were purchased from PE Biosystems (Foster City, Calif.). All synthetic 
oligonucleotide primers were synthesized by the Louisiana State University Gene 
Probes and Expression Systems Laboratory "GeneLab” using phosphoamidite 
chemistry on an Applied Biosystems ABI394 DNA/RNA synthesizer with PE 
Biosystems Inc. reagents.
Plasmids. Truncations in gK were generated by the insertion o f stop codons 
in the gK gene by PCR. Antisense oligonucleotides, which contained a stop codon 
and a BamHI restriction site a t their 5 ' termini were synthesized. Antisense primers 
were: AgKhpd-1 (5 -TCGGGATCCTCAGAGGGCGACGAACG-3'); AgKhpd-2 
(5 -CAGGATCCTCAGG ATATGAAAGCGG-3'); AgKhpd-3 (5 '- 
GCCGGGATCCTCAATACAGCTCTGTCAGGC-3'), and AgKhpd-4 (5 '- 
CCTGGGATCCTCAGTGAAGCGCCACGAGC-3'). The sense primer for all PCR 
reactions was UL52Kpn I (5 -TAGTCGCGTGCATCGAAACCC-3 *). PCR was 
performed as described previously with HSV-1 (KOS) viral DNA as a template 
(Chouljenko et al, 1996; Jayachandra et al, 1997). Reaction conditions for the XL 
PCR were as follows: 98°C fo r 3 seconds, and 72°C for 2 minutes for 30 cycles.
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The PCR products were precipitated, restricted with Kpnl and BamHI, and gel 
purified. Plasmid pSJ1723, containing the UL52, UL53, and UL54 genes was 
described previously (Jayachandra et al, 1997). PCR-derived DNA fragments 
containing stop codons within the gK gene were cloned into the unique Kpnl and 
BamHI sites o f plasmid pSJ1723 to produce plasmids pTF9101, pTF9l02, 
pTF9103, and pTF9104 coding for gK truncations after the first, second, third, and 
fourth putative hydrophobic domains, respectively (Fig. 5.1). Single-codon changes 
within the gK gene were produced by splice-overlap extension with synthetic 
oligonucleotides, and the PCR-derived gK gene containing single-codon changes 
was cloned into the acceptor plasmid pSJ1723. Plasmid pTF9120 specified gK with 
two C-to-S mutations within the CXXCC gK motif. Plasmid pTF9121 specified gK 
with a C-to-S change at amino acid position 269. Plasmid pTF9122 specified gK 
with a Y-to-S change within the YTK0 m otif. Plasmid pTF9105 was derived by 
insertion o f a PCR-amplified wild-type KOS gK DNA fragment into pSJ1723.
Construction and purification o f gK  m utant viruses. Plasmids specifying 
truncations in the UL53 gK gene were transfected into 50% confluent VK302 cells 
with Lipofectamine (GEBCO-BRL, Gaithersburg, Md.) according to the 
manufacturer’s instructions. Twenty-four hours posttransfection, the cells were 
infected at a multiplicity o f infection (MOI) o f  10 with the d27-l virus (ICP27-null) 
as described previously for the generation o f  the AgK virus (Jayachandra et al,
1997). At 48 hours post infection (h. p. i.), the cells were lysed by three freeze-thaw 
cycles, and the resultant virus stocks were plated onto VK302 cells and overlaid
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with agarose. Virus plaques were picked, and plaque-purified five times on VK302 
cells. Viruses specifying amino acid changes in gK were produced following a 
similar protocol with the exception that Vero cells were used instead o f VK302 cells 
to eliminate the possibility o f revertants arising from rescue o f mutants by the 
resident wild-type gK gene.
V iral DNA. Viral DNA w as prepared from infected Vero cells as described 
previously (Kousoulas et al, 1984). Briefly, Vero cells were infected with plaque 
purified virus at a MOI of 5. At 2 days post infection cells were lysed with 1% 
NP40, 0.5% deoxycholate in 10 mM Tris, and 1 mM EDTA (TE). The lysates were 
treated with RNase (10 pg/mL) for 10 min. at 37°C, followed by addition o f sodium 
dodecyl sulfate (1% final concentration) and proteinase K (10 pg/mL) at 55°C 
overnight. DNA was purified with two phenol-ether extractions and precipitated 
with 3M sodium acetate and ice-cold ethanol.
PC R  confirm ation and sequencing of gK -m utant viruses. The UL53 
region encoding the truncated gK was PCR amplified from plaque-purified 
recombinant viral DNA with the UL52KpnI oligonucleotide as the sense primer and 
the gKTr oligonucleotide (5'-CATACCCCGTTCCGCTTCC- 3'), which binds 
downstream o f the UL53 gene, as the antisense primer. The size differences o f each 
gK gene truncation were determined by agarose gel electrophoresis followed by 
ethidium bromide staining. Truncated gK genes as well as specific codon changes 
were confirmed by direct sequencing using the fmol® DNA Cycle Sequencing
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System (Promega, Madison, Wis.) according to the manufacturers ’ directions. 
Sequencing reactions were resolved in a Gel-Mix 6 polyacrylamide gel (GIBCO- 
BRL). Mutant viruses were tested for the absence o f any contaminating d27-l virus 
by diagnostic PCR using primers UL52KpnI and d27-la. These PCR reactions 
were performed under long-PCR conditions using XL-Polymerase (Perkin Elmer, 
Inc.) essentially as described previously (Chouljenko et al, 1996; Foster et al, 1999; 
Fosterer al, 1998).
Rescue and com plem entation o f gK-mutant viruses. Isolated viruses 
specifying truncations or mutations in the UL53 gene were rescued by transfecting 
plasmid pTF9105 into Vero cells and superinfecting with each o f the truncated virus 
isolates at 24 hours post transfection. At 48 h. p. i., the cells were freeze-thawed 
three times, plated to confluent Vero cells, and the number o f wild-type plaques in 
relation to AgK-like plaques was determined. The wild-type plaques were picked, 
plaque purified, and tested by PCR and sequencing to determine whether the wild- 
type UL53 gene was present. All gK mutant viruses were tested for their ability to 
form KOS-like plaques on the complementing cell line VK302, which complements 
the AgK virus (Jayachandra et al, 1997).
Electron m icroscopy o f gK -truncated virions in  Vero cells. Vero cells 
were infected with truncated viruses prepared from VK302 cells or KOS at an MOI 
o f 5 and incubated at 37°C for the time designated. The infected cells were 
prepared for negative staining electron microscopy as described previously
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(Jayachandra et al, 1997). All sections were examined with a Phillips 410 
transmission electron microscope.
Production o f infectious virions. Different subconfluent Vero monolayers 
containing approximately 8 x 10s cells per 9.62 cm2 well at the time o f infection 
were infected with each mutant virus at an MOI o f 5. After adsorption for 2 hours 
at 4° C, viruses were removed and cultures were washed with medium. Fresh pre­
warmed medium was added to the cells, and cultures were incubated at 37°C for the 
duration o f the study. At 12 and 24 h.p.i., the combined cells and supernatant fluid 
samples were frozen and thawed three times and sonicated, and the number o f 
infectious virions was determined by standard end-point plaque assays on VK302 
cells.
RESULTS
Construction and genetic characterization of HSV-1 (KOS) m utant 
viruses containing stop codons w ithin the gK  gene. Specific portions o f the gK 
gene were generated by PCR with a 3 '-oligonucleotide primer containing an in­
frame stop codon. Stop codons were inserted immediately after the gK gene 
sequences coding for each of the four putative hydrophobic domains o f gK, 
resulting in predicted truncated gKs o f 139, 239,268 and 326 amino acids.
Plasmids pTF9101, pTF9102, pTF9103, and pTF9104 contained the truncated gK 
genes between the UL52 and UL54 genes, reconstructing the prototypic sequence o f
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Figure 5.1. S trategy for the isolation and PCR detection o f HSV-1 m utants 
specifying gK truncations, (a) The top line represents the prototypic arrangement 
o f the HSV-1 genome with the unique long (U l) and unique short (Us) regions 
flanked by the terminal (TR) and internal repeat (IR) regions. Shown below is the 
region of the mutant virus HSV-l d27-l genome (between map units o f 0.7 and 0.8) 
containing the UL52, UL53 and the partially deleted UL54 open reading frames 
with relevant restriction endonuclease sites, (b) Plasmid constructs containing each 
o f the truncated gK genes used to generate the AgKhpd-1, -2, -3, and-4 mutant 
viruses. Represented on the HSV-1 (KOS) genome are the relative positions o f PCR 
primers, UL52KpnI/gKTr, used to detect the truncated gK genes. The hatched 
segments represent the portions o f genes that are expressed after truncation, while 
segments 3 ' to the TGA stop codon are portions of the gK genes that are deleted.
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the genes (UL52-UL53-UL54). Each plasmid was used to rescue the mutant virus 
d27-l (KOS), which has a lethal deletion within the UL54 gene specifying the 
immediate early-protein ICP27 as shown in figure S.l and described previously for 
the construction o f  the AgK virus (Jayachandra et al, 1997). Putative recombinant 
virus isolates were plaque-purified and tested by PCR for both the presence o f 
contaminating d27-l virus and the engineered gK truncations. Primers 
UL5 2KpnI/gKTr, which flank the gK-coding region, were used to  amplify the gK 
genes. This set o f  primers will not produce a PCR product against the d27-l virus, 
because primer gKTr is located within the deleted ICP27 gene portion o f the d27-l 
viral genome (Fig. 1). Amplification o f the gK gene specified by each o f the four 
different mutant viruses with the UL5 2KpnI/gKTr primer set generated the 
predicted DNA fragments o f 730 bp, 1,030 bp, 1,117 bp, and 1,291 bp confirming 
the presence o f the predicted truncated gK genes (Fig. 5.2a). The presence o f the 
engineered stop codons was confirmed by DNA sequencing (not shown). To 
confirm that there was no contaminating d27-l virus present, additional diagnostic 
PCR was performed using primer pair UL52KpnI/d27-1 a . The parental d27-l virus 
generated a single PCR product o f 1,613 bp (Fig. 5.2b, lane 6), while the wild-type 
strain KOS generated the predicted 3,241 bp DNA fragment (Fig. 5.2b, lane 7). The 
mutant viruses AgKhpd-1, -2, -3, and -4 , produced PCR-amplified DNA fragments 
o f2,358 bp, 2,658 bp, 2,745 bp, and 2,919 bp, respectively (Fig. 5.2b, lanes 2-5). 
None of the mutant viruses generated the d27-l specific DNA fragment o f 1,613 bp, 
indicating that there was no contaminating viral DNA in the mutant virus stocks 
(Fig. 5.2b, lanes 2-5).
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a) 1 2 3 4 5 6 7
b) 1 2 3 4 5 6 7 8
Figure 5.2. Diagnostic PCR o f recom binant viruses specifying truncations in gK.
(a) Agarose gel electrophoresis o f ds DNA PCR products with the UL52KpnI/gKTr 
primer pair used to detect the truncated gK genes. Lane 1: lambda phage DNA 
digested with Hindm (marker). Lanes 2, 3 ,4 , 5, and 6: Viral DNA o f AgKhpd-l, 
AgKhpd-2, AgKhpd-3, AgKhpd-4, and KOS viruses, respectively, amplified with PCR 
primer pair UL52KpnI/gKTr. Lane 7: Molecular mass marker (1-kbp ladder), (b) 
Agarose gel electrophoresis o f double stranded DNA PCR products with the UL52 
Kpnl/d27-la primer pair used to confirm the purity of the recombinant viruses after 
extensive plaque purification. Lane 1: lambda phage DNA digested with H indm  
(marker). Lanes 2, 3 ,4 , 5, 6 and 7: Viral DNA o f AgKhpd-l, AgKhpd-2, AgKhpd-3, 
AgKhpd-4, d27-l and KOS viruses, respectively, amplified with PCR primer pair 
UL52KpnI and d27-la. Lane 8: Molecular mass marker (1-kbp ladder).
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Plaque morphologies of virus isolates and viral yields. The plaque 
morphologies of mutant viruses were compared to that o f the AgK and KOS viruses 
on Vero cell monolayers. The AgKhpd-l and AgKhpd-2 viruses produced viral 
plaques that were reproducibly smaller (on average, approximately 20 to 30% fewer 
cells per plaque) than those o f the AgK virus, while the AgKhpd-3 virus produced 
plaques, which were slightly larger (on average, approximately 40 to 50% more 
cells per plaque) than those o f the AgK virus. AgKhpd-4 viral plaques were similar 
in size to those o f the wild-type KOS virus (Fig. 5.3). The AgK virus produces 
wild-type KOS-like viral plaques on the complementing cell line VK302 
(Jayachandra et al, 1997). Similarly, all four gK-mutant viruses produced KOS-like 
plaques on the complementing cell line VK302. Rescue o f the hpd-1, -2, and -3 
mutant viruses by plasmid pTF9105 containing the wild-type KOS gK gene 
produced viral yields similar to those o f  the KOS virus (not shown).
Subconfluent Vero cell monolayers were infected in parallel with viruses 
KOS, AgK, AgKhpd-l, AgKhpd-2, AgKhpd-3, and AgKhpd-4 and the total number 
o f infectious virions (intracellular and extracellular) was determined at 12 and 24 h. 
p. i. The viral yields o f AgKhpd-l and AgKhpd-2 viruses were similar to that o f 
AgK virus at 24 h.p.i. The viral yield o f the AgKhpd-3 virus was approximately 
five-fold higher than that o f AgK AgKhpd-l, and AgKhpd-2 viruses, while the viral 
yield o f the AgKhpd-4 virus was approximately ten-fold higher than that o f 
AgKhpd-3 and identical to that of KOS virus. The viral yields o f all four gK-mutant 
viruses were substantially higher in VK302 cells, approaching those o f KOS virus. 
The ratios o f extracellular to intracellular virus at 24 h.p.i. were similar for AgK
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Figure 5.3. Plaque m orphology o f KOS, AgK, AgKhpd-l, -2, -3, and  -4 on Vero 
cells. Panels A: AgK; B: AgKhpd-l; C: AgKhpd-2; D: AgKhpd-3; E: AgKhpd-4; F: 
KOS. The cells were infected at an MOI o f 0.01 PFU/cell and photographed using a 
phase-contrast microscope at 48 h.p.i.
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Table 5.1. Viral yields o f KOS and gK-truncated mutant viruses.
Virus Total Yield Out/in (24 h.p.i.)
12 h p.i. 24 h p.i.
AgK 3.2 x 105 3.7 x I0ft 0.043
AgKhpd-l 8.6 x 105 2.1 x 106 0.028
AgKhpd-2 1.6 x 106 2.6 x 106 0.056
AgKhpd-3 2.1 x 106 1.6 x 107 0.047
AgKhpd-4 3.0 x 106 3.0 x 108 0.5
KOS 3.5 x 106 3.0 x 108 0.5
Note: Subconfluent Vero cell monolayers (approximately 8 x 105 cells) were infected 
with each virus at an MOI o f 5, and at 12 and 24 h.p.i. the total number of infectious 
virions were determined as well as the number o f infectious virions within cells and 
extracellular fluids. The ratio of extracellular (OUT) to intracellular (IN) virions at 24 
h.p.i. is also shown. The viral yields represent one o f three experiments in which 
individual numbers varied by less than twofold.
184
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
AgKhpd-l, AgKhpd-2, and AgKhpd-3, while the AgKhpd-4 ratio was identical to 
that o f KOS virus (Table 5.1).
E lectron M icroscopy. Conventional fixation-embedding electron 
microscopic analysis was undertaken to examine the intracellular localization o f 
AgK mutant viruses in Vero cells as described previously (Jayachandra et al, 1997). 
Examination o f Vero cells infected with the AgKhpd-l mutant virus revealed the 
presence o f large double-membrane vesicles containing tens to hundreds of 
nucleocapsids in the cytoplasm located proximal to the nuclear membrane (Fig. 5.4: 
A, B, D). Single-membrane vesicles containing numerous nucleocapsids were also 
visualized within the perinuclear space in the process o f budding through the outer 
nuclear lamella at regions of high electron density (Fig. 5.4: C). In these 
micrographs it appeared that the outer membrane o f the cytoplasmic vesicles was 
derived from the outer lamellae of the nuclear membrane. Herpes virions are 
thought to acquire their envelopes by budding through the inner nuclear lamella; 
therefore, it is hypothesized that the internal membrane o f the double-membrane 
cytoplasmic vesicles must be derived from the inner nuclear lamella (Fig. 5.4: C,
D). In contrast to AgKhpd-l, only a few membrane vesicles were observed with 
AgKhpd-2, while no such vesicles were found in AgKhpd-3-, AgKhpd-4-, AgK-, or 
KOS- infected Vero cells. The AgKhpd-2 and AgKhpd-3 viruses accumulated 
virion particles in the cytoplasm of infected Vero cells (Fig. 5.5: B2 and C2). 
AgKhpd-l (Fig. 5.4: A and B), AgK (Fig. 5.5: A2), and AgKhpd-2 (Fig. 5.5: B2)
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Figure 5.4. E lectron m icrographs of Vero cells infected with the AgK hpd-l 
m utant virus. Subconfluent Vero cell monolayers were infected at an MOI of 5 
PFU/cell, incubated at 37°C for 36 hours and prepared for electron microscopy. The 
solid arrows in panels C and D mark nucleocapsids. The open arrows in panel C 
mark the outer and inner nuclear membranes in the cytoplasmic (c) and nuclear (n) 
compartments. The arrowheads mark membranes surrounding nucleocapsids within 
the perinuclear space in panels C and D. The scale bar = 0.5 pm for all panels.
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Figure 5.5. Electron micrographs of Vero cells infected with different gK mutant
viruses. Subconfluent Vero cells were infected with AgK virus (panel A l and A2), 
AgKhpd-2 (panels B1 and B2), AgKhpd-3 (panels C l and C2), AgKhpd-4 (panels D1 
and D2), and KOS (panels E l and E2). All cells were infected at an MOI o f 5 
PFU/cell, incubated at 37°C for 36 hours and prepared for electron microscopy. The 
arrowheads in panels A2 and B2 mark enveloped virions within cytoplasmic vacuoles. 
The open arrows mark extracellular virions in panels C l, D l, E l, and E2. The solid 
arrows mark enveloped virions within electron dense vesicles in panels C2, D2, and 
E2. The scale bar = 0.5 pm for all panels.
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infected cells contained enveloped virion particles within cytoplasmic vacuoles, 
while AgKhpd-3, -4 and KOS contained single enveloped virions within well- 
defined, electron dense vesicles (Fig. 5.5: C2, D2, and E2, respectively). The 
outside surfaces o f AgKhpd-l (Fig. 5.4A) and AgKhpd-2 (Fig. 5.5B1) infected cells 
were devoid o f virion particles, while only a few viruses per cell were detected in 
AgKhpd-3 infected cell surfaces (Fig. 5.5: C l), h i contrast, a high number o f 
virions were detected on the outside surfaces o f AgKhpd-4 and wild-type KOS- 
infected cells (Fig. 5.5: D l and E l, respectively).
Alignment o f gK specified by alphaherpesviruses. The gK gene is highly 
conserved among different herpesviruses. Motivated by the hypothesis that 
domains important in the structure and function o f  gK should be conserved among 
different herpesviruses, we investigated whether there are conserved amino acid 
motifs within gK domains II and EH. The gK primary structures o f six 
alphaherpesviruses were aligned using the MultAlign Program (Corpet, 1988) (Fig. 
5.6). The HSV-1 gK amino acid sequence contains 13 cysteine residues at positions 
37, 82, 114, 144, 187,220, 243, 257, 269, 296, 299, 300, 312. Cysteines 114, 243, 
296, 299, and 300 were conserved among all gK sequences. Cysteine 114 is located 
within domain I, while cysteines, 243, 296,299, and 300 are located within domain 
m , and both domains face the lumen or extracellular side (see Fig. 5.8). The 
alignment revealed conservation o f two short amino acid sequences. In the 
predicted luminal side o f gK, domain m  contained the cysteine-rich m otif 
(CXXCC). Domain II, predicted to be oriented toward the cytoplasm, was the most
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Figure 5.6. A lignm ent o f gK amino acid sequences specified by 
alphaherpesviruses. Alignment was performed using the MultiAlign Program 
(Corpet, 1988). Hydrophobic domains (signal peptide, hpd l, hpd2, hpd3, and hpd4) 
are presented as lightly shadowed. Dark shadowed areas contain conserved amino 
acid motifs. Y X X 0 is a tyrosine-based m otif known to function in vesicular 
transport o f membrane embedded glycoproteins. X denotes any amino acid and 0  
denotes a bulky hydrophobic amino acid. CXXCC is a cysteine-rich motif. The last 
line depicts the consensus gK sequence with conserved residues indicated by capital 
letters. $ depicts either L or M amino acids. % depicts either F or Y residues. # is 
anyone o f D or N. Amino acid residues I or V are depicted with an (!) marking.
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conserved among different herpesviruses and contained a conserved tyrosine-based 
amino acid m otif (Y X X0), where X denotes any amino acid and 0  denotes a bulky 
hydrophobic amino acid. The tyrosine-based and cysteine-rich motifs were also 
conserved in the alphaherpesviruses Marek’s disease virus and gallid herpesvirus 1 
(not shown).
Construction o f recom binant viruses specifying am ino acid changes 
within the CXXCC and Y X X 0 m otifs. To investigate the role o f the conserved 
amino acid motifs in the structure and function of gK, mutant viruses were 
constructed specifying single and double amino acid changes within these two 
motifs, respectively. Mutant virus gK/Y183S (gK/YS) specified gK with a single 
amino acid change (Y to S) within the Y TK 0 motif, and mutant virus gK/C304S- 
C307S (gK/CSCS) specified gK having two cysteines changed to serine residues 
within the cysteine-rich m otif (CXXCC changed to SXXSC) o f domain m. The 
mutant virus gK/CSCS produced small plaques (Fig. 5.7C) sim ilar to those o f the 
AgK virus (Fig. 5.7G); however, gK/CSCS viral yields were similar to AgKhpd3 
viral yields. Similarly, the mutant virus gK/YS (Fig. 5.7E) formed plaques that 
appeared to be similar in size to AgK viral plaques (Fig. S.7G). In contrast to all 
other gK mutant viruses, viral yields o f the gK/YS mutant were consistently lower 
by ten- to one hundred-fold than those o f the AgK virus (Table 5.1). The mutant 
virus, gK/C269S (Fig. 5.7B) specifying a C-to-S amino acid change exhibited 
plaque morphology and viral egress characteristics similar to those o f the wild-type 
KOS strain (Fig. 5.7A). All o f the gK-mutant viruses described above produced
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Figure 5.7. Plaque morphology of gK-mutant viruses with amino acid changes 
w ithin conserved gK motifs. Either Vero cells (panels A, B, C, E, and G) or 
VK302 cells (panels D, F, and H) were infected at an MOI o f 0.01 PFU/cell and 
photographed using a phase contrast microscope at 48 h.p.i. Panels A: KOS; B: 
gK/C269S; C and D: gK/C304S-C307S; E and F: gK/Y183S; G and H: AgK.
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substantially larger plaques in VK302 cells (Fig. 5.7 D, F, and H), approaching the 
KOS viral plaque in size (Fig. 5.7A), and their viral yields in VK302 approached 
those o f the AgK virus on VK302 cells.
DISCUSSION
Previously, we showed that the mutant virus AgK, which lacked the entire 
gK gene, replicated inefficiently and was unable to egress from infected cells 
(Jayachandra et al, 1997). To improve our understanding o f the role o f gK in virus 
replication and egress, we engineered either stop codons at different sites o f the gK 
gene or mutations specifying single-amino-acid changes altering amino acid motifs 
that are conserved among all alphaherpesviruses. Our results support and extend 
previous observations that gK plays an important role in virus replication and 
egress, and furthermore, they suggest that gK is a multifunctional protein involved 
in virion envelopment, intracellular virion transport and egress.
The initial prediction o f gK secondary structure prediction indicated that gK 
may possess four hydrophobic domains that transverse cellular membranes (Debroy 
et al, 1985). Recently, differential protection experiments with gK expressed in 
vitro in the presence o f microsomal membranes suggested that gK might have three 
membrane spanning regions (Mo et al, 1997). In support o f this model, computer- 
assisted predictions using different computer algorithms available through the 
Internet including: PSORT (Nakai etal, 1992), Tmpred (Hoffinan etal, 1993),
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Figure 5.8. Schematic model of the predicted secondary structure o f gK. The
gK model o f Debroy et al (1985) was m odified to have three instead o f four 
membrane spanning domains as suggested by Mo and Holland (1998), and as 
predicted by computer-based predictions using the PSORT ( Nakai et al, 1992), 
Tmpred ( Hoffman et al, 1993), and SOSUI ( Hirokawa et al, 1999) algorithms. The 
predicted putative hydrophobic domains (hpd) (lightly shaded circles)of gK which 
transverse the membrane (lines) are shown as embedded within the membrane. The 
arrows indicate the termination sites for truncated gK specified by the designated 
viruses. Asterisks mark syncytial mutations. Amino acid motifs that are conserved 
among alphaherpesviruses are contained w ithin shaded oval-shaped areas. The 
darkly shaded circles represent the signal peptide.
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and SOSUI (Hirokawa et al, 1999), revealed that the third hydrophobic domain 
predicted by Debroy et al (1985) has a  low probability for transversing cellular 
membranes (not shown). Based on these considerations, and to facilitate the 
discussion o f results, we present a modified version o f the secondary structure 
model initially proposed by Debroy et al (1985), having the third hydrophobic 
domain of gK located extracellularly (Fig. 5.8). A striking consequence o f having 
three instead o f four membrane spanning domains is that a substantial portion o f gK 
is predicted to lie within the lumen o f  cellular organelles that is functionally 
equivalent to the outside o f the cell. Based on this gK model, we have subdivided 
the gK primary structure into four domains: domain I is the amino-terminal portion 
o f gK terminating with the last amino acid o f the putative hydrophobic domain 
hpdl; domain II includes the entire intracellular portion o f gK and terminates with 
the last amino acid o f the putative hydrophobic domain hpd2; domain HI starts with 
the first hydrophilic amino acid immediately after hpd2 and terminates with the last 
hydrophobic amino acid o f the putative hydrophobic domain hpd4; domain IV 
includes the carboxyl-terminal 13 amino acids o f gK (Fig. 5.8). Characteristically, 
this model predicts that all syncytial mutations are on the external portion o f gK 
located within either domain I or domain IH suggesting that these domains may 
cooperate in virus-induced cell fusion (Dolter et al, 1994; Mo et al, 1997).
The mutant viruses AgKhpd-l or AgKhpd-2 produced substantially lower 
viral yields than the AgK virus, indicating that gK-truncations specified by these 
viruses interfered with infectious virus production, hi contrast, the viral yield o f the 
gK-mutant virus AgKhpd-3 was approximately ten-fold higher than that o f AgK
199
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
virus, indicating that this truncated gK retained partial function in the production o f 
infectious virus. Expression of the entire domain EH in gK specified by mutant virus 
AgKhpd-4 restored entirely wild-type viral replication and plaque morphology. 
Collectively, these results suggest that domain EH is important for the structure and 
function o f gK. Furthermore, the first 28 amino acids o f domain EH must contain 
gK elements that contribute to the structure and function o f gK, since viral yields o f 
AgKhpd-3 were higher than those o f  AgK. Deletion o f die terminal 12 amino acids 
in gK specified by the hpd4 mutant virus indicated that the carboxyl terminus o f gK 
(domain EV) is not required for virus replication and virus spread.
Electron microscopic examination o f over one hundred Vero ceUs infected 
with AgKhpd-l revealed the presence o f many large, double-membrane vesicles 
containing numerous capsids. Considering that each electron micrograph 
represented a cross-section of an infected ceU, it was estimated that each double­
membrane vesicle contained hundreds o f capsids. These vesicles were found 
adjacent to nuclear membranes as well as throughout the cytoplasm. The outer 
membrane o f each vesicle appeared electron dense and morphologically similar to 
that o f the outer nuclear lamellae, while an inner membrane o f each vesicle 
appeared less electron dense and otherwise morphologically similar to the inner 
nuclear membrane. Additional vesicles containing numerous capsids were found 
within the perinuclear spaces of infected cells. The overall appearance o f these 
vesicles suggested that they constituted precursor forms o f the double-membrane 
vesicles found in the cytoplasm o f infected cells. It is not clear from the electron 
microscopic data how these vesicles were formed. One possibility is that
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simultaneous budding o f multiple nucleocapsids may be responsible for the 
production o f  the large vesicles, indicating that the expression o f truncated gKs 
(AgKhpd-l and AgKhpd-2) interferes with viral envelopment mechanisms. 
Alternatively, the inner membrane o f the double-membrane vesicles may be derived 
from the fusion o f virion envelopes after budding into the perinuclear space. In this 
scenario, fusion o f enveloped virions within the perinuclear space must occur 
rapidly, because we could not find single enveloped virions w ithin perinuclear 
spaces.
Based on the assumption that conserved amino acid sequences among all 
herpesviruses may represent functional domains o f gK, we aligned gK sequences 
specified by alphaherpesviruses. This analysis revealed that the five cysteine 
residues which are conserved in all alphaherpesviruses are located either in domain I 
or m, suggesting that these cysteine residues may be involved in cooperative 
interactions between domain I and HI. Domain III contained a CXXCC m otif that 
was conserved among all alphaherpesviruses. Mutating the CXXCC m otif to 
SXXSC caused the appearance o f small plaques, while viral yields were similar to 
the AgKhpd-3 virus. In contrast, a single C-to-S change at position 269 did not 
adversely affect plaque formation nor viral yield. These results indicate that both 
the CXXCC m otif and the first 28 amino acids o f domain HI contribute to the 
structure and function o f gK, while the Cys269 does not affect gK functions.
Domain II, predicted to be oriented toward the cytoplasm, was the most conserved 
among different herpesviruses and contained the tyrosine-based amino acid m otif 
(Y X X 0). Similar motifs are known to serve as putative signals for post-Golgi
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glycoprotein transport, and receptor-specific endocytosis (Canfield et al, 1991; 
Kirchhausen et al, 1997; Marks et al, 1996; Mellman, 1996; Trowbridge, et al, 
1993). Proper subcellular localization o f the varicella-zoster virus glycoprotein I 
(gl) was shown to depend on two different determinants, one o f which is a tyrosine 
containing tetrapeptide related to endocytosis sorting signals (Alconada et al, 1996). 
Mutation o f the YXXL endocytosis m otif in the cytoplasmic tail o f pseudorabies 
virus gE, inhibited endocytosis o f gE and caused a small-plaque phenotype, while it 
did not alter in vivo virulence (Tirabassi et al, 1999). A single amino acid change of 
Y to S within this m otif caused the formation of small viral plaques and reduced 
viral yields drastically in comparison to AgK virus, indicating that the mutated gK 
interfered with virus replication.
It is conceivable that gK truncations and the other mutations described here 
may destabilize gK, causing its rapid degradation. Attempts to detect truncated gK 
in infected cellular extracts by radioimmunoprecipitation w ith rabbit antibodies 
raised against gK peptide antigens were inconclusive due to the high background 
reactivity o f these sera. However, the different phenotypic properties and viral 
yields of gK-mutant viruses strongly suggest that mutated gK proteins are expressed 
in biologically active forms. Specifically, the severe truncations o f AgKhpdl and 
AgKhpd2 reduced viral titers substantially in comparison to those o f the AgK virus, 
and produced large vesicles containing virions that were readily detected by electron 
microscopy. Similarly, we noted previously that expression o f 112 amino acids by 
FgK(3 resulted in gK-specific virus-induced cell fusion supporting our hypothesis 
that this amino terminal truncation o f gK is expressed (Jayachandra et al, 1997).
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The tyrosine-to-serine change within gK domain II produced small plaques and 
reduced viral yields drastically in comparison to those o f AgK, indicating that this 
truncated gK exerts a negative effect on infectious virus production. Mutations 
within the CXXCC m otif o f gK domain III produced viruses, which replicated more 
efficiently than the AgK virus, indicating that the mutant gK protein is expressed in 
a partially functional form. It is important to note, that all gK-mutant viruses 
produced viral yields and plaques which were similar to those o f the wild-type KOS 
virus when propagated in VK302 cells, indicating that VK302 cells complemented 
gK-mutant viruses in a frany-dominant manner overcoming the negative effect o f 
the hpdl, hpd2, and gK/Y183S mutations. This cellular complementation indicates 
that gK-mutant viruses do not contain any secondary mutations that may affect their 
phenotypic and replication properties. It is unclear at this point why VK302 cells 
complement all gK-mutant viruses. One of the possible explanations for the trans- 
dominant complementation o f gK mutations by VK302 cells is that gK expressed by 
the cellular gene complexes with cellular proteins found in limiting amounts within 
infected cells. In this scenario, mutated gK expressed by the virus cannot displace 
preformed gK-cellular protein complexes.
Our electron microscopic data is consistent with the hypothesis that 
enveloped virions are transported to the Golgi via vesicles, which originate from the 
outer nuclear lamellae. Such vesicles were readily observed in wild-type KOS- 
infected cells containing single-enveloped virions. Furthermore, expression o f 
truncated gKs (hpdl and hpd2) resulted in the accumulation o f hundreds o f virion 
particles within vesicles, which, except for their large size, otherwise appeared to be
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morphologically similar to those containing single KOS virions. The intracellular 
transport o f various intracellular cargo, including soluble and membrane-bound 
proteins, is achieved in cells through the use o f intricate systems o f targeted 
vesicular transport. These systems dictate a well-orchestrated cascade o f molecular 
events, which control the formation o f vesicles from the endoplasmic reticulum and 
their bi-directional transport to the Golgi, intracellular organelles, and extracellular 
spaces. The hallmark o f this cellular transport system is that specific targeting o f 
vesicles is achieved through the use o f pilot and sorter proteins embedded within the 
transport vesicle membrane and the receiving membrane, respectively (Rothman, 
1996; Rothman and Wieland, 1996; Teasdale and Jackson, 1996). It is tempting to 
consider that herpes simplex virions, which have evolved to use cellular systems 
masterfully to their advantage, may utilize specific elements o f the vesicular 
transport pathways for intracellular virion transport and virion egress. In this 
regard, differences in the virion egress pathways o f HSV in comparison to those o f 
pseudorabies virus and varicella-zoster virus may be due to the differential 
localization and functions o f gK and other viral proteins involved in virion egress.
204
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Chapter VI
CONCLUDING REMARKS AND SUMMARY
The evolution o f HSV with its host has produced a remarkably efficient 
human pathogen that expresses a limited set o f70-100 proteins upon infection. The 
ability o f the virus to accomplish so much with so little is greatly due to the 
multifunctionality o f each o f its proteins. HSV-1 gK was initially hypothesized to 
function during membrane fusion events because o f the propensity for single point 
mutations that caused extensive cell-to-cell fusion to map to its loci. Although 
initial characterizations o f HSV-1 gK by many laboratories has led to some 
confusion as to its role in the HSV-1 lifecycle, the genetic characterization o f  U l53  
(gK) deletions and mutations has begun to clear up some o f these 
misunderstandings. Furthermore, the development o f immunological reagents 
reported in this dissertation provides the unique ability to begin characterizing the 
gK protein in the context o f the cell, whereas previously, this characterization was 
limited to in vitro translated protein product.
The role o f HSV-1 gK in virus egress was initially reported by Hutchinson et 
al (1995) and Jayachandra et al (1997). Hutchison et al (1995) generated a Ul53 
(gK) null virus by insertionally inactivating the Ul53 gene with a (3-galactosidase 
expression cassette; however, the construction of this virus allowed for the amino 
terminal 1/3 o f the protein to be expressed. This virus, designated FgKf), was 
shown to be essential for virus replication and egress. Infection o f African green 
monkey kidney (Vero) cells with this virus propagated on a cell-line (Vero 
[VK302]) that expressed gK in trans, led to a non-productive infection and failure to
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isolate infectious virus. Ultrastructural examination revealed that virion particles 
were absent from extracellular spaces and large numbers o f unenveloped capsids 
were distributed throughout the cytoplasm (Hutchinson et al, 199S). Jayachandra et 
al (1997) significantly extended and revised these results and laid the groundwork 
for the contents o f this dissertation. Utilizing a novel strategy for the generation o f 
deletions and truncations in HSV-1 gK, Jayachandra et al generated a  gK null virus, 
designated AgK that specified an entire deletion o f the U^53 coding region. 
Comparison o f the AgK virus to the FgKp virus revealed many striking differences 
that were attributed to the ability o f the FgKp virus to express the amino terminal 
one-third o f gK. The first distinguishing characteristic o f AgK was its ability to 
form plaques, albeit to a much lesser extent than wild-type HSV, on Vero cells, 
indicating that gK was not essential for infectious virus production. Similar to 
FgKp, AgK failed to egress efficiently from Vero cells; however the ability to form 
infectious virus was greatly increased relative to FgKp (Jayachandra et al, 1997). 
These results would suggest that expression o f the amino terminal one-third o f gK 
had a deleterious effect on infectious virus production. It was also shown that the 
deletion o f gK could be partially complemented by infecting cells that were in log 
phase growth (Jayachandra et al, 1997). Therefore, the function o f gK could be at 
least partially complemented by cellular factors.
In continuation o f this work, chapter V o f this dissertation examined the 
effects o f truncations and mutations on infectious virus production and virus egress 
in a syngeneic system. Truncation o f gK after the first and second hydrophobic 
domain produced deleterious effects that were similar to that produced by FgKp.
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This included a  reduction in infectious virus production relative to AgK.
Interestingly, ultrastructural analysis o f AgKhpdl, which specified a truncation after 
the first hydrophobic domain, produced large multi-laminar vesicles that contained 
numerous unenveloped capsids. Furthermore, while enveloped virions were found 
within fragmented Golgi vacuoles for both AgKhpdl and AgKhpd2 viruses, 
enveloped virions were not observed within electron dense vesicles. In contrast, 
these structures were observed in AgKhpd4, wild-type KOS, and to a lesser extent in 
AgKhpd3 infected cells. The appearance o f extracellular enveloped virions 
coincided with these observed structures, which may represent vesicles that traffic 
enveloped virus to extracellular spaces. Therefore, it is interesting to hypothesize 
that it is gK that functions in this trafficking process. By either egress model (see 
Fig. 1.7 and corresponding discussion in introduction) trafficking o f infectious virus 
from the Golgi to extracellular spaces would occur within these vesicles. It is 
therefore intriguing that mutation o f a putative transport m otif (Y X X 0 to SX X 0) 
abolished the ability of the virus to egress from infected cells. The Y X X 0 m otif is 
predicted to lie within a cytoplasmic domain of gK, thereby allowing for the 
recruitment and interaction of cytoplasmic cellular vesicular transport proteins. 
However, it still remains to be resolved whether or not it is the inability o f HSV-1 
gK to be trafficked to cell surfaces that accounts for this phenotype or if  gK 
participates directly in the trafficking o f viruses to cell surfaces.
The observations from the truncations and mutations in  gK support both the 
envelopment/de-envelopment and vesicular transport models o f virus egress. 
However, in either regard, the phenotypes exhibited suggest that lack o f gK prevents
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post-GoIgi trafficking o f infectious virus to extracellular spaces. In support o f the 
envelopment/de-envelopment model, the numerous un-enveloped capsids found 
within the cytoplasm would represent a  backlog o f  virions awaiting final 
envelopment at Golgi membranes. Because Golgi vacuoles are being occupied by 
enveloped virions that fail to be transported, capsids would accumulate within the 
cytoplasm. Furthermore, the large multi-laminar vesicles observed for AgKhpdl 
virus infections would represent a failed virus to vesicle fusion event and thus 
preventing the release o f unenveloped nucleocapsids to the cytoplasm.
Contrastingly, in the vesicular transport model, the appearance of numerous 
unenveloped capsids within the cytoplasm would most likely be accredited to the 
unregulated fusion o f enveloped virus to transport vesicles due to the aberrant nature 
o f truncated gK. The appearance o f large multi-laminar vesicles observed in 
AgKhpdl infections could be attributed to an inability o f these vesicles to be 
transported due to their immense size. This assumption is supported by the apparent 
capture by electron microscopy o f the initial formation o f these vesicles. The 
directional budding of enveloped virions at areas o f  high electron density is very 
reminiscent o f endoplasmic reticulum to Golgi vesicular transport. Moreover, the 
presence o f the large multi-laminar vesicles appeared to be morphologically similar, 
except for their large size, to those containing single KOS virions. The intracellular 
transport o f various intracellular cargo, including soluble and membrane-bound 
proteins, is achieved in cells through the use o f intricate systems of targeted 
vesicular transport. These systems dictate a well-orchestrated cascade of molecular 
events, which control the formation o f vesicles at the ER and their bi-directional
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transport to the Golgi, intracellular organelles, and extracellular spaces. The 
hallmark o f this transport system is that specific targeting o f vesicles is achieved 
through the use o f pilot and sorter proteins embedded within the transport vesicle 
membrane and the receiving membrane, respectfully. It is tempting to consider that 
the phenotype o f the transport m otif (YXX0) mutant is directly attributable to a 
defect in this transport and therefore, a direct association between the vesicular 
transport model o f egress and gK could be derived.
The determination that HSV-1 gK was a structural component of virion 
particles as described in Chapter IV was possible due to the generation of anti-gK 
sera that was specific for domains II and m . Unfortunately, this sera reacted well 
with purified virions, but not cellular extracts, limiting its usefulness in the 
structural characterization o f gK. It did however confirm that like its 
alphaherpesvirus counterparts, PRV-1 and VZV, glycoprotein K was indeed a 
structural component o f purified virions. It will be interesting to determine if  the 
future production of sera using this expressed protein is able to generate antibodies 
that react well with cellular extracts o f HSV-1 gK.
The characterization o f gK as a structural component o f purified virions was 
an important first step in determining further the functions o f gK, for without its 
detection on purified virions, its role in virus entry could only be presumptive. We 
had known from our studies that the AgK virus could in fact infect Vero cells and 
produce infectious virus; however, the ability o f this virus to infect cells always 
seemed somewhat restricted. Following the examination o f virus entry kinetics into 
Vero cells, there was little doubt that gK null viruses had at least a delay in their
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ability to enter into this cell type; however the reason for this delay could not be 
explained.
In 1996, Montgomery et al, described the expression cloning isolation o f a 
human co-receptor for virus entry, HveA. Because Vero cells constituted the 
primary cell-line for our studies, we isolated and cloned the homolog to this 
receptor, HveAs, as described in Chapter IH o f this dissertation. Characterization o f 
HveAs revealed significant homology to its human counterpart, HveA; however, 
there were several deletions, insertions, and substitutions within the predicted amino 
acid sequence. HveAs facilitated wild-type virus entry into the normally resistant 
Chinese hamster ovary (CHO) cells as assayed by a virus that was generated to 
express the enhanced green fluorescent protein (EGFP). Moreover, expression of 
soluble HveAs as well as antibodies to HveAs blocked entry into HveAs 
transformed CHO cells, but not Vero cells. The inability o f these reagents to block 
virus infection into Vero cells can be attributed to the presence o f other mediators of 
virus entry, namely HveC and HIgR.
In order to rapidly characterize the role o f HSV-1 gK in virus entry, the gK 
null virus, AgK-EGFP, was constructed to constitutively express the green 
fluorescent protein as described in Chapter II. A wild-type KOS-EGFP counterpart 
was also constructed such that the EGFP expression cassette was inserted within the 
intergenic region between the Ul53 (gK) and Ul54 (ICP27) genes. Therefore, the 
wild-type KOS-EGFP and gK null, AgK-EGFP viruses differed only in the presence 
or absence o f the Ul53 (gK) open reading frame, respectively. Each of these viruses
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had plaque and replication phenotypes that resembled that o f their non-fluorescent 
counterparts.
The role o f HSV-1 gK in virus entry and receptor utilization was established 
in Chapter IV. It was hypothesized that the delay in the kinetics o f AgK virus entry 
into Vero cells was due to an altered recognition o f herpes virus entry mediating 
receptors. Therefore, we tested the ability o f the AgK-EGFP and KOS-EGFP to 
enter into CHO cells transformed with different herpesvirus receptors. While the 
wild-type KOS-EGFP virus entered into all the receptor types, except HveB, AgK- 
EGFP utilized all the receptors less efficiently. Trans-complementation of AgK- 
EGFP on a cell-line that expressed gK complimented virus entry into these cells 
indicating that the presence of gK during infectious virus production was necessary 
for assembly o f infectious virions that were capable o f utilizing these receptors. 
Interestingly, although AgK-EGFP entered into CHO-HveAh cells at approximately 
50% efficiency, HveAs was unable to facilitate AgK virus entry into CHO 
transformed cells. Complementation o f the gK null effect or use o f a gK-rescued 
virus reversed this phenotype. This phenotype was exhibited despite quite 
significant homology between the human HveA and the simian HveA (Fig. 3.4, in 
Chapter Ett).
In order to determine the region o f HveAh that facilitates entry of gK null 
viruses, chimeric receptors were constructed using splice overlap extension PCR. 
Although the final amino acids that functioned in gK-modulated virus entry are still 
yet to be determined, the ability to facilitate entry was mapped to the amino terminal 
one hundred amino acids that contain only twelve amino acid replacements. It will
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be o f great interest to eventually determine if  it is a single amino acid change within 
this region that alters the ability o f gK null viruses to utilize this receptor.
The original hypothesis posed by researchers that HSV-1 gK functions 
during membrane fusion events o f the virus lifecycle is at first glance a broad theory 
o f where its effects are actually exerted. However, the broadness o f this theory is 
now justified by the identification o f the multifiinctionality o f gK. This dissertation 
emphasizes that even a small 338 amino acid protein such as gK can exert its effects 
at several stages in the HSV lifecycle including: receptor recognition and utilization, 
virus entry, infectious virus assembly and production, translocation of virion 
particles through the cellular pathways and virus egress to extracellular spaces. 
Although it is tempting to assign a direct correlation o f the phenotypes we have 
observed, the possible connections between these processes cannot be ignored or 
completely dissociated. Therefore, in order to further our understanding o f the role 
gK plays in these processes, it will be essential that these stages eventually be 
dissected from one another. As technology and reagents advance, the roles o f 
HSV-1 gK in the virus lifecycle will be definitively determined.
FUTURE CONSIDERATIONS AND CHALLENGES
Characterization o f HSV-1 gK remains elusive in many respects. It has been 
fifteen years since Debroy et al (1985) initially published the sequence of a gene 
with a high propensity for syncytial mutations. In these fifteen years, information 
has not been forthcoming, despite extensive efforts from many laboratories. Only in 
recent years has their been descriptions o f the function o f gK in the virus lifecycle
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and yet there is still little information as to its structure. Characterization o f HSV-1 
gK will remain a challenge for some time to come. Those challenges aside, it has 
becoming increasingly apparent that gK provides a unique probe into both virus and 
cellular functions. .
Herpes simplex viruses have evolved to masterfully utilize cellular systems 
to their advantage. This dissertation has only begun to probe into these virus-cell 
interactions with respect to gK. The finding that gK may associate both with 
cellular receptors upon entry and cellular transport proteins upon egress, opens a 
wide field o f potential research. Furthermore, this dissertation has failed to address 
the rudimentary understanding o f the structure o f gK. However, the development of 
immunological and viral reagents does facilitate the rapid generation o f information 
in this arena. W ith this new understanding of gK, there are three areas that sorely 
need addressing: 1) the structure and localization o f gK in the context o f the cell; 2) 
the understanding o f the role gK plays in modulating virus entry and receptor 
utilization; 3) the interactions o f gK and the cell in the vesicular trafficking o f virus 
particles to extracellular spaces.
HSV-1 gK  and virus entry: This may be one o f the most controversial 
areas o f research with regards to HSV-1 gK. Through our research, it has become 
quite apparent that gK null viruses fail to utilize the HveAs receptor for virus entry 
and that this failure may account for the delays in the entry kinetics associated with 
AgK infection o f Vero cells. However, in contrast to other entry glycoproteins, it is 
also quite apparent that gK null viruses are capable o f entering into Vero cells with 
a similar efficiency given time to wild-type KOS virus. It could therefore be
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hypothesized that other viral receptors on Vero cells facilitate entry into these cells. 
In this regard, the receptors would have to function to a greater degree than those of 
the identified human receptors, because these receptors could only partially 
facilitate AgK entry. Therefore, the identification o f other simian receptors for virus 
entry, and in particular for AgK virus entry is warranted.
Utilizing reagents generated to investigate domains o f gK involved in egress, 
it would also be beneficial if  the domains o f gK were resolved for virus entry. This 
may aid in the understanding o f how gK functions in receptor utilization by 
identifying domains o f gK that participate in this process. This is not however a 
guarantee that gK is directly involved, just as the determination that gK is a 
structural component o f infectious virions does not directly associate its function 
with the observed differences in virus entry. Therefore, the structural composition of 
these viruses must be identified further.
It is readily apparent that these virions are quite different from their wild- 
type counter-parts simply by looking at their sedimentation in sucrose gradients. In 
these assays it will be important to determine: 1) the degree o f glycosylation o f 
these virions; 2) the relative amounts o f glycoproteins between these virions; 3) the 
particle to plaque forming unit ratio.
HSV-1 gK and virus egress: The determination that cellular transport 
motifs are contained within gK and that modification o f these motifs altered 
infectious virus production and virion egress in a manner as deleterious as deleting 
the protein in its entirety, may be the single most important finding o f this research. 
Cellular proteins that are known to interact with these motifs and facilitate transport
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have been identified and are well characterized. It only remains to be resolved 
whether or not these proteins in fact do interact with this transport motif.
If  indeed there is interactions between the transport m otif and cellular 
adapter proteins, it then remains to be resolved are the proteins only effecting the 
transport o f the protein itself to cell surfaces or are they also functioning to traffic 
virus within vesicles to cell surfaces. These two processes are not easily 
dissociated; however, with the emergence o f cell-lines defective in particular 
transport pathways and with better imaging techniques and immunological reagents, 
these pathways may soon be resolved.
The determination o f the trafficking and recycling o f gK from cell surfaces 
is critical in these studies. Immunological and viral reagents developed during this 
study can determine the effect on transport o f mutation o f the transport motif. 
Increasing this understanding may also aid in our understanding o f the role o f gK in 
virus induced cell-to-cell fusion.
S tructural characterization o f HSV-1 gK: It is not often that a protein’s 
function is characterized prior to any significant information being available as to its 
structure. The phenotypes discussed within this dissertation have all been based on 
alteration o f the Ul53 gene and observation o f the effect in infected cells. While 
this approach was necessary due to the limitations o f immunological reagents, it is 
by far not an ideal situation without similarly characterizing the protein product. 
Questions about the structure o f gK remain to be answered including: 1) To what 
extent is gK processed through glycosylation; 2) Is gK phosphorylated at sites 
adjacent to transport domains; 3) Are their other carbohydrate modifications that
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occur besides N-Iinked glycosylation; 4) Is the topology predictions that are 
presented accurate in the context o f the cell.
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